Organic electroluminescent materials and devices

ABSTRACT

A compound that includes a ligand L, having the formula, 
                         
is provided. In the structure of Formula I, each R 1 , R 2 , R 3 , R 4 , R 4 , R 5 , R 6 , R 7 , and R 8  is independently selected from a variety of substituents; any adjacent substituents are optionally joined or fused into a ring; at least one of R 3 , R 4 , and R 5  is not hydrogen; “a” is an integer from 0 to 10; (i) when a is 0, at least one of R 7 , R 8 , and an R 2  adjacent to ring B, is not hydrogen, and (ii) when a is 1 to 10, at least one of an R 2  adjacent to ring A and an R 6  adjacent to ring C is not hydrogen; ligand L is coordinated to a metal M having an atomic weight greater than 40; and ligand L is optionally linked with other ligands to comprise a tridentate, tetradentate, pentadentate or hexadentate ligand.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a non-provisional of U.S. patent application Ser. No. 62/320,915, filed Apr. 11, 2016, and a non-provisional of U.S. patent application Ser. No. 62/368,518, filed Jul. 29, 2016, the entire contents of which are incorporated herein by reference.

FIELD

The present invention relates to compounds for use as emitters, and devices, such as organic light emitting diodes, including the same.

BACKGROUND

Opto-electronic devices that make use of organic materials are becoming increasingly desirable for a number of reasons. Many of the materials used to make such devices are relatively inexpensive, so organic opto-electronic devices have the potential for cost advantages over inorganic devices. In addition, the inherent properties of organic materials, such as their flexibility, may make them well suited for particular applications such as fabrication on a flexible substrate. Examples of organic opto-electronic devices include organic light emitting diodes/devices (OLEDs), organic phototransistors, organic photovoltaic cells, and organic photodetectors. For OLEDs, the organic materials may have performance advantages over conventional materials. For example, the wavelength at which an organic emissive layer emits light may generally be readily tuned with appropriate dopants.

OLEDs make use of thin organic films that emit light when voltage is applied across the device. OLEDs are becoming an increasingly interesting technology for use in applications such as flat panel displays, illumination, and backlighting. Several OLED materials and configurations are described in U.S. Pat. Nos. 5,844,363, 6,303,238, and 5,707,745, which are incorporated herein by reference in their entirety.

One application for phosphorescent emissive molecules is a full color display. Industry standards for such a display call for pixels adapted to emit particular colors, referred to as “saturated” colors. In particular, these standards call for saturated red, green, and blue pixels. Alternatively the OLED can be designed to emit white light. In conventional liquid crystal displays emission from a white backlight is filtered using absorption filters to produce red, green and blue emission. The same technique can also be used with OLEDs. The white OLED can be either a single EML device or a stack structure. Color may be measured using CIE coordinates, which are well known to the art.

One example of a green emissive molecule is tris(2-phenylpyridine) iridium, denoted Ir(ppy)₃, which has the following structure:

In this, and later figures herein, we depict the dative bond from nitrogen to metal (here, Ir) as a straight line.

As used herein, the term “organic” includes polymeric materials as well as small molecule organic materials that may be used to fabricate organic opto-electronic devices. “Small molecule” refers to any organic material that is not a polymer, and “small molecules” may actually be quite large. Small molecules may include repeat units in some circumstances. For example, using a long chain alkyl group as a substituent does not remove a molecule from the “small molecule” class. Small molecules may also be incorporated into polymers, for example as a pendent group on a polymer backbone or as a part of the backbone. Small molecules may also serve as the core moiety of a dendrimer, which consists of a series of chemical shells built on the core moiety. The core moiety of a dendrimer may be a fluorescent or phosphorescent small molecule emitter. A dendrimer may be a “small molecule,” and it is believed that all dendrimers currently used in the field of OLEDs are small molecules.

As used herein, “top” means furthest away from the substrate, while “bottom” means closest to the substrate. Where a first layer is described as “disposed over” a second layer, the first layer is disposed further away from substrate. There may be other layers between the first and second layer, unless it is specified that the first layer is “in contact with” the second layer. For example, a cathode may be described as “disposed over” an anode, even though there are various organic layers in between.

As used herein, “solution processible” means capable of being dissolved, dispersed, or transported in and/or deposited from a liquid medium, either in solution or suspension form.

A ligand may be referred to as “photoactive” when it is believed that the ligand directly contributes to the photoactive properties of an emissive material. A ligand may be referred to as “ancillary” when it is believed that the ligand does not contribute to the photoactive properties of an emissive material, although an ancillary ligand may alter the properties of a photoactive ligand.

As used herein, and as would be generally understood by one skilled in the art, a first “Highest Occupied Molecular Orbital” (HOMO) or “Lowest Unoccupied Molecular Orbital” (LUMO) energy level is “greater than” or “higher than” a second HOMO or LUMO energy level if the first energy level is closer to the vacuum energy level. Since ionization potentials (IP) are measured as a negative energy relative to a vacuum level, a higher HOMO energy level corresponds to an IP having a smaller absolute value (an IP that is less negative). Similarly, a higher LUMO energy level corresponds to an electron affinity (EA) having a smaller absolute value (an EA that is less negative). On a conventional energy level diagram, with the vacuum level at the top, the LUMO energy level of a material is higher than the HOMO energy level of the same material. A “higher” HOMO or LUMO energy level appears closer to the top of such a diagram than a “lower” HOMO or LUMO energy level.

As used herein, and as would be generally understood by one skilled in the art, a first work function is “greater than” or “higher than” a second work function if the first work function has a higher absolute value. Because work functions are generally measured as negative numbers relative to vacuum level, this means that a “higher” work function is more negative. On a conventional energy level diagram, with the vacuum level at the top, a “higher” work function is illustrated as further away from the vacuum level in the downward direction. Thus, the definitions of HOMO and LUMO energy levels follow a different convention than work functions.

More details on OLEDs, and the definitions described above, can be found in U.S. Pat. No. 7,279,704, which is incorporated herein by reference in its entirety.

SUMMARY

According to an embodiment, a compound is provided that includes a ligand L, having the formula,

In the structure of Formula I:

R¹ and R⁶ represent mono, di, tri, or tetra substitution, or no substitution;

R² represents mono, di, or tri substitution, or no substitution;

each R¹, R², R³, R⁴, R⁴, R⁵, R⁶, R⁷, and R⁸ is independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof;

any adjacent substituents of R¹ R², R³, R⁴, R⁵, R⁶, R⁷, and R⁸ are optionally joined or fused into a ring;

at least one of R³, R⁴, and R⁵ is not hydrogen;

a is an integer from 0 to 10;

(i) when a is 0, at least one of R⁷, R⁸, and an R² adjacent to ring B, is not hydrogen, and (ii) when a is 1 to 10, at least one of an R² adjacent to ring A and an R⁶ adjacent to ring C is not hydrogen;

the ligand L is coordinated to a metal M having an atomic weight greater than 40; and

the ligand L is optionally linked with other ligands to comprise a tridentate, tetradentate, pentadentate or hexadentate ligand.

According to another embodiment, an organic light emitting diode/device (OLED) is also provided. The OLED can include an anode, a cathode, and an organic layer, disposed between the anode and the cathode. The organic layer can include a compound that includes a ligand L, having the formula,

According to yet another embodiment, the organic light emitting device is incorporated into one or more device selected from a consumer product, an electronic component module, and/or a lighting panel.

According to yet another embodiment, a formulation containing a compound including a ligand L, having the formula,

is provided.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 shows an organic light emitting device.

FIG. 2 shows an inverted organic light emitting device that does not have a separate electron transport layer.

DETAILED DESCRIPTION

Generally, an OLED comprises at least one organic layer disposed between and electrically connected to an anode and a cathode. When a current is applied, the anode injects holes and the cathode injects electrons into the organic layer(s). The injected holes and electrons each migrate toward the oppositely charged electrode. When an electron and hole localize on the same molecule, an “exciton,” which is a localized electron-hole pair having an excited energy state, is formed. Light is emitted when the exciton relaxes via a photoemissive mechanism. In some cases, the exciton may be localized on an excimer or an exciplex. Non-radiative mechanisms, such as thermal relaxation, may also occur, but are generally considered undesirable.

The initial OLEDs used emissive molecules that emitted light from their singlet states (“fluorescence”) as disclosed, for example, in U.S. Pat. No. 4,769,292, which is incorporated by reference in its entirety. Fluorescent emission generally occurs in a time frame of less than 10 nanoseconds.

More recently, OLEDs having emissive materials that emit light from triplet states (“phosphorescence”) have been demonstrated. Baldo et al., “Highly Efficient Phosphorescent Emission from Organic Electroluminescent Devices,” Nature, vol. 395, 151-154, 1998; (“Baldo-I”) and Baldo et al., “Very high-efficiency green organic light-emitting devices based on electrophosphorescence,” Appl. Phys. Lett., vol. 75, No. 3, 4-6 (1999) (“Baldo-II”), are incorporated by reference in their entireties. Phosphorescence is described in more detail in U.S. Pat. No. 7,279,704 at cols. 5-6, which are incorporated by reference.

FIG. 1 shows an organic light emitting device 100. The figures are not necessarily drawn to scale. Device 100 may include a substrate 110, an anode 115, a hole injection layer 120, a hole transport layer 125, an electron blocking layer 130, an emissive layer 135, a hole blocking layer 140, an electron transport layer 145, an electron injection layer 150, a protective layer 155, a cathode 160, and a barrier layer 170. Cathode 160 is a compound cathode having a first conductive layer 162 and a second conductive layer 164. Device 100 may be fabricated by depositing the layers described, in order. The properties and functions of these various layers, as well as example materials, are described in more detail in U.S. Pat. No. 7,279,704 at cols. 6-10, which are incorporated by reference.

More examples for each of these layers are available. For example, a flexible and transparent substrate-anode combination is disclosed in U.S. Pat. No. 5,844,363, which is incorporated by reference in its entirety. An example of a p-doped hole transport layer is m-MTDATA doped with F₄-TCNQ at a molar ratio of 50:1, as disclosed in U.S. Patent Application Publication No. 2003/0230980, which is incorporated by reference in its entirety. Examples of emissive and host materials are disclosed in U.S. Pat. No. 6,303,238 to Thompson et al., which is incorporated by reference in its entirety. An example of an n-doped electron transport layer is BPhen doped with Li at a molar ratio of 1:1, as disclosed in U.S. Patent Application Publication No. 2003/0230980, which is incorporated by reference in its entirety. U.S. Pat. Nos. 5,703,436 and 5,707,745, which are incorporated by reference in their entireties, disclose examples of cathodes including compound cathodes having a thin layer of metal such as Mg:Ag with an overlying transparent, electrically-conductive, sputter-deposited ITO layer. The theory and use of blocking layers is described in more detail in U.S. Pat. No. 6,097,147 and U.S. Patent Application Publication No. 2003/0230980, which are incorporated by reference in their entireties. Examples of injection layers are provided in U.S. Patent Application Publication No. 2004/0174116, which is incorporated by reference in its entirety. A description of protective layers may be found in U.S. Patent Application Publication No. 2004/0174116, which is incorporated by reference in its entirety.

FIG. 2 shows an inverted OLED 200. The device includes a substrate 210, a cathode 215, an emissive layer 220, a hole transport layer 225, and an anode 230. Device 200 may be fabricated by depositing the layers described, in order. Because the most common OLED configuration has a cathode disposed over the anode, and device 200 has cathode 215 disposed under anode 230, device 200 may be referred to as an “inverted” OLED. Materials similar to those described with respect to device 100 may be used in the corresponding layers of device 200. FIG. 2 provides one example of how some layers may be omitted from the structure of device 100.

The simple layered structure illustrated in FIGS. 1 and 2 is provided by way of non-limiting example, and it is understood that embodiments of the invention may be used in connection with a wide variety of other structures. The specific materials and structures described are exemplary in nature, and other materials and structures may be used. Functional OLEDs may be achieved by combining the various layers described in different ways, or layers may be omitted entirely, based on design, performance, and cost factors. Other layers not specifically described may also be included. Materials other than those specifically described may be used. Although many of the examples provided herein describe various layers as comprising a single material, it is understood that combinations of materials, such as a mixture of host and dopant, or more generally a mixture, may be used. Also, the layers may have various sublayers. The names given to the various layers herein are not intended to be strictly limiting. For example, in device 200, hole transport layer 225 transports holes and injects holes into emissive layer 220, and may be described as a hole transport layer or a hole injection layer. In one embodiment, an OLED may be described as having an “organic layer” disposed between a cathode and an anode. This organic layer may comprise a single layer, or may further comprise multiple layers of different organic materials as described, for example, with respect to FIGS. 1 and 2.

Structures and materials not specifically described may also be used, such as OLEDs comprised of polymeric materials (PLEDs) such as disclosed in U.S. Pat. No. 5,247,190 to Friend et al., which is incorporated by reference in its entirety. By way of further example, OLEDs having a single organic layer may be used. OLEDs may be stacked, for example as described in U.S. Pat. No. 5,707,745 to Forrest et al, which is incorporated by reference in its entirety. The OLED structure may deviate from the simple layered structure illustrated in FIGS. 1 and 2. For example, the substrate may include an angled reflective surface to improve out-coupling, such as a mesa structure as described in U.S. Pat. No. 6,091,195 to Forrest et al., and/or a pit structure as described in U.S. Pat. No. 5,834,893 to Bulovic et al., which are incorporated by reference in their entireties.

Unless otherwise specified, any of the layers of the various embodiments may be deposited by any suitable method. For the organic layers, preferred methods include thermal evaporation, ink-jet, such as described in U.S. Pat. Nos. 6,013,982 and 6,087,196, which are incorporated by reference in their entireties, organic vapor phase deposition (OVPD), such as described in U.S. Pat. No. 6,337,102 to Forrest et al., which is incorporated by reference in its entirety, and deposition by organic vapor jet printing (OVJP), such as described in U.S. Pat. No. 7,431,968, which is incorporated by reference in its entirety. Other suitable deposition methods include spin coating and other solution based processes. Solution based processes are preferably carried out in nitrogen or an inert atmosphere. For the other layers, preferred methods include thermal evaporation. Preferred patterning methods include deposition through a mask, cold welding such as described in U.S. Pat. Nos. 6,294,398 and 6,468,819, which are incorporated by reference in their entireties, and patterning associated with some of the deposition methods such as ink-jet and OVJD. Other methods may also be used. The materials to be deposited may be modified to make them compatible with a particular deposition method. For example, substituents such as alkyl and aryl groups, branched or unbranched, and preferably containing at least 3 carbons, may be used in small molecules to enhance their ability to undergo solution processing. Substituents having 20 carbons or more may be used, and 3-20 carbons is a preferred range. Materials with asymmetric structures may have better solution processability than those having symmetric structures, because asymmetric materials may have a lower tendency to recrystallize. Dendrimer substituents may be used to enhance the ability of small molecules to undergo solution processing.

Devices fabricated in accordance with embodiments of the present invention may further optionally comprise a barrier layer. One purpose of the barrier layer is to protect the electrodes and organic layers from damaging exposure to harmful species in the environment including moisture, vapor and/or gases, etc. The barrier layer may be deposited over, under or next to a substrate, an electrode, or over any other parts of a device including an edge. The barrier layer may comprise a single layer, or multiple layers. The barrier layer may be formed by various known chemical vapor deposition techniques and may include compositions having a single phase as well as compositions having multiple phases. Any suitable material or combination of materials may be used for the barrier layer. The barrier layer may incorporate an inorganic or an organic compound or both. The preferred barrier layer comprises a mixture of a polymeric material and a non-polymeric material as described in U.S. Pat. No. 7,968,146, PCT Pat. Application Nos. PCT/US2007/023098 and PCT/US2009/042829, which are herein incorporated by reference in their entireties. To be considered a “mixture”, the aforesaid polymeric and non-polymeric materials comprising the barrier layer should be deposited under the same reaction conditions and/or at the same time. The weight ratio of polymeric to non-polymeric material may be in the range of 95:5 to 5:95. The polymeric material and the non-polymeric material may be created from the same precursor material. In one example, the mixture of a polymeric material and a non-polymeric material consists essentially of polymeric silicon and inorganic silicon.

Devices fabricated in accordance with embodiments of the invention can be incorporated into a wide variety of electronic component modules (or units) that can be incorporated into a variety of electronic products or intermediate components. Examples of such electronic products or intermediate components include display screens, lighting devices such as discrete light source devices or lighting panels, etc. that can be utilized by the end-user product manufacturers. Such electronic component modules can optionally include the driving electronics and/or power source(s). Devices fabricated in accordance with embodiments of the invention can be incorporated into a wide variety of consumer products that have one or more of the electronic component modules (or units) incorporated therein. Such consumer products would include any kind of products that include one or more light source(s) and/or one or more of some type of visual displays. Some examples of such consumer products include flat panel displays, computer monitors, medical monitors, televisions, billboards, lights for interior or exterior illumination and/or signaling, heads-up displays, fully or partially transparent displays, flexible displays, laser printers, telephones, mobile phones, tablets, phablets, personal digital assistants (PDAs), wearable devices, laptop computers, digital cameras, camcorders, viewfinders, micro-displays (displays that are less than 2 inches diagonal), 3-D displays, virtual reality or augmented reality displays, vehicles, video walls comprising multiple displays tiled together, theater or stadium screen, and a sign. Various control mechanisms may be used to control devices fabricated in accordance with the present invention, including passive matrix and active matrix. Many of the devices are intended for use in a temperature range comfortable to humans, such as 18 degrees C. to 30 degrees C., and more preferably at room temperature (20-25 degrees C.), but could be used outside this temperature range, for example, from −40 degree C. to +80 degree C.

The materials and structures described herein may have applications in devices other than OLEDs. For example, other optoelectronic devices such as organic solar cells and organic photodetectors may employ the materials and structures. More generally, organic devices, such as organic transistors, may employ the materials and structures.

The term “halo,” “halogen,” or “halide” as used herein includes fluorine, chlorine, bromine, and iodine.

The term “alkyl” as used herein contemplates both straight and branched chain alkyl radicals. Preferred alkyl groups are those containing from one to fifteen carbon atoms and includes methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 2,2-dimethylpropyl, and the like. Additionally, the alkyl group may be optionally substituted.

The term “cycloalkyl” as used herein contemplates cyclic alkyl radicals. Preferred cycloalkyl groups are those containing 3 to 10 ring carbon atoms and includes cyclopropyl, cyclopentyl, cyclohexyl, adamantyl, and the like. Additionally, the cycloalkyl group may be optionally substituted.

The term “alkenyl” as used herein contemplates both straight and branched chain alkene radicals. Preferred alkenyl groups are those containing two to fifteen carbon atoms. Additionally, the alkenyl group may be optionally substituted.

The term “alkynyl” as used herein contemplates both straight and branched chain alkyne radicals. Preferred alkynyl groups are those containing two to fifteen carbon atoms. Additionally, the alkynyl group may be optionally substituted.

The terms “aralkyl” or “arylalkyl” as used herein are used interchangeably and contemplate an alkyl group that has as a substituent an aromatic group. Additionally, the aralkyl group may be optionally substituted.

The term “heterocyclic group” as used herein contemplates aromatic and non-aromatic cyclic radicals. Hetero-aromatic cyclic radicals also means heteroaryl. Preferred hetero-non-aromatic cyclic groups are those containing 3 to 7 ring atoms which includes at least one hetero atom, and includes cyclic amines such as morpholino, piperidino, pyrrolidino, and the like, and cyclic ethers, such as tetrahydrofuran, tetrahydropyran, and the like. Additionally, the heterocyclic group may be optionally substituted.

The term “aryl” or “aromatic group” as used herein contemplates single-ring groups and polycyclic ring systems. The polycyclic rings may have two or more rings in which two carbons are common to two adjoining rings (the rings are “fused”) wherein at least one of the rings is aromatic, e.g., the other rings can be cycloalkyls, cycloalkenyls, aryl, heterocycles, and/or heteroaryls. Preferred aryl groups are those containing six to thirty carbon atoms, preferably six to twenty carbon atoms, more preferably six to twelve carbon atoms. Especially preferred is an aryl group having six carbons, ten carbons or twelve carbons. Suitable aryl groups include phenyl, biphenyl, triphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene, preferably phenyl, biphenyl, triphenyl, triphenylene, fluorene, and naphthalene. Additionally, the aryl group may be optionally substituted.

The term “heteroaryl” as used herein contemplates single-ring hetero-aromatic groups that may include from one to five heteroatoms. The term heteroaryl also includes polycyclic hetero-aromatic systems having two or more rings in which two atoms are common to two adjoining rings (the rings are “fused”) wherein at least one of the rings is a heteroaryl, e.g., the other rings can be cycloalkyls, cycloalkenyls, aryl, heterocycles, and/or heteroaryls. Preferred heteroaryl groups are those containing three to thirty carbon atoms, preferably three to twenty carbon atoms, more preferably three to twelve carbon atoms. Suitable heteroaryl groups include dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine, preferably dibenzothiophene, dibenzofuran, dibenzoselenophene, carbazole, indolocarbazole, imidazole, pyridine, triazine, benzimidazole, 1,2-azaborine, 1,3-azaborine, 1,4-azaborine, borazine, and aza-analogs thereof. Additionally, the heteroaryl group may be optionally substituted.

The alkyl, cycloalkyl, alkenyl, alkynyl, aralkyl, heterocyclic group, aryl, and heteroaryl may be unsubstituted or may be substituted with one or more substituents selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, cyclic amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.

As used herein, “substituted” indicates that a substituent other than H is bonded to the relevant position, such as carbon. Thus, for example, where R¹ is mono-substituted, then one R¹ must be other than H. Similarly, where R¹ is di-substituted, then two of R¹ must be other than H. Similarly, where R¹ is unsubstituted, R¹ is hydrogen for all available positions.

The “aza” designation in the fragments described herein, i.e. aza-dibenzofuran, aza-dibenzothiophene, etc. means that one or more of the C—H groups in the respective fragment can be replaced by a nitrogen atom, for example, and without any limitation, azatriphenylene encompasses both dibenzo[f,h]quinoxaline and dibenzo[f,h]quinoline. One of ordinary skill in the art can readily envision other nitrogen analogs of the aza-derivatives described above, and all such analogs are intended to be encompassed by the terms as set forth herein.

It is to be understood that when a molecular fragment is described as being a substituent or otherwise attached to another moiety, its name may be written as if it were a fragment (e.g. phenyl, phenylene, naphthyl, dibenzofuryl) or as if it were the whole molecule (e.g. benzene, naphthalene, dibenzofuran). As used herein, these different ways of designating a substituent or attached fragment are considered to be equivalent.

According to one embodiment, a compound comprising a ligand L, having the formula,

is described. In the structure of Formula I:

R¹ and R⁶ represent mono, di, tri, or tetra substitution, or no substitution;

R² represents mono, di, or tri substitution, or no substitution;

each R¹, R², R³, R⁴, R⁴, R⁵, R⁶, R⁷, and R⁸ is independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof;

any adjacent substituents of R′ R², R³, R⁴, R⁵, R⁶, R⁷, and R⁸ are optionally joined or fused into a ring;

at least one of R³, R⁴, and R⁵ is not hydrogen;

a is an integer from 0 to 10;

(i) when a is 0, at least one of R⁷, R⁸, and an R² adjacent to ring B, is not hydrogen, and (ii) when a is 1 to 10, at least one of an R² adjacent to ring A and an R⁶ adjacent to ring C is not hydrogen;

the ligand L is coordinated to a metal M having an atomic weight greater than 40; and

the ligand L is optionally linked with other ligands to comprise a tridentate, tetradentate, pentadentate or hexadentate ligand.

In some embodiments, ring A is bonded to ring C at a position para to the N of ring C. In some embodiments, ring A is bonded to ring C as a position meta to the N of ring C. In some embodiments, ring B is bonded to ring C at a position para to the N of ring C or ring B is bonded to the adjacent ring A at a position para to ring C or an adjacent ring A. In some embodiments, ring B is bonded to ring C at a position meta to the N of ring C or ring B is bonded to the adjacent ring A at a position meta to ring C or an adjacent ring A.

In some embodiments, M is selected from the group consisting of Ir, Rh, Re, Ru, Os, Pt, Au, and Cu. In some embodiments, M is Ir or Pt.

In some embodiments, the compound is homoleptic. In other embodiments, the compound is heteroleptic.

In some embodiments, (i) when a is 0, at least one of R⁷, R⁸, and an R² adjacent to ring B, is selected from the group consisting of alkyl, cycloalkyl, partially or fully deuterated variants thereof, and combinations thereof, and (ii) when a is 1 to 10, at least one R² adjacent to ring A and an R⁶ adjacent to ring C is selected from the group consisting of alkyl, cycloalkyl, partially or fully deuterated variants thereof, and combinations thereof.

In some embodiments, at least one of R³, R⁴, and R⁵ is selected from the group consisting of alkyl, cycloalkyl, fluorine, partially or fully deuterated variants thereof, and combinations thereof.

In some embodiments, R¹ is hydrogen.

In some embodiments, (i) when a is 0, at least one R² adjacent to ring B is not hydrogen, and at least one of R⁷ and R⁸ is not hydrogen, and (ii) when a is 1 to 10, at least at one R² adjacent to ring A is not hydrogen, and at least one R⁶ adjacent to ring C is not hydrogen.

In some embodiments, when a is 1 to 10, R⁷ and R⁸ are hydrogen. In some embodiments, a is 2 to 10.

In some embodiments, ligand L is selected from the group consisting of:

In some embodiments, ligand L is selected from the group consisting of L^(A1) to L^(A1432), L^(B1) to L^(B1432), L^(C1) to L^(C1432), L^(D1) to L^(D1432) as defined in the following table based on the structures of

i in L^(Ai), L^(Bi), L^(Ci), L^(Di) R² R³ R⁴ R⁵ R⁷ or R⁶¹ R⁸ or R⁶² 1. CH₃ H CH₃ H H CH₃ 2. CH₃ H CH₂CH₃ H H CH₃ 3. CH₃ H CH(CH₃)₂ H H CH₃ 4. CH₃ H CH₂CH(CH₃)₂ H H CH₃ 5. CH₃ H C(CH₃)₃ H H CH₃ 6. CH₃ H CH₂C(CH₃)₃ H H CH₃ 7. CH₃ H CH₂CH₂CF₃ H H CH₃ 8. CH₃ H CH₂CCF₃(CH₃)₂ H H CH₃ 9. CH₃ H

H H CH₃ 10. CH₃ H

H H CH₃ 11. CH₃ H

H H CH₃ 12. CH₃ H

H H CH₃ 13. CH₃ H

H H CH₃ 14. CH₃ H

H H CH₃ 15. CH₃ H

H H CH₃ 16. CH₃ H

H H CH₃ 17. CH₃ H

H H CH₃ 18. CH₃ H

H H CH₃ 19. CH₃ H

H H CH₃ 20. CH₃ H

H H CH₃ 21. CH₃ H

H H CH₃ 22. CH₃ H

H H CH₃ 23. CH₃ H

H H CH₃ 24. CH₃ H

H H CH₃ 25. CH₃ H

H H CH₃ 26. CH₃ H

H H CH₃ 27. CH₃ H CH₃ H CH₃ CH₃ 28. CH₃ H CH₂CH₃ H CH₃ CH₃ 29. CH₃ H CH(CH₃)₂ H CH₃ CH₃ 30. CH₃ H CH₂CH(CH₃)₂ H CH₃ CH₃ 31. CH₃ H C(CH₃)₃ H CH₃ CH₃ 32. CH₃ H CH₂C(CH₃)₃ H CH₃ CH₃ 33. CH₃ H CH₂CH₂CF₃ H CH₃ CH₃ 34. CH₃ H CH₂CCF₃(CH₃)₂ H CH₃ CH₃ 35. CH₃ H

H CH₃ CH₃ 36. CH₃ H

H CH₃ CH₃ 37. CH₃ H

H CH₃ CH₃ 38. CH₃ H

H CH₃ CH₃ 39. CH₃ H

H CH₃ CH₃ 40. CH₃ H

H CH₃ CH₃ 41. CH₃ H

H CH₃ CH₃ 42. CH₃ H

H CH₃ CH₃ 43. CH₃ H

H CH₃ CH₃ 44. CH₃ H

H CH₃ CH₃ 45. CH₃ H

H CH₃ CH₃ 46. CH₃ H

H CH₃ CH₃ 47. CH₃ H

H CH₃ CH₃ 48. CH₃ H

H CH₃ CH₃ 49. CH₃ H

H CH₃ CH₃ 50. CH₃ H

H CH₃ CH₃ 51. CH₃ H

H CH₃ CH₃ 52. CH₃ H

H CH₃ CH₃ 53. H H CH₃ H H CH₃ 54. H H CH₂CH₃ H H CH₃ 55. CH(CH₃)₂ H H CH₃ 56. H H CH₂CH(CH₃)₂ H H CH₃ 57. H H C(CH₃)₃ H H CH₃ 58. H H CH₂C(CH₃)₃ H H CH₃ 59. H H CH₂CH₂CF₃ H H CH₃ 60. H H CH₂CCF₃(CH₃)₂ H H CH₃ 61. H H

H H CH₃ 62. H H

H H CH₃ 63. H H

H H CH₃ 64. H H

H H CH₃ 65. H H

H H CH₃ 66. H H

H H CH₃ 67. H H

H H CH₃ 68. H H

H H CH₃ 69. H H

H H CH₃ 70. H H

H H CH₃ 71. H H

H H CH₃ 72. H H

H H CH₃ 73. H H

H H CH₃ 74. H H

H H CH₃ 75. H H

H H CH₃ 76. H H

H H CH₃ 77. H H

H H CH₃ 78. H H

H H CH₃ 79. H H CH₃ H CH₃ CH₃ 80. H H CH₂CH₃ H CH₃ CH₃ 81. H H CH(CH₃)₂ H CH₃ CH₃ 82. H H CH₂CH(CH₃)₂ H CH₃ CH₃ 83. H H C(CH₃)₃ H CH₃ CH₃ 84. H H CH₂C(CH₃)₃ H CH₃ CH₃ 85. H H CH₂CH₂CF₃ H CH₃ CH₃ 86. H H CH₂CCF₃(CH₃)₂ H CH₃ CH₃ 87. H H

H CH₃ CH₃ 88. H H

H CH₃ CH₃ 89. H H

H CH₃ CH₃ 90. H H

H CH₃ CH₃ 91. H H

H CH₃ CH₃ 92. H H

H CH₃ CH₃ 93. H H

H CH₃ CH₃ 94. H H

H CH₃ CH₃ 95. H H

H CH₃ CH₃ 96. H H

H CH₃ CH₃ 97. H H

H CH₃ CH₃ 98. H H

H CH₃ CH₃ 99. H H

H CH₃ CH₃ 100. H H

H CH₃ CH₃ 101. H H

H CH₃ CH₃ 102. H H

H CH₃ CH₃ 103. H H

H CH₃ CH₃ 104. H H

H CH₃ CH₃ 105. CH₃ H CH₃ CH₃ H CH₃ 106. CH₃ H CH₂CH₃ CH₃ H CH₃ 107. CH₃ H CH(CH₃)₂ CH₃ H CH₃ 108. CH₃ H CH₂CH(CH₃)₂ CH₃ H CH₃ 109. CH₃ H C(CH₃)₃ CH₃ H CH₃ 110. CH₃ H CH₂C(CH₃)₃ CH₃ H CH₃ 111. CH₃ H CH₂CH₂CF₃ CH₃ H CH₃ 112. CH₃ H CH₂CCF₃(CH₃)₂ CH₃ H CH₃ 113. CH₃ H

CH₃ H CH₃ 114. CH₃ H

CH₃ H CH₃ 115. CH₃ H

CH₃ H CH₃ 116. CH₃ H

CH₃ H CH₃ 117. CH₃ H

CH₃ H CH₃ 118. CH₃ H

CH₃ H CH₃ 119. CH₃ H

CH₃ H CH₃ 120. CH₃ H

CH₃ H CH₃ 121. CH₃ H

CH₃ H CH₃ 122. CH₃ H

CH₃ H CH₃ 123. CH₃ H

CH₃ H CH₃ 124. CH₃ H

CH₃ H CH₃ 125. CH₃ H

CH₃ H CH₃ 126. CH₃ H

CH₃ H CH₃ 127. CH₃ H

CH₃ H CH₃ 128. CH₃ H

CH₃ H CH₃ 129. CH₃ H

CH₃ H CH₃ 130. CH₃ H

CH₃ H CH₃ 131. CH₃ CH₃ CH₃ CH₃ H CH₃ 132. CH₃ CH₃ CH₂CH₃ CH₃ H CH₃ 133. CH₃ CH₃ CH(CH₃)₂ CH₃ H CH₃ 134. CH₃ CH₃ CH₂CH(CH₃)₂ CH₃ H CH₃ 135. CH₃ CH₃ C(CH₃)₃ CH₃ H CH₃ 136. CH₃ CH₃ CH₂C(CH₃)₃ CH₃ H CH₃ 137. CH₃ CH₃ CH₂CH₂CF₃ CH₃ H CH₃ 138. CH₃ CH₃ CH₂CCF₃(CH₃)₂ CH₃ H CH₃ 139. CH₃ CH₃

CH₃ H CH₃ 140. CH₃ CH₃

CH₃ H CH₃ 141. CH₃ CH₃

CH₃ H CH₃ 142. CH₃ CH₃

CH₃ H CH₃ 143. CH₃ CH₃

CH₃ H CH₃ 144. CH₃ CH₃

CH₃ H CH₃ 145. CH₃ CH₃

CH₃ H CH₃ 146. CH₃ CH₃

CH₃ H CH₃ 147. CH₃ CH₃

CH₃ H CH₃ 148. CH₃ CH₃

CH₃ H CH₃ 149. CH₃ CH₃

CH₃ H CH₃ 150. CH₃ CH₃

CH₃ H CH₃ 151. CH₃ CH₃

CH₃ H CH₃ 152. CH₃ CH₃

CH₃ H CH₃ 153. CH₃ CH₃

CH₃ H CH₃ 154. CH₃ CH₃

CH₃ H CH₃ 155. CH₃ CH₃

CH₃ H CH₃ 156. CH₃ CH₃

CH₃ H CH₃ 157. CH₃ CH₃

CH₃ H CH₃ 158. CH₃ CH₃

CH₃ H CH₃ 159. CD₃ H CD₃ H H CD₃ 160. CD₃ H CD₃CD₃ H H CD₃ 161. CD₃ H CD₂CH₃ H H CD₃ 162. CD₃ H CD(CD₃)₂ H H CD₃ 163. CD₃ H CD(CH₃)₂ H H CD₃ 164. CD₃ H CD₂CD(CD₃)₂ H H CD₃ 165. CD₃ H CD₂CH(CH₃)₂ H H CD₃ 166. CD₃ H CD₂C(CD₃)₃ H H CD₃ 167. CD₃ H CD₂C(CH₃)₃ H H CD₃ 168. CD₃ H CD₂CD₂CF₃ H H CD₃ 169. CD₃ H CD₂CH₂CF₃ H H CD₃ 170. CD₃ H CD₂CCF₃(CH₃)₂ H H CD₃ 171. CD₃ H

H H CD₃ 172. CD₃ H

H H CD₃ 173. CD₃ H

H H CD₃ 174. CD₃ H

H H CD₃ 175. CD₃ H

H H CD₃ 176. CD₃ H

H H CD₃ 177. CD₃ H

H H CD₃ 178. CD₃ H

H H CD₃ 179. CD₃ H

H H CD₃ 180. CD₃ H

H H CD₃ 181. CD₃ H

H H CD₃ 182. CD₃ H

H H CD₃ 183. CD₃ H

H H CD₃ 184. CD₃ H

H H CD₃ 185. CD₃ H

H H CD₃ 186. CD₃ H

H H CD₃ 187. CD₃ H

H H CD₃ 188. CD₃ H

H H CD₃ 189. CD₃ H

H H CD₃ 190. CD₃ H

H H CD₃ 191. CD₃ H CD₃ H CD₃ CD₃ 192. CD₃ H CD₂CD₃ H CD₃ CD₃ 193. CD₃ H CD₂CH₃ H CD₃ CD₃ 194. CD₃ H CD(CD₃)₂ H CD₃ CD₃ 195. CD₃ H CD(CH₃)₂ H CD₃ CD₃ 196. CD₃ H CD₂CD(CD₃)₂ H CD₃ CD₃ 197. CD₃ H CD₂CH(CH₃)₂ H CD₃ CD₃ 198. CD₃ H CD₂C(CD₃)₃ H CD₃ CD₃ 199. CD₃ H CD₂C(CH₃)₃ H CD₃ CD₃ 200. CD₃ H CD₂CD₂CF₃ H CD₃ CD₃ 201. CD₃ H CD₂CH₂CF₃ H CD₃ CD₃ 202. CD₃ H CD₂CCF₃(CH₃)₂ H CD₃ CD₃ 203. CD₃ H

H CD₃ CD₃ 204. CD₃ H

H CD₃ CD₃ 205. CD₃ H

H CD₃ CD₃ 206. CD₃ H

H CD₃ CD₃ 207. CD₃ H

H CD₃ CD₃ 208. CD₃ H

H CD₃ CD₃ 209. CD₃ H

H CD₃ CD₃ 210. CD₃ H

H CD₃ CD₃ 211. CD₃ H

H CD₃ CD₃ 212. CD₃ H

H CD₃ CD₃ 213. CD₃ H

H CD₃ CD₃ 214. CD₃ H

H CD₃ CD₃ 215. CD₃ H

H CD₃ CD₃ 216. CD₃ H

H CD₃ CD₃ 217. CD₃ H

H CD₃ CD₃ 218. CD₃ H

H CD₃ CD₃ 219. CD₃ H

H CD₃ CD₃ 220. CD₃ H

H CD₃ CD₃ 221. CD₃ H

H CD₃ CD₃ 222. CD₃ H

H CD₃ CD₃ 223. H H CD₃ H H CD₃ 224. H H CD₂CD₃ H H CD₃ 225. H H CD₂CH₃ H H CD₃ 226. H H CD(CD₃)₂ H H CD₃ 227. H H CD(CH₃)₂ H H CD₃ 228. H H CD₂CD(CD₃)₂ H H CD₃ 229. H H CD₂CH(CH₃)₂ H H CD₃ 230. H H CD₂C(CD₃)₃ H H CD₃ 231. H H CD₂C(CH₃)₃ H H CD₃ 232. H H CD₂CD₂CF₃ H H CD₃ 233. H H CD₂CH₂CF₃ H H CD₃ 234. H H CD₂CCF₃(CH₃)₂ H H CD₃ 235. H H

H H CD₃ 236. H H

H H CD₃ 237. H H

H H CD₃ 238. H H

H H CD₃ 239. H H

H H CD₃ 240. H H

H H CD₃ 241. H H

H H CD₃ 242. H H

H H CD₃ 243. H H

H H CD₃ 244. H H

H H CD₃ 245. H H

H H CD₃ 246. H H

H H CD₃ 247. H H

H H CD₃ 248. H H

H H CD₃ 249. H H

H H CD₃ 250. H H

H H CD₃ 251. H H

H H CD₃ 252. H H

H H CD₃ 253. H H

H H CD₃ 254. H H

H H CD₃ 255. H H CD₃ H CD₃ CD₃ 256. H H CD₂CD₃ H CD₃ CD₃ 257. H H CD₂CH₃ H CD₃ CD₃ 258. H H CD(CD₃)₂ H CD₃ CD₃ 259. H H CD(CH₃)₂ H CD₃ CD₃ 260. H H CD₂CD(CD₃)₂ H CD₃ CD₃ 261. H H CD₂CH(CH₃)₂ H CD₃ CD₃ 262. H H CD₂C(CD₃)₃ H CD₃ CD₃ 263. H H CD₂C(CH₃)₃ H CD₃ CD₃ 264. H H CD₂CD₂CF₃ H CD₃ CD₃ 265. H H CD₂CH₂CF₃ H CD₃ CD₃ 266. H H CD₂CCF₃(CH₃)₂ H CD₃ CD₃ 267. H H

H CD₃ CD₃ 268. H H

H CD₃ CD₃ 269. H H

H CD₃ CD₃ 270. H H

H CD₃ CD₃ 271. H H

H CD₃ CD₃ 272. H H

H CD₃ CD₃ 273. H H

H CD₃ CD₃ 274. H H

H CD₃ CD₃ 275. H H

H CD₃ CD₃ 276. H H

H CD₃ CD₃ 277. H H

H CD₃ CD₃ 278. H H

H CD₃ CD₃ 279. H H

H CD₃ CD₃ 280. H H

H CD₃ CD₃ 281. H H

H CD₃ CD₃ 282. H H

H CD₃ CD₃ 283. H H

H CD₃ CD₃ 284. H H

H CD₃ CD₃ 285. H H

H CD₃ CD₃ 286. H H

H CD₃ CD₃ 287. CD₃ H CD₃ CD₃ CD₃ CD₃ 288. CD₃ H CD₂CD₃ CD₃ CD₃ CD₃ 289. CD₃ H CD₂CH₃ CD₃ CD₃ CD₃ 290. CD₃ H CD(CD₃)₂ CD₃ CD₃ CD₃ 291. CD₃ H CD(CH₃)₂ CD₃ CD₃ CD₃ 292. CD₃ H CD₂CD(CD₃)₂ CD₃ CD₃ CD₃ 293. CD₃ H CD₂CH(CH₃)₂ CD₃ CD₃ CD₃ 294. CD₃ H CD₂C(CD₃)₃ CD₃ CD₃ CD₃ 295. CD₃ H CD₂C(CH₃)₃ CD₃ CD₃ CD₃ 296. CD₃ H CD₂CD₂CF₃ CD₃ CD₃ CD₃ 297. CD₃ H CD₂CH₂CF₃ CD₃ CD₃ CD₃ 298. CD₃ H CD₂CCF₃(CH₃)₂ CD₃ CD₃ CD₃ 299. CD₃ H

CD₃ CD₃ CD₃ 300. CD₃ H

CD₃ CD₃ CD₃ 301. CD₃ H

CD₃ CD₃ CD₃ 302. CD₃ H

CD₃ CD₃ CD₃ 303. CD₃ H

CD₃ CD₃ CD₃ 304. CD₃ H

CD₃ CD₃ CD₃ 305. CD₃ H

CD₃ CD₃ CD₃ 306. CD₃ H

CD₃ CD₃ CD₃ 307. CD₃ H

CD₃ CD₃ CD₃ 308. CD₃ H

CD₃ CD₃ CD₃ 309. CD₃ H

CD₃ CD₃ CD₃ 310. CD₃ H

CD₃ CD₃ CD₃ 311. CD₃ H

CD₃ CD₃ CD₃ 312. CD₃ H

CD₃ CD₃ CD₃ 313. CD₃ H

CD₃ CD₃ CD₃ 314. CD₃ H

CD₃ CD₃ CD₃ 315. CD₃ H

CD₃ CD₃ CD₃ 316. CD₃ H

CD₃ CD₃ CD₃ 317. CD₃ H

CD₃ CD₃ CD₃ 318. CD₃ H

CD₃ CD₃ CD₃ 319. CH₃ CH₂CH₃ CH₃ CH₃ H CH₃ 320. CH₃ CH(CH₃)₂ CH₃ CH₃ CH₃ 321. CH₃ CH₂CH(CH₃)₂ CH₃ CH₃ H CH₃ 322. CH₃ C(CH₃)₃ CH₃ CH₃ CH₃ 323. CH₃ CH₂C(CH₃)₃ CH₃ CH₃ H CH₃ 324. CH₃ CH₂CH₂CF₃ CH₃ CH₃ CH₃ 325. CH₃ CH₂CCF₃(CH₃)₂ CH₃ CH₃ H CH₃ 326. CH₃

CH₃ CH₃ CH₃ 327. CH₃

CH₃ CH₃ H CH₃ 328. CH₃

CH₃ CH₃ CH₃ 329. CH₃

CH₃ CH₃ H CH₃ 330. CH₃

CH₃ CH₃ H CH₃ 331. CH₃

CH₃ CH₃ H CH₃ 332. CH₃

CH₃ CH₃ CH₃ 333. CH₃

CH₃ CH₃ H CH₃ 334. CH₃

CH₃ CH₃ CH₃ 335. CH₃

CH₃ CH₃ H CH₃ 336. CH₃

CH₃ CH₃ CH₃ 337. CH₃

CH₃ CH₃ H CH₃ 338. CH₃

CH₃ CH₃ CH₃ 339. CH₃

CH₃ CH₃ H CH₃ 340. CH₃

CH₃ CH₃ CH₃ 341. CH₃

CH₃ CH₃ H CH₃ 342. CH₃

CH₃ CH₃ CH₃ 343. CH₃

CH₃ CH₃ H CH₃ 344. CH₃

CH₃ CH₃ CH₃ 345. CH₃

CH₃ CH₃ H CH₃ 346. CD₃ CD₂CD₃ CD₃ CD₃ H CD₃ 347. CD₃ CD₂CH₃ CD₃ CD₃ CD₃ 348. CD₃ CD(CD₃)₂ CD₃ CD₃ H CD₃ 349. CD₃ CD(CH₃)₂ CD₃ CD₃ CD₃ 350. CD₃ CD₂CD(CD₃)₂ CD₃ CD₃ H CD₃ 351. CD₃ CD₂CH(CH₃)₂ CD₃ CD₃ CD₃ 352. CD₃ CD₂C(CD₃)₃ CD₃ CD₃ H CD₃ 353. CD₃ CD₂C(CH₃)₃ CD₃ CD₃ CD₃ 354. CD₃ CD₂CD₂CF₃ CD₃ CD₃ H CD₃ 355. CD₃ CD₂CH₂CF₃ CD₃ CD₃ CD₃ 356. CD₃ CD₂CCF₃(CH₃)₂ CD₃ CD₃ H CD₃ 357. CD₃

CD₃ CD₃ H CD₃ 358. CD₃

CD₃ CD₃ H CD₃ 359. CD₃

CD₃ CD₃ CD₃ 360. CD₃

CD₃ CD₃ H CD₃ 361. CD₃

CD₃ CD₃ CD₃ 362. CD₃

CD₃ CD₃ H CD₃ 363. CD₃

CD₃ CD₃ CD₃ 364. CD₃

CD₃ CD₃ H CD₃ 365. CD₃

CD₃ CD₃ CD₃ 366. CD₃

CD₃ CD₃ H CD₃ 367. CD₃

CD₃ CD₃ CD₃ 368. CD₃

CD₃ CD₃ H CD₃ 369. CD₃

CD₃ CD₃ CD₃ 370. CD₃

CD₃ CD₃ H CD₃ 371. CD₃

CD₃ CD₃ CD₃ 372. CD₃

CD₃ CD₃ H CD₃ 373. CD₃

CD₃ CD₃ CD₃ 374. CD₃

CD₃ CD₃ H CD₃ 375. CD₃

CD₃ CD₃ CD₃ 376. CD₃

CD₃ CD₃ H CD₃ 377. CD₃ CD₂CD₃ CD₃ CD₃ CD₂CD₃ CD₃ 378. CD₃ CD₂CH₃ CD₃ CD₃ CD₂CD₃ CD₃ 379. CD₃ CD(CD₃)₂ CD₃ CD₃ CD₂CD₃ CD₃ 380. CD₃ CD(CH₃)₂ CD₃ CD₃ CD₂CD₃ CD₃ 381. CD₃ CD₂CD(CD₃)₂ CD₃ CD₃ CD₂CD₃ CD₃ 382. CD₃ CD₂CH(CH₃)₂ CD₃ CD₃ CD₂CD₃ CD₃ 383. CD₃ CD₂C(CD₃)₃ CD₃ CD₃ CD₂CD₃ CD₃ 384. CD₃ CD₂C(CH₃)₃ CD₃ CD₃ CD₂CD₃ CD₃ 385. CD₃ CD₂CD₂CF₃ CD₃ CD₃ CD₂CD₃ CD₃ 386. CD₃ CD₂CH₂CF₃ CD₃ CD₃ CD₂CD₃ CD₃ 387. CD₃ CD₂CCF₃(CH₃)₂ CD₃ CD₃ CD₂CD₃ CD₃ 388. CD₃

CD₃ CD₃ CD₂CD₃ CD₃ 389. CD₃

CD₃ CD₃ CD₂CD₃ CD₃ 390. CD₃

CD₃ CD₃ CD₂CD₃ CD₃ 391. CD₃

CD₃ CD₃ CD₂CD₃ CD₃ 392. CD₃

CD₃ CD₃ CD₂CD₃ CD₃ 393. CD₃

CD₃ CD₃ CD₂CD₃ CD₃ 394. CD₃

CD₃ CD₃ CD₂CD₃ CD₃ 395. CD₃

CD₃ CD₃ CD₂CD₃ CD₃ 396. CD₃

CD₃ CD₃ CD₂CD₃ CD₃ 397. CD₃

CD₃ CD₃ CD₂CD₃ CD₃ 398. CD₃

CD₃ CD₃ CD₂CD₃ CD₃ 399. CD₃

CD₃ CD₃ CD₂CD₃ CD₃ 400. CD₃

CD₃ CD₃ CD₂CD₃ CD₃ 401. CD₃

CD₃ CD₃ CD₂CD₃ CD₃ 402. CD₃

CD₃ CD₃ CD₂CD₃ CD₃ 403. CD₃

CD₃ CD₃ CD₂CD₃ CD₃ 404. CD₃

CD₃ CD₃ CD₂CD₃ CD₃ 405. CD₃

CD₃ CD₃ CD₂CD₃ CD₃ 406. CD₃

CD₃ CD₃ CD₂CD₃ CD₃ 407. CD₃

CD₃ CD₃ CD₂CD₃ CD₃ 408. CH₃ CH₃ H H H CH₃ 409. CH₃ CH₂CH₃ H H H CH₃ 410. CH₃ CH(CH₃)₂ H H H CH₃ 411. CH₃ CH₂CH(CH₃)₂ H H H CH₃ 412. CH₃ C(CH₃)₃ H H H CH₃ 413. CH₃ CH₂C(CH₃)₃ H H H CH₃ 414. CH₃ CH₂CH₂CF₃ H H H CH₃ 415. CH₃ CH₂CCF₃(CH₃)₂ H H H CH₃ 416. CH₃

H H H CH₃ 417. CH₃

H H H CH₃ 418. CH₃

H H H CH₃ 419. CH₃

H H H CH₃ 420. CH₃

H H H CH₃ 421. CH₃

H H H CH₃ 422. CH₃

H H H CH₃ 423. CH₃

H H H CH₃ 424. CH₃

H H H CH₃ 425. CH₃

H H H CH₃ 426. CH₃

H H H CH₃ 427. CH₃

H H H CH₃ 428. CH₃

H H H CH₃ 429. CH₃

H H H CH₃ 430. CH₃

H H H CH₃ 431. CH₃

H H H CH₃ 432. CH₃

H H H CH₃ 433. CH₃

H H H CH₃ 434. CH₃

H H H CH₃ 435. CH₃

H H H CH₃ 436. CD₃ CD₃ H H H CD₂CD₃ 437. CD₃ CD₃ H H H CD₂CD₃ 438. CD₃ CD₂CH₃ H H H CD₂CD₃ 439. CD₃ CD(CD₃)₂ H H H CD₂CD₃ 440. CD₃ CD(CH₃)₂ H H H CD₂CD₃ 441. CD₃ CD₂CD(CD₃)₂ H H H CD₂CD₃ 442. CD₃ CD₂CH(CH₃)₂ H H H CD₂CD₃ 443. CD₃ CD₂C(CD₃)₃ H H H CD₂CD₃ 444. CD₃ CD₂C(CH₃)₃ H H H CD₂CD₃ 445. CD₃ CD₂CD₂CF₃ H H H CD₂CD₃ 446. CD₃ CD₂CH₂CF₃ H H H CD₂CD₃ 447. CD₃ CD₂CCF₃(CH₃)₂ H H H CD₂CD₃ 448. CD₃

H H H CD₂CD₃ 449. CD₃

H H H CD₂CD₃ 450. CD₃

H H H CD₂CD₃ 451. CD₃

H H H CD₂CD₃ 452. CD₃

H H H CD₂CD₃ 453. CD₃

H H H CD₂CD₃ 454. CD₃

H H H CD₂CD₃ 455. CD₃

H H H CD₂CD₃ 456. CD₃

H H H CD₂CD₃ 457. CD₃

H H H CD₂CD₃ 458. CD₃

H H H CD₂CD₃ 459. CD₃

H H H CD₂CD₃ 460. CD₃

H H H CD₂CD₃ 461. CD₃

H H H CD₂CD₃ 462. CD₃

H H H CD₂CD₃ 463. CD₃

H H H CD₂CD₃ 464. CD₃

H H H CD₂CD₃ 465. CD₃

H H H CD₂CD₃ 466. CD₃

H H H CD₂CD₃ 467. CD₃

H H H CD₂CD₃ 468. CH₃ H CH₃ H H CH₃ 469. CH₃ H CH₂CH₃ H H CH₃ 470. CH₃ H CH(CH₃)₂ H H CH₃ 471. CH₃ H CH₂CH(CH₃)₂ H H CH₃ 472. CH₃ H C(CH₃)₃ H H CH₃ 473. CH₃ H CH₂C(CH₃)₃ H H CH₃ 474. CH₃ H CH₂CH₂CF₃ H H CH₃ 475. CH₃ H CH₂CCF₃(CH₃)₂ H H CH₃ 476. CH₃ H

H H CH₃ 477. CH₃ H

H H CH₃ 478. CH₃ H

H H CH₃ 479. CH₃ H

H H CH₃ 480. CH₃ H

H H CH₃ 481. CH₃ H

H H CH₃ 482. CH₃ H

H H CH₃ 483. CH₃ H

H H CH₃ 484. CH₃ H

H H CH₃ 485. CH₃ H

H H CH₃ 486. CH₃ H

H H CH₃ 487. CH₃ H

H H CH₃ 488. CH₃ H

H H CH₃ 489. CH₃ H

H H CH₃ 490. CH₃ H

H H CH₃ 491. CH₃ H

H H CH₃ 492. CH₃ H

H H CH₃ 493. CH₃ H

H H CH₃ 494. CH₃ H

H H CH₃ 495. CH₃ H

H H CH₃ 496. CD₃ H CD₃ H H CD₂CD₃ 497. CD₃ H CD₂CD₃ H H CD₂CD₃ 498. CD₃ H CD₂CH₃ H H CD₂CD₃ 499. CD₃ H CD(CD₃)₂ H H CD₂CD₃ 500. CD₃ H CD(CH₃)₂ H H CD₂CD₃ 501. CD₃ H CD₂CD(CD₃)₂ H H CD₂CD₃ 502. CD₃ H CD₂CH(CH₃)₂ H H CD₂CD₃ 503. CD₃ H CD₂C(CD₃)₃ H H CD₂CD₃ 504. CD₃ H CD₂C(CH₃)₃ H H CD₂CD₃ 505. CD₃ H CD₂CD₂CF₃ H H CD₂CD₃ 506. CD₃ H CD₂CH₂CF₃ H H CD₂CD₃ 507. CD₃ H CD₂CCF₃(CH₃)₂ H H CD₂CD₃ 508. CD₃ H

H H CD₂CD₃ 509. CD₃ H

H H CD₂CD₃ 510. CD₃ H

H H CD₂CD₃ 511. CD₃ H

H H CD₂CD₃ 512. CD₃ H

H H CD₂CD₃ 513. CD₃ H

H H CD₂CD₃ 514. CD₃ H

H H CD₂CD₃ 515. CD₃ H

H H CD₂CD₃ 516. CD₃ H

H H CD₂CD₃ 517. CD₃ H

H H CD₂CD₃ 518. CD₃ H

H H CD₂CD₃ 519. CD₃ H

H H CD₂CD₃ 520. CD₃ H

H H CD₂CD₃ 521. CD₃ H

H H CD₂CD₃ 522. CD₃ H

H H CD₂CD₃ 523. CD₃ H

H H CD₂CD₃ 524. CD₃ H

H H CD₂CD₃ 525. CD₃ H

H H CD₂CD₃ 526. CD₃ H

H H CD₂CD₃ 527. CD₃ H

H H CD₂CD₃ 528. CH(CH₃)₂ H H CH₃ CH₃ CH₃ 529. CH(CH₃)₂ H H CH₂CH₃ CH₃ CH₃ 530. CH(CH₃)₂ H H CH(CH₃)₂ CH₃ CH₃ 531. CH(CH₃)₂ H H CH₂CH(CH₃)₂ CH₃ CH₃ 532. CH(CH₃)₂ H H C(CH₃)₃ CH₃ CH₃ 533. CH(CH₃)₂ H H CH₂C(CH₃)₃ CH₃ CH₃ 534. CH(CH₃)₂ H H CH₂CH₂CF₃ CH₃ CH₃ 535. CH(CH₃)₂ H H CH₂CCF₃(CH₃)₂ CH₃ CH₃ 536. CH(CH₃)₂ H H

CH₃ CH₃ 537. CH(CH₃)₂ H H

CH₃ CH₃ 538. CH(CH₃)₂ H H

CH₃ CH₃ 539. CH(CH₃)₂ H H

CH₃ CH₃ 540. CH(CH₃)₂ H H

CH₃ CH₃ 541. CH(CH₃)₂ H H

CH₃ CH₃ 542. CH(CH₃)₂ H H

CH₃ CH₃ 543. CH(CH₃)₂ H H

CH₃ CH₃ 544. CH(CH₃)₂ H H

CH₃ CH₃ 545. CH(CH₃)₂ H H

CH₃ CH₃ 546. CH(CH₃)₂ H H

CH₃ CH₃ 547. CH(CH₃)₂ H H

CH₃ CH₃ 548. CH(CH₃)₂ H H

CH₃ CH₃ 549. CH(CH₃)₂ H H

CH₃ CH₃ 550. CH(CH₃)₂ H H

CH₃ CH₃ 551. CH(CH₃)₂ H H

CH₃ CH₃ 552. CH(CH₃)₂ H H

CH₃ CH₃ 553. CH(CH₃)₂ H H

CH₃ CH₃ 554. CH(CH₃)₂ H H

CH₃ CH₃ 555. CH(CH₃)₂ H H

CH₃ CH₃ 556. CD₃ H H CD₃ CD₃ CD₃ 557. CD₃ H H CD₂CD₃ CD₃ CD₃ 558. CD₃ H H CD₂CH₃ CD₃ CD₃ 559. CD₃ H H CD(CD₃)₂ CD₃ CD₃ 560. CD₃ H H CD(CH₃)₂ CD₃ CD₃ 561. CD₃ H H CD₂CD(CD₃)₂ CD₃ CD₃ 562. CD₃ H H CD₂CH(CH₃)₂ CD₃ CD₃ 563. CD₃ H H CD₂C(CD₃)₃ CD₃ CD₃ 564. CD₃ H H CD₂C(CH₃)₃ CD₃ CD₃ 565. CD₃ H H CD₂CD₂CF₃ CD₃ CD₃ 566. CD₃ H H CD₂CH₂CF₃ CD₃ CD₃ 567. CD₃ H H CD₂CCF₃(CH₃)₂ CD₃ CD₃ 568. CD₃ H H

CD₃ CD₃ 569. CD₃ H H

CD₃ CD₃ 570. CD₃ H H

CD₃ CD₃ 571. CD₃ H H

CD₃ CD₃ 572. CD₃ H H

CD₃ CD₃ 573. CD₃ H H

CD₃ CD₃ 574. CD₃ H H

CD₃ CD₃ 575. CD₃ H H

CD₃ CD₃ 576. CD₃ H H

CD₃ CD₃ 577. CD₃ H H

CD₃ CD₃ 578. CD₃ H H

CD₃ CD₃ 579. CD₃ H H

CD₃ CD₃ 580. CD₃ H H

CD₃ CD₃ 581. CD₃ H H

CD₃ CD₃ 582. CD₃ H H

CD₃ CD₃ 583. CD₃ H H

CD₃ CD₃ 584. CD₃ H H

CD₃ CD₃ 585. CD₃ H H

CD₃ CD₃ 586. CD₃ H H

CD₃ CD₃ 587. CD₃ H H

CD₃ CD₃ 588. H CH₃ CH₃ H CH₃ CH₃ 589. H CH₂CH₃ CH₃ H CH₃ CH₃ 590. H CH(CH₃)₂ CH₃ H CH₃ CH₃ 591. H CH₂CH(CH₃)₂ CH₃ H CH₃ CH₃ 592. H C(CH₃)₃ CH₃ H CH₃ CH₃ 593. H CH₂C(CH₃)₃ CH₃ H CH₃ CH₃ 594. H CH₂CH₂CF₃ CH₃ H CH₃ CH₃ 595. H CH₂CCF₃(CH₃)₂ CH₃ H CH₃ CH₃ 596. H

CH₃ H CH₃ CH₃ 597. H

CH₃ H CH₃ CH₃ 598. H

CH₃ H CH₃ CH₃ 599. H

CH₃ H CH₃ CH₃ 600. H

CH₃ H CH₃ CH₃ 601. H

CH₃ H CH₃ CH₃ 602. H

CH₃ H CH₃ CH₃ 603. H

CH₃ H CH₃ CH₃ 604. H

CH₃ H CH₃ CH₃ 605. H

CH₃ H CH₃ CH₃ 606. H

CH₃ H CH₃ CH₃ 607. H

CH₃ H CH₃ CH₃ 608. H

CH₃ H CH₃ CH₃ 609. H

CH₃ H CH₃ CH₃ 610. H

CH₃ H CH₃ CH₃ 611. H

CH₃ H CH₃ CH₃ 612. H

CH₃ H CH₃ CH₃ 613. H

CH₃ H CH₃ CH₃ 614. H

CH₃ H CH₃ CH₃ 615. H

CH₃ H CH₃ CH₃ 616. CD₃ CD₃ CD₃ H CD₃ CD₃ 617. CD₃ CD₂CD₃ CD₃ H CD₃ CD₃ 618. CD₃ CD₂CH₃ CD₃ H CD₃ CD₃ 619. CD₃ CD(CD₃)₂ CD₃ H CD₃ CD₃ 620. CD₃ CD(CH₃)₂ CD₃ H CD₃ CD₃ 621. CD₃ CD₂CD(CD₃)₂ CD₃ H CD₃ CD₃ 622. CD₃ CD₂CH(CH₃)₂ CD₃ H CD₃ CD₃ 623. CD₃ CD₂C(CD₃)₃ CD₃ H CD₃ CD₃ 624. CD₃ CD₂C(CH₃)₃ CD₃ H CD₃ CD₃ 625. CD₃ CD₂CD₂CF₃ CD₃ H CD₃ CD₃ 626. CD₃ CD₂CH₂CF₃ CD₃ H CD₃ CD₃ 627. CD₃ CD₂CCF₃(CH₃)₂ CD₃ H CD₃ CD₃ 628. CD₃

CD₃ H CD₃ CD₃ 629. CD₃

CD₃ H CD₃ CD₃ 630. CD₃

CD₃ H CD₃ CD₃ 631. CD₃

CD₃ H CD₃ CD₃ 632. CD₃

CD₃ H CD₃ CD₃ 633. CD₃

CD₃ H CD₃ CD₃ 634. CD₃

CD₃ H CD₃ CD₃ 635. CD₃

CD₃ H CD₃ CD₃ 636. CD₃

CD₃ H CD₃ CD₃ 637. CD₃

CD₃ H CD₃ CD₃ 638. CD₃

CD₃ H CD₃ CD₃ 639. CD₃

CD₃ H CD₃ CD₃ 640. CD₃

CD₃ H CD₃ CD₃ 641. CD₃

CD₃ H CD₃ CD₃ 642. CD₃

CD₃ H CD₃ CD₃ 643. CD₃

CD₃ H CD₃ CD₃ 644. CD₃

CD₃ H CD₃ CD₃ 645. CD₃

CD₃ H CD₃ CD₃ 646. CD₃

CD₃ H CD₃ CD₃ 647. CD₃

CD₃ H CD₃ CD₃ 648. CH₃ CH₃ CH₂CH₃ H CH₃ CH₂CH₃ 649. CH₃ CH₃ CH(CH₃)₂ H CH₃ CH₂CH₃ 650. CH₃ CH₃ CH₂CH(CH₃)₂ H CH₃ CH₂CH₃ 651. CH₃ CH₃ C(CH₃)₃ H CH₃ CH₂CH₃ 652. CH₃ CH₃ CH₂C(CH₃)₃ H CH₃ CH₂CH₃ 653. CH₃ CH₃ CH₂CH₂CF₃ H CH₃ CH₂CH₃ 654. CH₃ CH₃ CH₂CCF₃(CH₃)₂ H CH₃ CH₂CH₃ 655. CH₃ CH₃

H CH₃ CH₂CH₃ 656. CH₃ CH₃

H CH₃ CH₂CH₃ 657. CH₃ CH₃

H CH₃ CH₂CH₃ 658. CH₃ CH₃

H CH₃ CH₂CH₃ 659. CH₃ CH₃

H CH₃ CH₂CH₃ 660. CH₃ CH₃

H CH₃ CH₂CH₃ 661. CH₃ CH₃

H CH₃ CH₂CH₃ 662. CH₃ CH₃

H CH₃ CH₂CH₃ 663. CH₃ CH₃

H CH₃ CH₂CH₃ 664. CH₃ CH₃

H CH₃ CH₂CH₃ 665. CH₃ CH₃

H CH₃ CH₂CH₃ 666. CH₃ CH₃

H CH₃ CH₂CH₃ 667. CH₃ CH₃

H CH₃ CH₂CH₃ 668. CH₃ CH₃

H CH₃ CH₂CH₃ 669. CH₃ CH₃

H CH₃ CH₂CH₃ 670. CH₃ CH₃

H CH₃ CH₂CH₃ 671. CH₃ CH₃

H CH₃ CH₂CH₃ 672. CH₃ CH₃

H CH₃ CH₂CH₃ 673. CH₃ CH₃

H CH₃ CH₂CH₃ 674. CH₃ CH₃

H CH₃ CH₂CH₃ 675. CD₃ CD₃ CD₂CD₃ H CD₂CH₃ CD₂CH₃ 676. CD₃ CD₃ CD₂CH₃ H CD₂CH₃ CD₂CH₃ 677. CD₃ CD₃ CD(CD₃)₂ H CD₂CH₃ CD₂CH₃ 678. CD₃ CD₃ CD(CH₃)₂ H CD₂CH₃ CD₂CH₃ 679. CD₃ CD₃ CD₂CD(CD₃)₂ H CD₂CH₃ CD₂CH₃ 680. CD₃ CD₃ CD₂CH(CH₃)₂ H CD₂CH₃ CD₂CH₃ 681. CD₃ CD₃ CD₂C(CD₃)₃ H CD₂CH₃ CD₂CH₃ 682. CD₃ CD₃ CD₂C(CH₃)₃ H CD₂CH₃ CD₂CH₃ 683. CD₃ CD₃ CD₂CD₂CF₃ H CD₂CH₃ CD₂CH₃ 684. CD₃ CD₃ CD₂CH₂CF₃ H CD₂CH₃ CD₂CH₃ 685. CD₃ CD₃ CD₂CCF₃(CH₃)₂ H CD₂CH₃ CD₂CH₃ 686. CD₃ CD₃

H CD₂CH₃ CD₂CH₃ 687. CD₃ CD₃

H CD₂CH₃ CD₂CH₃ 688. CD₃ CD₃

H CD₂CH₃ CD₂CH₃ 689. CD₃ CD₃

H CD₂CH₃ CD₂CH₃ 690. CD₃ CD₃

H CD₂CH₃ CD₂CH₃ 691. CD₃ CD₃

H CD₂CH₃ CD₂CH₃ 692. CD₃ CD₃

H CD₂CH₃ CD₂CH₃ 693. CD₃ CD₃

H CD₂CH₃ CD₂CH₃ 694. CD₃ CD₃

H CD₂CH₃ CD₂CH₃ 695. CD₃ CD₃

H CD₂CH₃ CD₂CH₃ 696. CD₃ CD₃

H CD₂CH₃ CD₂CH₃ 697. CD₃ CD₃

H CD₂CH₃ CD₂CH₃ 698. CD₃ CD₃

H CD₂CH₃ CD₂CH₃ 699. CD₃ CD₃

H CD₂CH₃ CD₂CH₃ 700. CD₃ CD₃

H CD₂CH₃ CD₂CH₃ 701. CD₃ CD₃

H CD₂CH₃ CD₂CH₃ 702. CD₃ CD₃

H CD₂CH₃ CD₂CH₃ 703. CD₃ CD₃

H CD₂CH₃ CD₂CH₃ 704. CD₃ CD₃

H CD₂CH₃ CD₂CH₃ 705. CD₃ CD₃

H CD₂CH₃ CD₂CH₃ 706. H CH₃ CH₃ CH₃ CH₂CH₃ CH₂CH₃ 707. H CH₃ CH₂CH₃ CH₃ CH₂CH₃ CH₂CH₃ 708. H CH₃ CH(CH₃)₂ CH₃ CH₂CH₃ CH₂CH₃ 709. H CH₃ CH₂CH(CH₃)₂ CH₃ CH₂CH₃ CH₂CH₃ 710. H CH₃ C(CH₃)₃ CH₃ CH₂CH₃ CH₂CH₃ 711. H CH₃ CH₂C(CH₃)₃ CH₃ CH₂CH₃ CH₂CH₃ 712. H CH₃ CH₂CH₂CF₃ CH₃ CH₂CH₃ CH₂CH₃ 713. H CH₃ CH₂CCF₃(CH₃)₂ CH₃ CH₂CH₃ CH₂CH₃ 714. H CH₃

CH₃ CH₂CH₃ CH₂CH₃ 715. H CH₃

CH₃ CH₂CH₃ CH₂CH₃ 716. H CH₃

CH₃ CH₂CH₃ CH₂CH₃ 717. H CH₃

CH₃ CH₂CH₃ CH₂CH₃ 718. H CH₃

CH₃ CH₂CH₃ CH₂CH₃ 719. H CH₃

CH₃ CH₂CH₃ CH₂CH₃ 720. H CH₃

CH₃ CH₂CH₃ CH₂CH₃ 721. H CH₃

CH₃ CH₂CH₃ CH₂CH₃ 722. H CH₃

CH₃ CH₂CH₃ CH₂CH₃ 723. H CH₃

CH₃ CH₂CH₃ CH₂CH₃ 724. H CH₃

CH₃ CH₂CH₃ CH₂CH₃ 725. H CH₃

CH₃ CH₂CH₃ CH₂CH₃ 726. H CH₃

CH₃ CH₂CH₃ CH₂CH₃ 727. H CH₃

CH₃ CH₂CH₃ CH₂CH₃ 728. H CH₃

CH₃ CH₂CH₃ CH₂CH₃ 729. H CH₃

CH₃ CH₂CH₃ CH₂CH₃ 730. H CH₃

CH₃ CH₂CH₃ CH₂CH₃ 731. H CH₃

CH₃ CH₂CH₃ CH₂CH₃ 732. H CH₃

CH₃ CH₂CH₃ CH₂CH₃ 733. H CH₃

CH₃ CH₂CH₃ CH₂CH₃ 734. CD₃ CD₃ CD₃ CD₃ CD₂CH₃ CD₂CH₃ 735. CD₃ CD₃ CD₂CD₃ CD₃ CD₂CH₃ CD₂CH₃ 736. CD₃ CD₃ CD₂CH₃ CD₃ CD₂CH₃ CD₂CH₃ 737. CD₃ CD₃ CD(CD₃)₂ CD₃ CD₂CH₃ CD₂CH₃ 738. CD₃ CD₃ CD(CH₃)₂ CD₃ CD₂CH₃ CD₂CH₃ 739. CD₃ CD₃ CD₂CD(CD₃)₂ CD₃ CD₂CH₃ CD₂CH₃ 740. CD₃ CD₃ CD₂CH(CH₃)₂ CD₃ CD₂CH₃ CD₂CH₃ 741. CD₃ CD₃ CD₂C(CD₃)₃ CD₃ CD₂CH₃ CD₂CH₃ 742. CD₃ CD₃ CD₂C(CH₃)₃ CD₃ CD₂CH₃ CD₂CH₃ 743. CD₃ CD₃ CD₂CD₂CF₃ CD₃ CD₂CH₃ CD₂CH₃ 744. CD₃ CD₃ CD₂CH₂CF₃ CD₃ CD₂CH₃ CD₂CH₃ 745. CD₃ CD₃ CD₂CCF₃(CH₃)₂ CD₃ CD₂CH₃ CD₂CH₃ 746. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃ 747. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃ 748. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃ 749. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃ 750. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃ 751. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃ 752. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃ 753. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃ 754. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃ 755. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃ 756. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃ 757. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃ 758. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃ 759. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃ 760. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃ 761. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃ 762. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃ 763. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃ 764. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃ 765. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃ 766. CH₃ CH₂CH₃ CH₃ CH₂CH₃ H CH₂CH₃ 767. CH₃ CH(CH₃)₂ CH₃ CH(CH₃)₂ H CH₂CH₃ 768. CH₃ CH₂CH(CH₃)₂ CH₃ CH₂CH(CH₃)₂ H CH₂CH₃ 769. CH₃ C(CH₃)₃ CH₃ C(CH₃)₃ H CH₂CH₃ 770. CH₃ CH₂C(CH₃)₃ CH₃ CH₂C(CH₃)₃ H CH₂CH₃ 771. CH₃ CH₂CH₂CF₃ CH₃ CH₂CH₂CF₃ H CH₂CH₃ 772. CH₃ CH₂CCF₃(CH₃)₂ CH₃ CH₂CCF₃(CH₃)₂ H CH₂CH₃ 773. CH₃

CH₃

H CH₂CH₃ 774. CH₃

CH₃

H CH₂CH₃ 775. CH₃

CH₃

H CH₂CH₃ 776. CH₃

CH₃

H CH₂CH₃ 777. CH₃

CH₃

H CH₂CH₃ 778. CH₃

CH₃

H CH₂CH₃ 779. CH₃

CH₃

H CH₂CH₃ 780. CH₃

CH₃

H CH₂CH₃ 781. CH₃

CH₃

H CH₂CH₃ 782. CH₃

CH₃

H CH₂CH₃ 783. CH₃

CH₃

H CH₂CH₃ 784. CH₃

CH₃

H CH₂CH₃ 785. CH₃

CH₃

H CH₂CH₃ 786. CH₃

CH₃

H CH₂CH₃ 787. CH₃

CH₃

H CH₂CH₃ 788. CH₃

CH₃

H CH₂CH₃ 789. CH₃

CH₃

H CH₂CH₃ 790. CH₃

CH₃

H CH₂CH₃ 791. CH₃

CH₃

H CH₂CH₃ 792. CH₃

CH₃

H CH₂CH₃ 793. CD₃ CD₂CD₃ CD₃ CD₂CD₃ H CD₂CH₃ 794. CD₃ CD₂CH₃ CD₃ CD₂CH₃ H CD₂CH₃ 795. CD₃ CD(CD₃)₂ CD₃ CD(CD₃)₂ H CD₂CH₃ 796. CD₃ CD(CH₃)₂ CD₃ CD(CH₃)₂ H CD₂CH₃ 797. CD₃ CD₂CD(CD₃)₂ CD₃ CD₂CD(CD₃)₂ H CD₂CH₃ 798. CD₃ CD₂CH(CH₃)₂ CD₃ CD₂CH(CH₃)₂ H CD₂CH₃ 799. CD₃ CD₂C(CD₃)₃ CD₃ CD₂C(CD₃)₃ H CD₂CH₃ 800. CD₃ CD₂C(CH₃)₃ CD₃ CD₂C(CH₃)₃ H CD₂CH₃ 801. CD₃ CD₂CD₂CF₃ CD₃ CD₂CD₂CF₃ H CD₂CH₃ 802. CD₃ CD₂CH₂CF₃ CD₃ CD₂CH₂CF₃ H CD₂CH₃ 803. CD₃ CD₂CCF₃(CH₃)₂ CD₃ CD₂CCF₃(CH₃)₂ H CD₂CH₃ 804. CD₃

CD₃

H CD₂CH₃ 805. CD₃

CD₃

H CD₂CH₃ 806. CD₃

CD₃

H CD₂CH₃ 807. CD₃

CD₃

H CD₂CH₃ 808. CD₃

CD₃

H CD₂CH₃ 809. CD₃

CD₃

H CD₂CH₃ 810. CD₃

CD₃

H CD₂CH₃ 811. CD₃

CD₃

H CD₂CH₃ 812. CD₃

CD₃

H CD₂CH₃ 813. CD₃

CD₃

H CD₂CH₃ 814. CD₃

CD₃

H CD₂CH₃ 815. CD₃

CD₃

H CD₂CH₃ 816. CD₃

CD₃

H CD₂CH₃ 817. CD₃

CD₃

H CD₂CH₃ 818. CD₃

CD₃

H CD₂CH₃ 819. CD₃

CD₃

H CD₂CH₃ 820. CD₃

CD₃

H CD₂CH₃ 821. CD₃

CD₃

H CD₂CH₃ 822. CD₃

CD₃

H CD₂CH₃ 823. CD₃

CD₃

H CD₂CH₃ 824. CH₂CH₃ CH₃ H H H CH(CH₃)₂ 825. CH₂CH₃ CH₂CH₃ H H H CH(CH₃)₂ 826. CH₂CH₃ CH(CH₃)₂ H H H CH(CH₃)₂ 827. CH₂CH₃ CH₂CH(CH₃)₂ H H H CH(CH₃)₂ 828. CH₂CH₃ C(CH₃)₃ H H H CH(CH₃)₂ 829. CH₂CH₃ CH₂C(CH₃)₃ H H H CH(CH₃)₂ 830. CH₂CH₃ CH₂CH₂CF₃ H H H CH(CH₃)₂ 831. CH₂CH₃ CH₂CCF₃(CH₃)₂ H H H CH(CH₃)₂ 832. CH₂CH₃

H H H CH(CH₃)₂ 833. CH₂CH₃

H H H CH(CH₃)₂ 834. CH₂CH₃

H H H CH(CH₃)₂ 835. CH₂CH₃

H H H CH(CH₃)₂ 836. CH₂CH₃

H H H CH(CH₃)₂ 837. CH₂CH₃

H H H CH(CH₃)₂ 838. CH₂CH₃

H H H CH(CH₃)₂ 839. CH₂CH₃

H H H CH(CH₃)₂ 840. CH₂CH₃

H H H CH(CH₃)₂ 841. CH₂CH₃

H H H CH(CH₃)₂ 842. CH₂CH₃

H H H CH(CH₃)₂ 843. CH₂CH₃

H H H CH(CH₃)₂ 844. CH₂CH₃

H H H CH(CH₃)₂ 845. CH₂CH₃

H H H CH(CH₃)₂ 846. CH₂CH₃

H H H CH(CH₃)₂ 847. CH₂CH₃

H H H CH(CH₃)₂ 848. CH₂CH₃

H H H CH(CH₃)₂ 849. CH₂CH₃

H H H CH(CH₃)₂ 850. CH₂CH₃

H H H CH(CH₃)₂ 851. CH₂CH₃

H H H CH(CH₃)₂ 852. CD₂CH₃ CD₃ H H CD₂CH₃ CD₂CH₃ 853. CD₂CH₃ CD₂CD₃ H H CD₂CH₃ CD₂CH₃ 854. CD₂CH₃ CD₂CH₃ H H CD₂CH₃ CD₂CH₃ 855. CD₂CH₃ CD(CD₃)₂ H H CD₂CH₃ CD₂CH₃ 856. CD₂CH₃ CD(CH₃)₂ H H CD₂CH₃ CD₂CH₃ 857. CD₂CH₃ CD₂CD(CD₃)₂ H H CD₂CH₃ CD₂CH₃ 858. CD₂CH₃ CD₂CH(CH₃)₂ H H CD₂CH₃ CD₂CH₃ 859. CD₂CH₃ CD₂C(CD₃)₃ H H CD₂CH₃ CD₂CH₃ 860. CD₂CH₃ CD₂C(CH₃)₃ H H CD₂CH₃ CD₂CH₃ 861. CD₂CH₃ CD₂CD₂CF₃ H H CD₂CH₃ CD₂CH₃ 862. CD₂CH₃ CD₂CH₂CF₃ H H CD₂CH₃ CD₂CH₃ 863. CD₂CH₃ CD₂CCF₃(CH₃)₂ H H CD₂CH₃ CD₂CH₃ 864. CD₂CH₃

H H CD₂CH₃ CD₂CH₃ 865. CD₂CH₃

H H CD₂CH₃ CD₂CH₃ 866. CD₂CH₃

H H CD₂CH₃ CD₂CH₃ 867. CD₂CH₃

H H CD₂CH₃ CD₂CH₃ 868. CD₂CH₃

H H CD₂CH₃ CD₂CH₃ 869. CD₂CH₃

H H CD₂CH₃ CD₂CH₃ 870. CD₂CH₃

H H CD₂CH₃ CD₂CH₃ 871. CD₂CH₃

H H CD₂CH₃ CD₂CH₃ 872. CD₂CH₃

H H CD₂CH₃ CD₂CH₃ 873. CD₂CH₃

H H CD₂CH₃ CD₂CH₃ 874. CD₂CH₃

H H CD₂CH₃ CD₂CH₃ 875. CD₂CH₃

H H CD₂CH₃ CD₂CH₃ 876. CD₂CH₃

H H CD₂CH₃ CD₂CH₃ 877. CD₂CH₃

H H CD₂CH₃ CD₂CH₃ 878. CD₂CH₃

H H CD₂CH₃ CD₂CH₃ 879. CD₂CH₃

H H CD₂CH₃ CD₂CH₃ 880. CD₂CH₃

H H CD₂CH₃ CD₂CH₃ 881. CD₂CH₃

H H CD₂CH₃ CD₂CH₃ 882. CD₂CH₃

H H CD₂CH₃ CD₂CH₃ 883. CD₂CH₃

H H CD₂CH₃ CD₂CH₃ 884. CD₂CD₃ CD₃ H H H CD(CH₃)₂ 885. CD₂CD₃ CD₂CD₃ H H H CD(CH₃)₂ 886. CD₂CD₃ CD₂CH₃ H H H CD(CH₃)₂ 887. CD₂CD₃ CD(CD₃)₂ H H H CD(CH₃)₂ 888. CD₂CD₃ CD(CH₃)₂ H H H CD(CH₃)₂ 889. CD₂CD₃ CD₂CD(CD₃)₂ H H H CD(CH₃)₂ 890. CD₂CD₃ CD₂CH(CH₃)₂ H H H CD(CH₃)₂ 891. CD₂CD₃ CD₂C(CD₃)₃ H H H CD(CH₃)₂ 892. CD₂CD₃ CD₂C(CH₃)₃ H H H CD(CH₃)₂ 893. CD₂CD₃ CD₂CD₂CF₃ H H H CD(CH₃)₂ 894. CD₂CD₃ CD₂CH₂CF₃ H H H CD(CH₃)₂ 895. CD₂CD₃ CD₂CCF₃(CH₃)₂ H H H CD(CH₃)₂ 896. CD₂CD₃

H H H CD(CH₃)₂ 897. CD₂CD₃

H H H CD(CH₃)₂ 898. CD₂CD₃

H H H CD(CH₃)₂ 899. CD₂CD₃

H H H CD(CH₃)₂ 900. CD₂CD₃

H H H CD(CH₃)₂ 901. CD₂CD₃

H H H CD(CH₃)₂ 902. CD₂CD₃

H H H CD(CH₃)₂ 903. CD₂CD₃

H H H CD(CH₃)₂ 904. CD₂CD₃

H H H CD(CH₃)₂ 905. CD₂CD₃

H H H CD(CH₃)₂ 906. CD₂CD₃

H H H CD(CH₃)₂ 907. CD₂CD₃

H H H CD(CH₃)₂ 908. CD₂CD₃

H H H CD(CH₃)₂ 909. CD₂CD₃

H H H CD(CH₃)₂ 910. CD₂CD₃

H H H CD(CH₃)₂ 911. CD₂CD₃

H H H CD(CH₃)₂ 912. CD₂CD₃

H H H CD(CH₃)₂ 913. CD₂CD₃

H H H CD(CH₃)₂ 914. CD₂CD₃

H H H CD(CH₃)₂ 915. CD₂CD₃

H H H CD(CH₃)₂ 916. CH₂CH₃ H CH₂CH₃ H CH₂CH₃ CH₂CH₃ 917. CH₂CH₃ H CH(CH₃)₂ H CH₂CH₃ CH₂CH₃ 918. CH₂CH₃ H CH₂CH(CH₃)₂ H CH₂CH₃ CH₂CH₃ 919. CH₂CH₃ H C(CH₃)₃ H CH₂CH₃ CH₂CH₃ 920. CH₂CH₃ H CH₂C(CH₃)₃ H CH₂CH₃ CH₂CH₃ 921. CH₂CH₃ H CH₂CH₂CF₃ H CH₂CH₃ CH₂CH₃ 922. CH₂CH₃ H CH₂CCF₃(CH₃)₂ H CH₂CH₃ CH₂CH₃ 923. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃ 924. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃ 925. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃ 926. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃ 927. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃ 928. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃ 929. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃ 930. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃ 931. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃ 932. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃ 933. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃ 934. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃ 935. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃ 936. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃ 937. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃ 938. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃ 939. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃ 940. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃ 941. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃ 942. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃ 943. CD₂CH₃ H CD₃ H CD(CH₃)₂ CD(CH₃)₂ 944. CD₂CH₃ H CD₂CD₃ H CD(CH₃)₂ CD(CH₃)₂ 945. CD₂CH₃ H CD₂CH₃ H CD(CH₃)₂ CD(CH₃)₂ 946. CD₂CH₃ H CD(CD₃)₂ H CD(CH₃)₂ CD(CH₃)₂ 947. CD₂CH₃ H CD(CH₃)₂ H CD(CH₃)₂ CD(CH₃)₂ 948. CD₂CH₃ H CD₂CD(CD₃)₂ H CD(CH₃)₂ CD(CH₃)₂ 949. CD₂CH₃ H CD₂CH(CH₃)₂ H CD(CH₃)₂ CD(CH₃)₂ 950. CD₂CH₃ H CD₂C(CD₃)₃ H CD(CH₃)₂ CD(CH₃)₂ 951. CD₂CH₃ H CD₂C(CH₃)₃ H CD(CH₃)₂ CD(CH₃)₂ 952. CD₂CH₃ H CD₂CD₂CF₃ H CD(CH₃)₂ CD(CH₃)₂ 953. CD₂CH₃ H CD₂CH₂CF₃ H CD(CH₃)₂ CD(CH₃)₂ 954. CD₂CH₃ H CD₂CCF₃(CH₃)₂ H CD(CH₃)₂ CD(CH₃)₂ 955. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂ 956. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂ 957. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂ 958. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂ 959. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂ 960. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂ 961. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂ 962. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂ 963. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂ 964. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂ 965. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂ 966. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂ 967. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂ 968. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂ 969. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂ 970. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂ 971. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂ 972. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂ 973. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂ 974. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂ 975. CD₂CD₃ CD₃ CD₃ H H CD₂CD(CD₃)₂ 976. CD₂CD₃ CD₃ CD₂CH₃ H H CD₂CD(CD₃)₂ 977. CD₂CD₃ CD₃ CD₂CH₃ H H CD₂CD(CD₃)₂ 978. CD₂CD₃ CD₃ CD(CD₃)₂ H H CD₂CD(CD₃)₂ 979. CD₂CD₃ CD₃ CD(CH₃)₂ H H CD₂CD(CD₃)₂ 980. CD₂CD₃ CD₃ CD₂CD(CD₃)₂ H H CD₂CD(CD₃)₂ 981. CD₂CD₃ CD₃ CD₂CH(CH₃)₂ H H CD₂CD(CD₃)₂ 982. CD₂CH₃ CD₃ CD₂C(CD₃)₃ H H CD₂CD(CD₃)₂ 983. CD₂CD₃ CD₃ CD₂C(CH₃)₃ H H CD₂CD(CD₃)₂ 984. CD₂CD₃ CD₃ CD₂CD₂CF₃ H H CD₂CD(CD₃)₂ 985. CD₂CD₃ CD₃ CD₂CH₂CF₃ H H CD₂CD(CD₃)₂ 986. CD₂CD₃ CD₃ CD₂CCF₃(CH₃)₂ H H CD₂CD(CD₃)₂ 987. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂ 988. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂ 989. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂ 990. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂ 991. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂ 992. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂ 993. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂ 994. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂ 995. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂ 996. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂ 997. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂ 998. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂ 999. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂ 1000. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂ 1001. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂ 1002. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂ 1003. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂ 1004. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂ 1005. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂ 1006. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂ 1007. CD₂CH₃ H H CD₃ CD₂CH₃ CD₂CH₃ 1008. CD₂CH₃ H H CD₂CD₃ CD₂CH₃ CD₂CH₃ 1009. CD₂CH₃ H H CD₂CH₃ CD₂CH₃ CD₂CH₃ 1010. CD₂CH₃ H H CD(CD₃)₂ CD₂CH₃ CD₂CH₃ 1011. CD₂CH₃ H H CD(CH₃)₂ CD₂CH₃ CD₂CH₃ 1012. CD₂CH₃ H H CD₂CD(CD₃)₂ CD₂CH₃ CD₂CH₃ 1013. CD₂CH₃ H H CD₂CH(CH₃)₂ CD₂CH₃ CD₂CH₃ 1014. CD₂CH₃ H H CD₂C(CD₃)₃ CD₂CH₃ CD₂CH₃ 1015. CD₂CH₃ H H CD₂C(CH₃)₃ CD₂CH₃ CD₂CH₃ 1016. CD₂CH₃ H H CD₂CD₂CF₃ CD₂CH₃ CD₂CH₃ 1017. CD₂CH₃ H H CD₂CH₂CF₃ CD₂CH₃ CD₂CH₃ 1018. CD₂CH₃ H H CD₂CCF₃(CH₃)₂ CD₂CH₃ CD₂CH₃ 1019. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃ 1020. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃ 1021. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃ 1022. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃ 1023. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃ 1024. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃ 1025. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃ 1026. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃ 1027. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃ 1028. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃ 1029. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃ 1030. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃ 1031. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃ 1032. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃ 1033. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃ 1034. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃ 1035. CD₂CH₃ CD₃ H CD₃ CD(CH₃)₂ CD(CH₃)₂ 1036. CD₂CH₃ CD₃ H CD₂CD₃ CD(CH₃)₂ CD(CH₃)₂ 1037. CD₂CH₃ CD₃ H CD₂CH₃ CD(CH₃)₂ CD(CH₃)₂ 1038. CD₂CH₃ CD₃ H CD(CD₃)₂ CD(CH₃)₂ CD(CH₃)₂ 1039. CD₂CH₃ CD₃ H CD(CH₃)₂ CD(CH₃)₂ CD(CH₃)₂ 1040. CD₂CH₃ CD₃ H CD₂CD(CD₃)₂ CD(CH₃)₂ CD(CH₃)₂ 1041. CD₂CH₃ CD₃ H CD₂CH(CH₃)₂ CD(CH₃)₂ CD(CH₃)₂ 1042. CD₂CH₃ CD₃ H CD₂C(CD₃)₂ CD(CH₃)₂ CD(CH₃)₂ 1043. CD₂CH₃ CD₃ H CD₂C(CH₃)₂ CD(CH₃)₂ CD(CH₃)₂ 1044. CD₂CH₃ CD₃ H CD₂CD₂CF₃ CD(CH₃)₂ CD(CH₃)₂ 1045. CD₂CH₃ CD₃ H CD₂CH₂CF₃ CD(CH₃)₂ CD(CH₃)₂ 1046. CD₂CH₃ CD₃ H CD₂CCF₃(CH₃)₂ CD(CH₃)₂ CD(CH₃)₂ 1047. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂ 1048. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂ 1049. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂ 1050. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂ 1051. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂ 1052. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂ 1053. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂ 1054. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂ 1055. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂ 1056. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂ 1057. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂ 1058. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂ 1059. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂ 1060. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂ 1061. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂ 1062. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂ 1063. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂ 1064. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂ 1065. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂ 1066. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂ 1067. CD(CH₃)₂ CD₃ H H H

1068. CD(CH₃)₂ CD₂CD₃ H H H

1069. CD(CH₃)₂ CD₂CH₃ H H H

1070. CD(CH₃)₂ CD(CD₃)₂ H H H

1071. CD(CH₃)₂ CD(CH₃)₂ H H H

1072. CD(CH₃)₂ CD₂CD(CD₃)₂ H H H

1073. CD(CH₃)₂ CD₂CH(CH₃)₂ H H H

1074. CD(CH₃)₂ CD₂C(CD₃)₃ H H H

1075. CD(CH₃)₂ CD₂C(CH₃)₃ H H H

1076. CD(CH₃)₂ CD₂CD₂CF₃ H H H

1077. CD(CH₃)₂ CD₂CH₂CF₃ H H H

1078. CD(CH₃)₂ CD₂CCF₃(CH₃)₂ H H H

1079. CD(CH₃)₂

H H H

1080. CD(CH₃)₂

H H H

1081. CD(CH₃)₂

H H H

1082. CD(CH₃)₂

H H H

1083. CD(CH₃)₂

H H H

1084. CD(CH₃)₂

H H H

1085. CD(CH₃)₂

H H H

1086. CD(CH₃)₂

H H H

1087. CD(CH₃)₂

H H H

1088. CD(CH₃)₂

H H H

1089. CD(CH₃)₂

H H H

1090. CD(CH₃)₂

H H H

1091. CD(CH₃)₂

H H H

1092. CD(CH₃)₂

H H H

1093. CD(CH₃)₂

H H H

1094. CD(CH₃)₂

H H H

1095. CD(CH₃)₂

H H H

1096. CD(CH₃)₂

H H H

1097. CD(CH₃)₂

H H H

1098. CD(CH₃)₂

H H H

1099. CD(CD₃)₂ CD₃ H H H

1100. CD(CD₃)₂ CD₂CD₃ H H H

1101. CD(CD₃)₂ CD₂CH₃ H H H

1102. CD(CD₃)₂ CD(CD₃)₂ H H H

1103. CD(CD₃)₂ CD(CH₃)₂ H H H

1104. CD(CD₃)₂ CD₂CD(CD₃)₂ H H H

1105. CD(CD₃)₂ CD₂CH(CH₃)₂ H H H

1106. CD(CD₃)₂ CD₂C(CD₃)₃ H H H

1107. CD(CD₃)₂ CD₂C(CH₃)₃ H H H

1108. CD(CD₃)₂ CD₂CD₂CF₃ H H H

1109. CD(CD₃)₂ CD₂CH₂CF₃ H H H

1110. CD(CD₃)₂ CD₂CCF₃(CH₃)₂ H H H

1111. CD(CD₃)₂

H H H

1112. CD(CD₃)₂

H H H

1113. CD(CD₃)₂

H H H

1114. CD(CD₃)₂

H H H

1115. CD(CD₃)₂

H H H

1116. CD(CD₃)₂

H H H

1117. CD(CD₃)₂

H H H

1118. CD(CD₃)₂

H H H

1119. CD(CD₃)₂

H H H

1120. CD(CD₃)₂

H H H

1121. CD(CD₃)₂

H H H

1122. CD(CD₃)₂

H H H

1123. CD(CD₃)₂

H H H

1124. CD(CD₃)₂

H H H

1125. CD(CD₃)₂

H H H

1126. CD(CD₃)₂

H H H

1127. CD(CD₃)₂

H H H

1128. CD(CD₃)₂

H H H

1129. CD(CD₃)₂

H H H

1130. CD(CD₃)₂

H H H

1131. CH(CH₃)₂ H CH₂CH₃ H H

1132. CH(CH₃)₂ H CH(CH₃)₂ H H

1133. CH(CH₃)₂ H CH₂CH(CH₃)₂ H H

1134. CH(CH₃)₂ H C(CH₃)₃ H H

1135. CH(CH₃)₂ H CH₂C(CH₃)₃ H H

1136. CH(CH₃)₂ H CH₂CH₂CF₃ H H

1137. CH(CH₃)₂ H CH₂CCF₃(CH₃)₂ H H

1138. CH(CH₃)₂ H

H H

1139. CH(CH₃)₂ H

H H

1140. CH(CH₃)₂ H

H H

1141. CH(CH₃)₂ H

H H

1142. CH(CH₃)₂ H

H H

1143. CH(CH₃)₂ H

H H

1144. CH(CH₃)₂ H

H H

1145. CH(CH₃)₂ H

H H

1146. CH(CH₃)₂ H

H H

1147. CH(CH₃)₂ H

H H

1148. CH(CH₃)₂ H

H H

1149. CH(CH₃)₂ H

H H

1150. CH(CH₃)₂ H

H H

1151. CH(CH₃)₂ H

H H

1152. CH(CH₃)₂ H

H H

1153. CH(CH₃)₂ H

H H

1154. CH(CH₃)₂ H

H H

1155. CH(CH₃)₂ H

H H

1156. CH(CH₃)₂ H

H H

1157. CH(CH₃)₂ H

H H

1158. CD(CH₃)₂ H CD₃ H

CD₃ 1159. CD(CH₃)₂ H CD₂CD₃ H

CD₃ 1160. CD(CH₃)₂ H CD₂CH₃ H

CD₃ 1161. CD(CH₃)₂ H CD(CD₃)₂ H

CD₃ 1162. CD(CH₃)₂ H CD(CH₃)₂ H

CD₃ 1163. CD(CH₃)₂ H CD₂CD(CD₃)₂ H

CD₃ 1164. CD(CH₃)₂ H CD₂CH(CH₃)₂ H

CD₃ 1165. CD(CH₃)₂ H CD₂C(CD₃)₃ H

CD₃ 1166. CD(CH₃)₂ H CD₂C(CH₃)₃ H

CD₃ 1167. CD(CH₃)₂ H CD₂CD₂CF₃ H

CD₃ 1168. CD(CH₃)₂ H CD₂CH₂CF₃ H

CD₃ 1169. CD(CH₃)₂ H CD₂CCF₃(CH₃)₂ H

CD₃ 1170. CD(CH₃)₂ H

H

CD₃ 1171. CD(CH₃)₂ H

H

CD₃ 1172. CD(CH₃)₂ H

H

CD₃ 1173. CD(CH₃)₂ H

H

CD₃ 1174. CD(CH₃)₂ H

H

CD₃ 1175. CD(CH₃)₂ H

H

CD₃ 1176. CD(CH₃)₂ H

H

CD₃ 1177. CD(CH₃)₂ H

H

CD₃ 1178. CD(CH₃)₂ H

H

CD₃ 1179. CD(CH₃)₂ H

H

CD₃ 1180. CD(CH₃)₂ H

H

CD₃ 1181. CD(CH₃)₂ H

H

CD₃ 1182. CD(CH₃)₂ H

H

CD₃ 1183. CD(CH₃)₂ H

H

CD₃ 1184. CD(CH₃)₂ H

H

CD₃ 1185. CD(CH₃)₂ H

H

CD₃ 1186. CD(CH₃)₂ H

H

CD₃ 1187. CD(CH₃)₂ H

H

CD₃ 1188. CD(CH₃)₂ H

H

CD₃ 1189. CD(CH₃)₂ H

H

CD₃ 1190. CD(CD₃)₂ H CD₃ H CD(CD₃)₂ CD(CD₃)₂ 1191. CD(CD₃)₂ H CD₂CD₃ H CD(CD₃)₂ CD(CD₃)₂ 1192. CD(CD₃)₂ H CD₂CH₃ H CD(CD₃)₂ CD(CD₃)₂ 1193. CD(CD₃)₂ H CD(CD₃)₂ H CD(CD₃)₂ CD(CD₃)₂ 1194. CD(CD₃)₂ H CD(CH₃)₂ H CD(CD₃)₂ CD(CD₃)₂ 1195. CD(CD₃)₂ H CD₂CD(CD₃)₂ H CD(CD₃)₂ CD(CD₃)₂ 1196. CD(CD₃)₂ H CD₂CH(CH₃)₂ H CD(CD₃)₂ CD(CD₃)₂ 1197. CD(CD₃)₂ H CD₂C(CD₃)₃ H CD(CD₃)₂ CD(CD₃)₂ 1198. CD(CD₃)₂ H CD₂C(CH₃)₃ H CD(CD₃)₂ CD(CD₃)₂ 1199. CD(CD₃)₂ H CD₂CD₂CF₃ H CD(CD₃)₂ CD(CD₃)₂ 1200. CD(CD₃)₂ H CD₂CH₂CF₃ H CD(CD₃)₂ CD(CD₃)₂ 1201. CD(CD₃)₂ H CD₂CCF₃(CH₃)₂ H CD(CD₃)₂ CD(CD₃)₂ 1202. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂ 1203. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂ 1204. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂ 1205. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂ 1206. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂ 1207. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂ 1208. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂ 1209. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂ 1210. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂ 1211. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂ 1212. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂ 1213. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂ 1214. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂ 1215. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂ 1216. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂ 1217. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂ 1218. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂ 1219. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂ 1220. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂ 1221. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂ 1222. CH(CH₃)₂ H H CH₃ H CH₃ 1223. CH(CH₃)₂ H H CH₂CH₃ H CH₃ 1224. CH(CH₃)₂ H H CH(CH₃)₂ H CH3 1225. CH(CH₃)₂ H H CH₂CH(CH₃)₂ H CH₃ 1226. CH(CH₃)₂ H H C(CH₃)₃ H CH₃ 1227. CH(CH₃)₂ H H CH₂C(CH₃)₃ H CH₃ 1228. CH(CH₃)₂ H H CH₂CH₂CF₃ H CH₃ 1229. CH(CH₃)₂ H H CH₂CCF₃(CH₃)₂ H CH₃ 1230. CH(CH₃)₂ H H

H CH₃ 1231. CH(CH₃)₂ H H

H CH₃ 1232. CH(CH₃)₂ H H

H CH₃ 1233. CH(CH₃)₂ H H

H CH₃ 1234. CH(CH₃)₂ H H

H CH₃ 1235. CH(CH₃)₂ H H

H CH₃ 1236. CH(CH₃)₂ H H

H CH₃ 1237. CH(CH₃)₂ H H

H CH₃ 1238. CH(CH₃)₂ H H

H CH₃ 1239. CH(CH₃)₂ H H

H CH₃ 1240. CH(CH₃)₂ H H

H CH₃ 1241. CH(CH₃)₂ H H

H CH₃ 1242. CH(CH₃)₂ H H

H CH₃ 1243. CH(CH₃)₂ H H

H CH₃ 1244. CH(CH₃)₂ H H

H CH₃ 1245. CH(CH₃)₂ H H

H CH₃ 1246. CH(CH₃)₂ H H

H CH₃ 1247. CH(CH₃)₂ H H

H CH₃ 1248. CH(CH₃)₂ H H

H CH₃ 1249. CH(CH₃)₂ H H

H CH₃ 1250. CH(CH₃)₂ CH₃ CH₃ H CH₃ CH₃ 1251. CH(CH₃)₂ CH₂CH₃ CH₃ H CH₃ CH₃ 1252. CH(CH₃)₂ CH(CH₃)₂ CH₃ H CH₃ CH₃ 1253. CH(CH₃)₂ CH₂CH(CH₃)₂ CH₃ H CH₃ CH₃ 1254. CH(CH₃)₂ C(CH₃)₃ CH₃ H CH₃ CH₃ 1255. CH(CH₃)₂ CH₂C(CH₃)₃ CH₃ H CH₃ CH₃ 1256. CH(CH₃)₂ CH₂CH₂CF₃ CH₃ H CH₃ CH₃ 1257. CH(CH₃)₂ CH₂CCF₃(CH₃)₂ CH₃ H CH₃ CH₃ 1258. CH(CH₃)₂

CH₃ H CH₃ CH₃ 1259. CH(CH₃)₂

CH₃ H CH₃ CH₃ 1260. CH(CH₃)₂

CH₃ H CH₃ CH₃ 1261. CH(CH₃)₂

CH₃ H CH₃ CH₃ 1262. CH(CH₃)₂

CH₃ H CH₃ CH₃ 1263. CH(CH₃)₂

CH₃ H CH₃ CH₃ 1264. CH(CH₃)₂

CH₃ H CH₃ CH₃ 1265. CH(CH₃)₂

CH₃ H CH₃ CH₃ 1266. CH(CH₃)₂

CH₃ H CH₃ CH₃ 1267. CH(CH₃)₂

CH₃ H CH₃ CH₃ 1268. CH(CH₃)₂

CH₃ H CH₃ CH₃ 1269. CH(CH₃)₂

CH₃ H CH₃ CH₃ 1270. CH(CH₃)₂

CH₃ H CH₃ CH₃ 1271. CH(CH₃)₂

CH₃ H CH₃ CH₃ 1272. CH(CH₃)₂

CH₃ H CH₃ CH₃ 1273. CH(CH₃)₂

CH₃ H CH₃ CH₃ 1274. CH(CH₃)₂

CH₃ H CH₃ CH₃ 1275. CH(CH₃)₂

CH₃ H CH₃ CH₃ 1276. CH(CH₃)₂

CH₃ H CH₃ CH₃ 1277. CH(CH₃)₂

CH₃ H CH₃ CH₃ 1278. CD(CH₃)₂ CD₃ CD₃ H CH₃ CH₃ 1279. CD(CH₃)₂ CD₂CD₃ CD₃ H CH₃ CH₃ 1280. CD(CH₃)₂ CD₂CH₃ CD₃ H CH₃ CH₃ 1281. CD(CH₃)₂ CD(CD₃)₂ CD₃ H CH₃ CH₃ 1282. CD(CH₃)₂ CD(CH₃)₂ CD₃ H CH₃ CH₃ 1283. CD(CH₃)₂ CD₂CD(CD₃)₂ CD₃ H CH₃ CH₃ 1284. CD(CH₃)₂ CD₂CH(CH₃)₂ CD₃ H CH₃ CH₃ 1285. CD(CH₃)₂ CD₂C(CD₃)₃ CD₃ H CH₃ CH₃ 1286. CD(CH₃)₂ CD₂C(CH₃)₃ CD₃ H CH₃ CH₃ 1287. CD(CH₃)₂ CD₂CD₂CF₃ CD₃ H CH₃ CH₃ 1288. CD(CH₃)₂ CD₂CH₂CF₃ CD₃ H CH₃ CH₃ 1289. CD(CH₃)₂ CD₂CCF₃(CH₃)₂ CD₃ H CH₃ CH₃ 1290. CD(CH₃)₂

CD₃ H CH₃ CH₃ 1291. CD(CH₃)₂

CD₃ H CH₃ CH₃ 1292. CD(CH₃)₂

CD₃ H CH₃ CH₃ 1293. CD(CH₃)₂

CD₃ H CH₃ CH₃ 1294. CD(CH₃)₂

CD₃ H CH₃ CH₃ 1295. CD(CH₃)₂

CD₃ H CH₃ CH₃ 1296. CD(CH₃)₂

CD₃ H CH₃ CH₃ 1297. CD(CH₃)₂

CD₃ H CH₃ CH₃ 1298. CD(CH₃)₂

CD₃ H CH₃ CH₃ 1299. CD(CH₃)₂

CD₃ H CH₃ CH₃ 1300. CD(CH₃)₂

CD₃ H CH₃ CH₃ 1301. CD(CH₃)₂

CD₃ H CH₃ CH₃ 1302. CD(CH₃)₂

CD₃ H CH₃ CH₃ 1303. CD(CH₃)₂

CD₃ H CH₃ CH₃ 1304. CD(CH₃)₂

CD₃ H CH₃ CH₃ 1305. CD(CH₃)₂

CD₃ H CH₃ CH₃ 1306. CD(CH₃)₂

CD₃ H CH₃ CH₃ 1307. CD(CH₃)₂

CD₃ H CH₃ CH₃ 1308. CD(CH₃)₂

CD₃ H CH₃ CH₃ 1309. CD(CH₃)₂

CD₃ H CH₃ CH₃ 1310. CD(CD₃)₂ CD₂CD₃ CD₃ H CD₂CD₃ CD₂CD₃ 1311. CD(CD₃)₂ CD₂CH₃ CD₃ H CD₂CD₃ CD₂CD₃ 1312. CD(CD₃)₂ CD(CD₃)₂ CD₃ H CD₂CD₃ CD₂CD₃ 1313. CD(CD₃)₂ CD(CH₃)₂ CD₃ H CD₂CD₃ CD₂CD₃ 1314. CD(CD₃)₂ CD₂CD(CD₃)₂ CD₃ H CD₂CD₃ CD₂CD₃ 1315. CD(CD₃)₂ CD₂CH(CH₃)₂ CD₃ H CD₂CD₃ CD₂CD₃ 1316. CD(CD₃)₂ CD₂C(CD₃)₃ CD₃ H CD₂CD₃ CD₂CD₃ 1317. CD(CD₃)₂ CD₂C(CH₃)₃ CD₃ H CD₂CD₃ CD₂CD₃ 1318. CD(CD₃)₂ CD₂CD₂CF₃ CD₃ H CD₂CD₃ CD₂CD₃ 1319. CD(CD₃)₂ CD₂CH₂CF₃ CD₃ H CD₂CD₃ CD₂CD₃ 1320. CD(CD₃)₂ CD₂CCF₃(CH₃)₂ CD₃ H CD₂CD₃ CD₂CD₃ 1321. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃ 1322. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃ 1323. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃ 1324. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃ 1325. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃ 1326. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃ 1327. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃ 1328. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃ 1329. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃ 1330. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃ 1331. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃ 1332. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃ 1333. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃ 1334. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃ 1335. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃ 1336. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃ 1337. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃ 1338. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃ 1339. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃ 1340. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃ 1341. CH(CH₃)₂ CH₃ CH₂CH₃ H CD₂CD₃ CD₂CD₃ 1342. CH(CH₃)₂ CH₃ CH(CH₃)₂ H CD₂CD₃ CD₂CD₃ 1343. CH(CH₃)₂ CH₃ CH₂CH(CH₃)₂ H CD₂CD₃ CD₂CD₃ 1344. CH(CH₃)₂ CH₃ C(CH₃)₃ H CD₂CD₃ CD₂CD₃ 1345. CH(CH₃)₂ CH₃ CH₂C(CH₃)₃ H CD₂CD₃ CD₂CD₃ 1346. CH(CH₃)₂ CH₃ CH₂CH₂CF₃ H CD₂CD₃ CD₂CD₃ 1347. CH(CH₃)₂ CH₃ CH₂CCF₃(CH₃)₂ H CD₂CD₃ CD₂CD₃ 1348. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃ 1349. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃ 1350. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃ 1351. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃ 1352. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃ 1353. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃ 1354. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃ 1355. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃ 1356. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃ 1357. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃ 1358. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃ 1359. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃ 1360. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃ 1361. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃ 1362. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃ 1363. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃ 1364. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃ 1365. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃ 1366. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃ 1367. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃ 1368. CD(CH₃)₂ CD₃ CD₂CD₃ H CD₂CD₃ CD₂CD₃ 1369. CD(CH₃)₂ CD₃ CD₂CH₃ H CD₂CD₃ CD₂CD₃ 1370. CD(CH₃)₂ CD₃ CD(CD₃)₂ H CD₂CD₃ CD₂CD₃ 1371. CD(CH₃)₂ CD₃ CD(CH₃)₂ H CD₂CD₃ CD₂CD₃ 1372. CD(CH₃)₂ CD₃ CD₂CD(CD₃)₂ H CD₂CD₃ CD₂CD₃ 1373. CD(CH₃)₂ CD₃ CD₂CH(CH₃)₂ H CD₂CD₃ CD₂CD₃ 1374. CD(CH₃)₂ CD₃ CD₂C(CD₃)₃ H CD₂CD₃ CD₂CD₃ 1375. CD(CH₃)₂ CD₃ CD₂C(CH₃)₃ H CD₂CD₃ CD₂CD₃ 1376. CD(CH₃)₂ CD₃ CD₂CD₂CF₃ H CD₂CD₃ CD₂CD₃ 1377. CD(CH₃)₂ CD₃ CD₂CH₂CF₃ H CD₂CD₃ CD₂CD₃ 1378. CD(CH₃)₂ CD₃ CD₂CCF₃(CH₃)₂ H CD₂CD₃ CD₂CD₃ 1379. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃ 1380. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃ 1381. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃ 1382. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃ 1383. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃ 1384. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃ 1385. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃ 1386. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃ 1387. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃ 1388. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃ 1389. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃ 1390. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃ 1391. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃ 1392. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃ 1393. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃ 1394. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃ 1395. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃ 1396. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃ 1397. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃ 1398. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃ 1399.

CD₃ H H H CD₃ 1400.

CD₃ CD₃ H H CD₃ 1401.

CD₃ H CD₃ H CD₃ 1402.

CD₃ CD₃ CD₃ H CD₃ 1403.

CD₃ H H H CD₃ 1404.

CD₃ CD₃ H H CD₃ 1405.

CD₃ H CD₃ H CD₃ 1406.

CD₃ CD₃ CD₃ H CD₃ 1407.

CD₃ H H H CD₃ 1408.

CD₃ CD₃ H H CD₃ 1409.

CD₃ H CD₃ H CD₃ 1410.

CD₃ CD₃ CD₃ H CD₃ 1411.

CD₃ H H H CD₃ 1412.

CD₃ CD₃ H H CD₃ 1413.

CD₃ H CD₃ H CD₃ 1414.

CD₃ CD₃ CD₃ H CD₃ 1415.

CD₃ H H H CD₃ 1416.

CD₃ CD₃ H H CD₃ 1417.

CD₃ H CD₃ H CD₃ 1418.

CD₃ CD₃ CD₃ H CD₃ 1419.

CD₃ H H H CD₃ 1420.

CD₃ CD₃ H H CD₃ 1421.

CD₃ H CD₃ H CD₃ 1422.

CD₃ CD₃ CD₃ H CD₃ 1423.

CD₃ H H H CD₃ 1424.

CD₃ CD₃ H H CD₃ 1425.

CD₃ H CD₃ H CD₃ 1426.

CD₃ CD₃ CD₃ H CD₃ 1427.

CD₃ H H H CD₃ 1428.

CD₃ CD₃ H H CD₃ 1429.

CD₃ H CD₃ H H 1430.

CD₃ CD₃ CD₃ H H 1431. CD₃ H

H H H 1432. CD₃ CD₃ CD₃ H H H

In some embodiments, the compound has a formula of ML_(n)(L_(B))_(m-n), where M is Ir or Pt; L_(B) is a bidentate ligand; when M is Ir, m is 3, and n is 1, 2, or 3; and when M is Pt, m is 2, and n is 1, or 2.

In some such embodiments, the compound has a formula of IrL₃. In some such embodiments, the compound has a formula of IrL(L_(B))₂; and wherein L_(B) is different from L.

In some embodiments, the compound has a formula of Ir(L)₂(L_(B)), and L_(B) is different from L.

In some embodiments, the compound has a formula of Pt(L)(L_(B)), and wherein L and L_(B) can be the same or different. In some such embodiments, L and L_(B) are connected to form a tetradentate ligand. In some embodiments, wherein L and L_(B) are connected at two places to form a macrocyclic tetradentate ligand.

In some embodiments where the compound has a formula of ML_(n)(L_(B))_(m-n), either (i) M is Ir, m is 3, and n is 1 or 2, or (ii) M is Pt, m is 2, and n is 1; and L_(B) is selected from the group consisting of:

where:

-   -   each of X¹ to X¹³ are independently selected from the group         consisting of carbon and nitrogen;     -   X is selected from the group consisting of BR′, NR′, PR′, O, S,         Se, C═O, S═O, SO₂, CR′R″, SiR′R″, and GeR′R″;     -   R′ and R″ are optionally fused or joined to form a ring;     -   each R_(a), R_(b), R_(c), and R_(d) may represent from mono         substitution to the possible maximum number of substitution, or         no substitution;     -   R′, R″, R_(a), R_(b), R_(c), and R_(d) are each independently         selected from the group consisting of hydrogen, deuterium,         halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy,         aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl,         alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids,         ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl,         phosphino, and combinations thereof; and     -   any two adjacent substitutents of R_(a), R_(b), R_(c), and R_(d)         are optionally fused or joined to form a ring or form a         multidentate ligand.

In some embodiments where the compound has a formula of ML_(n)(L_(B))_(m-n), either (i) M is Ir, m is 3, and n is 1 or 2, or (ii) M is Pt, m is 2, and n is 1; and L_(B) is selected from the group consisting of L_(B1) to L_(B300) as shown below:

Ligand L can be L^(A1) to L^(A1432), L^(B1) to L^(B1432), L^(C1) to L^(C1432), and L^(D1) to L^(D1432), while L_(B) can be another ligand in the organometallic complex. Thus, it should be readily apparent that ligands L^(B1) to L^(B1432) are different and distinct from ligands L_(B1) to L_(B300).

In some embodiments, the compound is selected from the group consisting of compound A-1 to compound A-429,600, compound B-1 to compound B-429,600, compound C-1 to compound C-429,600, and compound D-1 to compound D-429,600, where:

-   -   Compound k-x has the formula Ir(L^(ki))(L_(Bj))₂;     -   x=300i+j−300; k is A, B, C, or D; i is an integer from 1 to         1430, and j is an integer from 1 to 300; and     -   L_(B1) to L_(B300) have the structures provided herein.

In some embodiments, the compound can be an emissive dopant. In some embodiments, the compound can produce emissions via phosphorescence, fluorescence, thermally activated delayed fluorescence, i.e., TADF (also referred to as E-type delayed fluorescence), triplet-triplet annihilation, or combinations of these processes.

In another embodiment, an organic light emitting device (OLED) comprising an anode; a cathode; and an organic layer, disposed between the anode and the cathode is described. In some embodiments, a consumer product containing an OLED as described herein is described. The organic layer includes a compound having a ligand L having the formula:

as described herein.

According to another aspect of the present disclosure, a formulation comprising the compound having a ligand L with the structure

is provided.

The OLED disclosed herein can be incorporated into one or more of a consumer product, an electronic component module, and a lighting panel. The organic layer can be an emissive layer and the compound can be an emissive dopant in some embodiments, while the compound can be a non-emissive dopant in other embodiments.

The organic layer can also include a host. In some embodiments, two or more hosts are preferred. In some embodiments, the hosts used maybe a) bipolar, b) electron transporting, c) hole transporting or d) wide band gap materials that play little role in charge transport. In some embodiments, the host can include a metal complex. The host can be a triphenylene containing benzo-fused thiophene or benzo-fused furan. Any substituent in the host can be an unfused substituent independently selected from the group consisting of C_(n)H_(2n+1), OC_(n)H_(2n+1), OAr₁, N(C_(n)H_(2n+1))₂, N(Ar₁)(Ar₂), CH═CH—C_(n)H_(2n+1), C≡C—C_(n)H_(2n+1), Ar₁, Ar₁-Ar₂, and C_(n)H_(2n)-Ar₁, or the host has no substitutions. In the preceding substituents n can range from 1 to 10; and Ar₁ and Ar₂ can be independently selected from the group consisting of benzene, biphenyl, naphthalene, triphenylene, carbazole, and heteroaromatic analogs thereof. The host can be an inorganic compound. For example, a Zn containing inorganic material e.g. ZnS.

The host can be a compound comprising at least one chemical group selected from the group consisting of triphenylene, carbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, azatriphenylene, azacarbazole, aza-dibenzothiophene, aza-dibenzofuran, and aza-dibenzoselenophene. The host can include a metal complex. The host can be, but is not limited to, a specific compound selected from the group consisting of:

and combinations thereof. Additional information on possible hosts is provided below.

In yet another aspect of the present disclosure, a formulation that comprises a compound according to Formula I is described. The formulation can include one or more components selected from the group consisting of a solvent, a host, a hole injection material, hole transport material, and an electron transport layer material, disclosed herein.

Combination with Other Materials

The materials described herein as useful for a particular layer in an organic light emitting device may be used in combination with a wide variety of other materials present in the device. For example, emissive dopants disclosed herein may be used in conjunction with a wide variety of hosts, transport layers, blocking layers, injection layers, electrodes and other layers that may be present. The materials described or referred to below are non-limiting examples of materials that may be useful in combination with the compounds disclosed herein, and one of skill in the art can readily consult the literature to identify other materials that may be useful in combination.

Conductivity Dopants:

A charge transport layer can be doped with conductivity dopants to substantially alter its density of charge carriers, which will in turn alter its conductivity. The conductivity is increased by generating charge carriers in the matrix material, and depending on the type of dopant, a change in the Fermi level of the semiconductor may also be achieved. Hole-transporting layer can be doped by p-type conductivity dopants and n-type conductivity dopants are used in the electron-transporting layer.

Non-limiting examples of the conductivity dopants that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: EP01617493, EP01968131, EP2020694, EP2684932, US20050139810, US20070160905, US20090167167, US2010288362, WO06081780, WO2009003455, WO2009008277, WO2009011327, WO2014009310, US2007252140, US2015060804 and US2012146012.

HIL/HTL:

A hole injecting/transporting material to be used in the present invention is not particularly limited, and any compound may be used as long as the compound is typically used as a hole injecting/transporting material. Examples of the material include, but are not limited to: a phthalocyanine or porphyrin derivative; an aromatic amine derivative; an indolocarbazole derivative; a polymer containing fluorohydrocarbon; a polymer with conductivity dopants; a conducting polymer, such as PEDOT/PSS; a self-assembly monomer derived from compounds such as phosphonic acid and silane derivatives; a metal oxide derivative, such as MoO_(x); a p-type semiconducting organic compound, such as 1,4,5,8,9,12-Hexaazatriphenylenehexacarbonitrile; a metal complex, and a cross-linkable compounds.

Examples of aromatic amine derivatives used in HIL or HTL include, but not limit to the following general structures:

Each of Ar¹ to Ar⁹ is selected from the group consisting of aromatic hydrocarbon cyclic compounds such as benzene, biphenyl, triphenyl, triphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene; the group consisting of aromatic heterocyclic compounds such as dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine; and the group consisting of 2 to 10 cyclic structural units which are groups of the same type or different types selected from the aromatic hydrocarbon cyclic group and the aromatic heterocyclic group and are bonded to each other directly or via at least one of oxygen atom, nitrogen atom, sulfur atom, silicon atom, phosphorus atom, boron atom, chain structural unit and the aliphatic cyclic group. Each Ar may be unsubstituted or may be substituted by a substituent selected from the group consisting of deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.

In one aspect, Ar¹ to Ar⁹ is independently selected from the group consisting of:

wherein k is an integer from 1 to 20; X¹⁰¹ to X¹⁰⁸ is C (including CH) or N; Z¹⁰¹ is NAr¹, O, or S; Ar¹ has the same group defined above.

Examples of metal complexes used in HIL or HTL include, but are not limited to the following general formula:

wherein Met is a metal, which can have an atomic weight greater than 40; (Y¹⁰¹-Y¹⁰²) is a bidentate ligand, Y¹⁰¹ and Y¹⁰² are independently selected from C, N, O, P, and S; L¹⁰¹ is an ancillary ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal; and k′+k″ is the maximum number of ligands that may be attached to the metal.

In one aspect, (Y¹⁰¹-Y¹⁰²) is a s a 2-phenylpyridine derivative. In another aspect, (Y¹⁰¹-Y¹⁰²) is a carbene ligand. In another aspect, Met is selected from Ir, Pt, Os, and Zn. In a further aspect, the metal complex has a smallest oxidation potential in solution vs. Fc⁺/Fc couple less than about 0.6 V.

Non-limiting examples of the HIL and HTL materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: CN102702075, DE102012005215, EP01624500, EP01698613, EP01806334, EP01930964, EP01972613, EP01997799, EP02011790, EP02055700, EP02055701, EP1725079, EP2085382, EP2660300, EP650955, JP07-073529, JP2005112765, JP2007091719, JP2008021687, JP2014-009196, KR20110088898, KR20130077473, TW201139402, U.S. Ser. No. 06/517,957, US20020158242, US20030162053, US20050123751, US20060182993, US20060240279, US20070145888, US20070181874, US20070278938, US20080014464, US20080091025, US20080106190, US20080124572, US20080145707, US20080220265, US20080233434, US20080303417, US2008107919, US20090115320, US20090167161, US2009066235, US2011007385, US20110163302, US2011240968, US2011278551, US2012205642, US2013241401, US20140117329, US2014183517, U.S. Pat. Nos. 5,061,569, 5,639,914, WO05075451, WO07125714, WO08023550, WO08023759, WO2009145016, WO2010061824, WO2011075644, WO2012177006, WO2013018530, WO2013039073, WO2013087142, WO2013118812, WO2013120577, WO2013157367, WO2013175747, WO2014002873, WO2014015935, WO2014015937, WO2014030872, WO2014030921, WO2014034791, WO2014104514, WO2014157018.

EBL:

An electron blocking layer (EBL) may be used to reduce the number of electrons and/or excitons that leave the emissive layer. The presence of such a blocking layer in a device may result in substantially higher efficiencies, and or longer lifetime, as compared to a similar device lacking a blocking layer. Also, a blocking layer may be used to confine emission to a desired region of an OLED. In some embodiments, the EBL material has a higher LUMO (closer to the vacuum level) and/or higher triplet energy than the emitter closest to the EBL interface. In some embodiments, the EBL material has a higher LUMO (closer to the vacuum level) and or higher triplet energy than one or more of the hosts closest to the EBL interface. In one aspect, the compound used in EBL contains the same molecule or the same functional groups used as one of the hosts described below.

Host:

The light emitting layer of the organic EL device of the present invention preferably contains at least a metal complex as light emitting material, and may contain a host material using the metal complex as a dopant material. Examples of the host material are not particularly limited, and any metal complexes or organic compounds may be used as long as the triplet energy of the host is larger than that of the dopant. Any host material may be used with any dopant so long as the triplet criteria is satisfied.

Examples of metal complexes used as host are preferred to have the following general formula:

wherein Met is a metal; (Y¹⁰³-Y¹⁰⁴) is a bidentate ligand, Y¹⁰³ and Y¹⁰⁴ are independently selected from C, N, O, P, and S; L¹⁰¹ is an another ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal; and k′+k″ is the maximum number of ligands that may be attached to the metal.

In one aspect, the metal complexes are:

wherein (O—N) is a bidentate ligand, having metal coordinated to atoms O and N.

In another aspect, Met is selected from Ir and Pt. In a further aspect, (Y¹⁰³-Y¹⁰⁴) is a carbene ligand.

Examples of other organic compounds used as host are selected from the group consisting of aromatic hydrocarbon cyclic compounds such as benzene, biphenyl, triphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene; the group consisting of aromatic heterocyclic compounds such as dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine; and the group consisting of 2 to 10 cyclic structural units which are groups of the same type or different types selected from the aromatic hydrocarbon cyclic group and the aromatic heterocyclic group and are bonded to each other directly or via at least one of oxygen atom, nitrogen atom, sulfur atom, silicon atom, phosphorus atom, boron atom, chain structural unit and the aliphatic cyclic group. Each option within each group may be unsubstituted or may be substituted by a substituent selected from the group consisting of deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.

In one aspect, the host compound contains at least one of the following groups in the molecule:

wherein each of R¹⁰¹ to R¹⁰⁷ is independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and when it is aryl or heteroaryl, it has the similar definition as Ar's mentioned above. k is an integer from 0 to 20 or 1 to 20; k′″ is an integer from 0 to 20. X¹⁰¹ to X¹⁰⁸ is selected from C (including CH) or N. Z¹⁰¹ and Z¹⁰² is selected from NR¹⁰¹, O, or S.

Non-limiting examples of the host materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: EP2034538, EP2034538A, EP2757608, JP2007254297, KR20100079458, KR20120088644, KR20120129733, KR20130115564, TW201329200, US20030175553, US20050238919, US20060280965, US20090017330, US20090030202, US20090167162, US20090302743, US20090309488, US20100012931, US20100084966, US20100187984, US2010187984, US2012075273, US2012126221, US2013009543, US2013105787, US2013175519, US2014001446, US20140183503, US20140225088, US2014034914, U.S. Pat. No. 7,154,114, WO2001039234, WO2004093207, WO2005014551, WO2005089025, WO2006072002, WO2006114966, WO2007063754, WO2008056746, WO2009003898, WO2009021126, WO2009063833, WO2009066778, WO2009066779, WO2009086028, WO2010056066, WO2010107244, WO2011081423, WO2011081431, WO2011086863, WO2012128298, WO2012133644, WO2012133649, WO2013024872, WO2013035275, WO2013081315, WO2013191404, WO2014142472,

Additional Emitters:

One or more additional emitter dopants may be used in conjunction with the compound of the present disclosure. Examples of the additional emitter dopants are not particularly limited, and any compounds may be used as long as the compounds are typically used as emitter materials. Examples of suitable emitter materials include, but are not limited to, compounds which can produce emissions via phosphorescence, fluorescence, thermally activated delayed fluorescence, i.e., TADF (also referred to as E-type delayed fluorescence), triplet annihilation, or combinations of these processes.

Non-limiting examples of the emitter materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: CN103694277, CN1696137, EB01238981, EP01239526, EP01961743, EP1239526, EP1244155, EP1642951, EP1647554, EP1841834, EP1841834B, EP2062907, EP2730583, JP2012074444, JP2013110263, JP4478555, KR1020090133652, KR20120032054, KR20130043460, TW201332980, U.S. Ser. No. 06/699,599, U.S. Ser. No. 06/916,554, US20010019782, US20020034656, US20030068526, US20030072964, US20030138657, US20050123788, US20050244673, US2005123791, US2005260449, US20060008670, US20060065890, US20060127696, US20060134459, US20060134462, US20060202194, US20060251923, US20070034863, US20070087321, US20070103060, US20070111026, US20070190359, US20070231600, US2007034863, US2007104979, US2007104980, US2007138437, US2007224450, US2007278936, US20080020237, US20080233410, US20080261076, US20080297033, US200805851, US2008161567, US2008210930, US20090039776, US20090108737, US20090115322, US20090179555, US2009085476, US2009104472, US20100090591, US20100148663, US20100244004, US20100295032, US2010102716, US2010105902, US2010244004, US2010270916, US20110057559, US20110108822, US20110204333, US2011215710, US2011227049, US2011285275, US2012292601, US20130146848, US2013033172, US2013165653, US2013181190, US2013334521, US20140246656, US2014103305, U.S. Pat. Nos. 6,303,238, 6,413,656, 6,653,654, 6,670,645, 6,687,266, 6,835,469, 6,921,915, 7,279,704, 7,332,232, 7,378,162, 7,534,505, 7,675,228, 7,728,137, 7,740,957, 7,759,489, 7,951,947, 8,067,099, 8,592,586, 8,871,361, WO06081973, WO06121811, WO07018067, WO07108362, WO07115970, WO07115981, WO08035571, WO2002015645, WO2003040257, WO2005019373, WO2006056418, WO2008054584, WO2008078800, WO2008096609, WO2008101842, WO2009000673, WO2009050281, WO2009100991, WO2010028151, WO2010054731, WO2010086089, WO2010118029, WO2011044988, WO2011051404, WO2011107491, WO2012020327, WO2012163471, WO2013094620, WO2013107487, WO2013174471, WO2014007565, WO2014008982, WO2014023377, WO2014024131, WO2014031977, WO2014038456, WO2014112450.

HBL:

A hole blocking layer (HBL) may be used to reduce the number of holes and/or excitons that leave the emissive layer. The presence of such a blocking layer in a device may result in substantially higher efficiencies and/or longer lifetime as compared to a similar device lacking a blocking layer. Also, a blocking layer may be used to confine emission to a desired region of an OLED. In some embodiments, the HBL material has a lower HOMO (further from the vacuum level) and or higher triplet energy than the emitter closest to the HBL interface. In some embodiments, the HBL material has a lower HOMO (further from the vacuum level) and or higher triplet energy than one or more of the hosts closest to the HBL interface.

In one aspect, compound used in HBL contains the same molecule or the same functional groups used as host described above.

In another aspect, compound used in HBL contains at least one of the following groups in the molecule:

wherein k is an integer from 1 to 20; L¹⁰¹ is an another ligand, k′ is an integer from 1 to 3. ETL:

Electron transport layer (ETL) may include a material capable of transporting electrons. Electron transport layer may be intrinsic (undoped), or doped. Doping may be used to enhance conductivity. Examples of the ETL material are not particularly limited, and any metal complexes or organic compounds may be used as long as they are typically used to transport electrons.

In one aspect, compound used in ETL contains at least one of the following groups in the molecule:

wherein R¹⁰¹ is selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, when it is aryl or heteroaryl, it has the similar definition as Ar's mentioned above. Ar¹ to Ar³ has the similar definition as Ar's mentioned above. k is an integer from 1 to 20. X¹⁰¹ to X¹⁰⁸ is selected from C (including CH) or N.

In another aspect, the metal complexes used in ETL contains, but not limit to the following general formula:

wherein (O—N) or (N—N) is a bidentate ligand, having metal coordinated to atoms O, N or N, N; L¹⁰¹ is another ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal.

Non-limiting examples of the ETL materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: CN103508940, EP01602648, EP01734038, EP01956007, JP2004-022334, JP2005149918, JP2005-268199, KR0117693, KR20130108183, US20040036077, US20070104977, US2007018155, US20090101870, US20090115316, US20090140637, US20090179554, US2009218940, US2010108990, US2011156017, US2011210320, US2012193612, US2012214993, US2014014925, US2014014927, US20140284580, U.S. Pat. Nos. 6,656,612, 8,415,031, WO2003060956, WO2007111263, WO2009148269, WO2010067894, WO2010072300, WO2011074770, WO2011105373, WO2013079217, WO2013145667, WO2013180376, WO2014104499, WO2014104535,

Charge Generation Layer (CGL)

In tandem or stacked OLEDs, the CGL plays an essential role in the performance, which is composed of an n-doped layer and a p-doped layer for injection of electrons and holes, respectively. Electrons and holes are supplied from the CGL and electrodes. The consumed electrons and holes in the CGL are refilled by the electrons and holes injected from the cathode and anode, respectively; then, the bipolar currents reach a steady state gradually. Typical CGL materials include n and p conductivity dopants used in the transport layers.

In any above-mentioned compounds used in each layer of the OLED device, the hydrogen atoms can be partially or fully deuterated. Thus, any specifically listed substituent, such as, without limitation, methyl, phenyl, pyridyl, etc. may be undeuterated, partially deuterated, and fully deuterated versions thereof. Similarly, classes of substituents such as, without limitation, alkyl, aryl, cycloalkyl, heteroaryl, etc. also may be undeuterated, partially deuterated, and fully deuterated versions thereof.

Experimental Synthesis of compound Ir L^(A1431)(L_(B91))₂

Step 1

A 250 mL two-necked round-bottomed flask was flushed with nitrogen, then charged with 2-bromo-4-chloro-5-methylpyridine (9.88 g, 47.9 mmol), phenylboronic acid (6.42 g, 52.6 mmol), diacetoxypalladium (0.537 g, 2.393 mmol), triphenylphosphane (2.51 g, 9.57 mmol), potassium hydroxide (5.37 g, 96 mmol) and acetonitrile (150 ml)/ethanol (75 ml) mixture under nitrogen to give a red suspension. The reaction mixture was heated to 60° C. under nitrogen for 16 hrs. Then the reaction mixture was cooled to room temperature (˜22° C.), filtered through a silica gel pad, and evaporated to dryness. The residue was purified by column chromatography (silica gel, heptanes/EtOAc=2/1 (v:v)) and crystallized from heptanes as colorless crystals (6.5 g, 67% yield).

Step 2

4-Chloro-5-methyl-2-phenylpyridine (5 g, 24.55 mmol), (4-cyclohexylphenyl)boronic acid (5.01 g, 24.55 mmol), potassium phosphate tribasic monohydrate (11.31 g, 49.1 mmol), tris(dibenzylideneacetone)dipalladium(0) (Pd₂(dba)₃) (2 mol %) and 2-dicyclohexylphosphino-2′,6′-dimethoxybiphenyl (SPhos) (4 mol %) were dissolved in a dimethoxyethane (DME) (70 ml)/water (5 ml) mixture under nitrogen to give a red suspension. The reaction mixture was degassed and heated to reflux for 16 hrs.

The reaction mixture was then cooled to room temperature (˜22° C.). The organic phase was then separated, filtered, evaporated, and purified by column chromatography on silica gel, eluted with heptanes/tetrahydrofuran (THF) 9/1 (v/v) to yield a clear solidified colorless oil (6.8 g, 85% yield).

Step 3

4-(4-Cyclohexylphenyl)-5-methyl-2-phenylpyridine (6.8 g, 20.77 mmol), ((methyl-d₃)sulfinyl)methane-d₃ (61.2 g, 727 mmol), and sodium 2-methylpropan-2-olate (0.998 g, 10.38 mmol) were suspended together in a flask under nitrogen. The flask was immersed in an oil bath at 71° C. for 18 hrs. The reaction mixture was then cooled to room temperature (˜22° C.), quenched with 3 equivalents of D₂O, diluted with brine, and extracted with EtOAc. The organic phase was separated, filtered, evaporated, and purified using a silica gel column, eluted with heptanes/THF 95/5 (v/v) to yield colorless crystals (6.0 g, 87% yield).

Step 4

Methanol-solvated iridium triflate salt (4 g, 5.12 mmol) and 4-(4-(cyclohexyl-1-d)phenyl)-5-(methyl-d₃)-2-phenylpyridine (5.94 g, 17.90 mmol) were suspended in an ethanol (30 ml)/methanol (30.0 ml) mixture under nitrogen. The reaction mixture was degassed, then the flask was immersed in the oil bath at 70° C. for 3 days. The reaction mixture then was cooled to room temperature (˜22° C.) and filtered, and the solid material was dried. The mixture was purified by column chromatographyon silica gel column that was eluted with a gradient heptane/toluene 4/1 to 1/4 (v/v) mixture. Pure fractions were evaporated and crystallized from DCM/ethanol, to produce 1.8 g (39% yield) of bright yellow solid.

Synthesis of Ir L^(A1432)(L_(B91))₂

Step 1

4-Chloro-5-methyl-2-phenylpyridine (6 g, 29.5 mmol), (3,4-dimethylphenyl)boronic acid (4.86 g, 32.4 mmol), and potassium phosphate tribasic hydrate (13.57 g, 58.9 mmol) were dissolved in a mixture of DME (60 ml)/water (2 mL) under nitrogen to give a colorless suspension. Pd₂(dba)₃ (0.405 g, 0.442 mmol) and SPhos (0.410 g, 0.884 mmol) were added as one portion, before the reaction mixture was degassed and heated to 100° C. under nitrogen for 16 h. The reaction mixture was then cooled down to room temperature (˜22° C.). The organic phase was separated, evaporated, and purified by column chromatography using a silica gel column eluted with heptanes/THF 95/5 (v/v), then crystallized from heptanes to yield white crystals (7.0 g, 85% yield).

Step 2

4-(3,4-Dimethylphenyl)-5-methyl-2-phenylpyridine (7 g, 25.6 mmol), ((methyl-d3)sulfinyl)methane-d3 (86 g, 1024 mmol), and sodium 2-methylpropan-2-olate (1.723 g, 17.92 mmol) were mixed in a flask under nitrogen to give a brown solution. The flask was immersed in an oil bath at 71° C. for 14 h, cooled down to room temperature (˜22° C.), quenched with 3 equivalents of D₂O, then diluted with brine. The resulting solution was extracted with EtOAc and the organic extracts were combined, filtered and evaporated. The crude material was purified by column chromatography using a silica gel column eluted with heptanes/THF 95/5 (v/v) to yield 4-(3,4-bis(methyl-d3)phenyl)-5-(methyl-d3)-2-phenylpyridine as a white solid (6.0 g, 83% yield).

Step 3

Methanol-solvated iridium triflate salt (2.8 g, 3.58 mmol) and 4-(3,4-bis(methyl-d3)phenyl)-5-(methyl-d3)-2-phenylpyridine (3.03 g, 10.74 mmol) were suspended in an EtOH (30 ml)/MeOH (30.0 ml) mixture in a flask under nitrogen to give a yellow suspension. The flask was immersed in the oil bath 71° C. and stirred under nitrogen for 3 days. The resulting mixture was cooled to room temperature (˜22° C.) and the resulting yellow solid was filtered off and purified by column chromatography using a silica gel column eluted with toluene/heptanes 85/15 (v/v), then crystallized from toluene/ethanol and toluene/heptanes to yield a yellow solid (1.8 g, 59% yield).

Device Examples

All example devices were fabricated by high vacuum (<10⁻⁷ Torr) thermal evaporation. The anode electrode was 800 Å of indium tin oxide (ITO). The cathode consisted of 10 Å of Liq (8-hydroxyquinoline lithium) followed by 1,000 Å of Al. All devices were encapsulated with a glass lid sealed with an epoxy resin in a nitrogen glove box (<1 ppm of H₂O and O₂) immediately after fabrication with a moisture getter incorporated inside the package. The organic stack of the device examples consisted of sequentially, from the ITO Surface: 100 Å of HAT-CN as the hole injection layer (HIL); 450 Å of HTM as a hole transporting layer (HTL); emissive layer (EML) with thickness 400 Å. Emissive layer containing H-host (HO: E-host (H2) in 6:4 ratio and 12 weight % of green emitter. 350 Å of Liq (8-hydroxyquinoline lithium) doped with 40% of ETM as the ETL. Table 1 shows the schematic device structure. The chemical structures of the device materials are shown below.

The fabricated devices were evaluated for EL, JVL and lifetime at DC 80 mA/cm². LT97 at 9,000 nits was calculated from 80 mA/cm2 LT data assuming an acceleration factor of 1.8. Device performance is shown in the table 2.

TABLE 1 schematic device structure Layer Material Thickness [Å] Anode ITO 800 HIL HAT-CN 100 HTL HTM 450 Green H1:H2: example 400 EML dopant ETL Liq:ETM 40% 350 EIL Liq 10 Cathode Al 1,000

TABLE 2 Device performance 1931 CIE At 10 mA/cm² At 9K nits λ max FWHM Voltage LE EQE PE calculated Emitter 12% x y [nm] [nm] [V] [cd/A] [%] [lm/W] 97%[h]** Comparative Example 0.373 0.598 539 80 4.7 81.8 22.5 54.8 1,084 Ir L^(A1431)(L_(B91))₂ 0.365 0.603 537 78 4.6 92.2 25.2 62.3 1,194 Ir L^(A1432)(L_(B91))₂ 0.347 0.613 532 77 4.5 86.5 23.6 59.8 1,194

The efficiency of example Ir L^(A1431)(L_(B91))₂ and Ir L^(A1432)(L_(B91))₂ is higher than the comparative example. Presumably, the alike substitution in the peripheral ring has better alignment with transition dipolar moment of the molecular. The concept is illustrated in the following image. Furthermore, compounds Ir L^(A1431)(L_(B91))₂ and Ir L^(A1432)(L_(B91))₂ are both blue shifted from the comparative example with a lower device lifetime.

It is understood that the various embodiments described herein are by way of example only, and are not intended to limit the scope of the invention. For example, many of the materials and structures described herein may be substituted with other materials and structures without deviating from the spirit of the invention. The present invention as claimed may therefore include variations from the particular examples and preferred embodiments described herein, as will be apparent to one of skill in the art. It is understood that various theories as to why the invention works are not intended to be limiting. 

We claim:
 1. A compound comprising a ligand L having the formula:

wherein R¹ and R⁶ represents mono, di, tri, or tetra substitution, or no substitution; wherein R² represents mono, di, or tri substitution, or no substitution; wherein each R¹, R⁶, R⁷, and R⁸ is independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein R³, R⁴, and R⁵ are independently selected from the group consisting of hydrogen, deuterium, alkyl, partially or fully fluorinated alkyl, cycloalkyl, partially or fully fluorinated cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein each R² is independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein any adjacent substituents of R¹, R³, R⁴, R⁵, R⁶, R⁷, and R⁸ are optionally joined or fused into a ring; wherein at least one of R³, R⁴, and R⁵ is not hydrogen or deuterium; wherein a is an integer from 0 to 10; wherein the compound is heteroleptic; wherein (i) when a is 0, at least one of R⁷, R⁸, and an R² adjacent to ring B, is not hydrogen or deuterium, and (ii) when a is 1 to 10, at least one of an R² adjacent to ring A and an R⁶ adjacent to ring C is not hydrogen; wherein the ligand L is coordinated to a metal M having an atomic weight greater than 40; and wherein the ligand L is optionally linked with other ligands to comprise a tridentate, tetradentate, pentadentate or hexadentate ligand.
 2. The compound of claim 1, wherein M is selected from the group consisting of Ir, Rh, Re, Ru, Os, Pt, Au, and Cu.
 3. The compound of claim 1, wherein M is Ir or Pt.
 4. The compound of claim 1, wherein (i) when a is 0, at least one of R⁷, R⁸, and an R² adjacent to ring B, is selected from the group consisting of alkyl, cycloalkyl, partially or fully deuterated variants thereof, and combinations thereof, and (ii) when a is 1 to 10, at least one of an R² adjacent to ring A and an R⁶ adjacent to ring C is selected from the group consisting of alkyl, cycloalkyl, partially or fully deuterated variants thereof, and combinations thereof.
 5. The compound of claim 1, wherein at least one of R³, R⁴, and R⁵ is selected from the group consisting of alkyl, cycloalkyl, partially or fully deuterated variants thereof, and combinations thereof.
 6. The compound of claim 1, wherein (i) when a is 0, at least one R² adjacent to ring B is not hydrogen or deuterium, and at least one of R⁷, and R⁸ is not hydrogen or deuterium, and (ii) when a is 1 to 10, at least at one R² adjacent to ring A is not hydrogen or deuterium, and at least one R⁶ adjacent to ring C is not hydrogen or deuterium.
 7. The compound of claim 1, wherein ligand L is selected from the group consisting of:


8. The compound of claim 1, wherein ligand L is selected from the group consisting of L^(A1) to L^(A1432), L^(B1) to L^(B1432), L^(C1) to L^(C1432), L^(D1) to L^(D1432) as defined in the following table based on the structures of

L^(Ai)

L^(Bi)

L^(Ci)

L^(Di) i in L^(Ai), L^(Bi), L^(Ci), L^(Di) R² R³ R⁴ R⁵ R⁷ or R⁶¹ R⁸ or R⁶²
 1. CH₃ H CH₃ H H CH₃
 2. CH₃ H CH₂CH₃ H H CH₃
 3. CH₃ H CH(CH₃)₂ H H CH₃
 4. CH₃ H CH₂CH(CH₃)₂ H H CH₃
 5. CH₃ H C(CH₃)₃ H H CH₃
 6. CH₃ H CH₂C(CH₃)₃ H H CH₃
 7. CH₃ H CH₂CH₂CF₃ H H CH₃
 8. CH₃ H CH₂CCF₃(CH₃)₂ H H CH₃
 9. CH₃ H

H H CH₃
 10. CH₃ H

H H CH₃
 11. CH₃ H

H H CH₃
 12. CH₃ H

H H CH₃
 13. CH₃ H

H H CH₃
 14. CH₃ H

H H CH₃
 15. CH₃ H

H H CH₃
 16. CH₃ H

H H CH₃
 17. CH₃ H

H H CH₃
 18. CH₃ H

H H CH₃
 19. CH₃ H

H H CH₃
 20. CH₃ H

H H CH₃
 21. CH₃ H

H H CH₃
 22. CH₃ H

H H CH₃
 23. CH₃ H

H H CH₃
 24. CH₃ H

H H CH₃
 25. CH₃ H

H H CH₃
 26. CH₃ H

H H CH₃
 27. CH₃ H CH₃ H CH₃ CH₃
 28. CH₃ H CH₂CH₃ H CH₃ CH₃
 29. CH₃ H CH(CH₃)₂ H CH₃ CH₃
 30. CH₃ H CH₂CH(CH₃)₂ H CH₃ CH₃
 31. CH₃ H C(CH₃)₃ H CH₃ CH₃
 32. CH₃ H CH₂C(CH₃)₃ H CH₃ CH₃
 33. CH₃ H CH₂CH₂CF₃ H CH₃ CH₃
 34. CH₃ H CH₂CCF₃(CH₃)₂ H CH₃ CH₃
 35. CH₃ H

H CH₃ CH₃
 36. CH₃ H

H CH₃ CH₃
 37. CH₃ H

H CH₃ CH₃
 38. CH₃ H

H CH₃ CH₃
 39. CH₃ H

H CH₃ CH₃
 40. CH₃ H

H CH₃ CH₃
 41. CH₃ H

H CH₃ CH₃
 42. CH₃ H

H CH₃ CH₃
 43. CH₃ H

H CH₃ CH₃
 44. CH₃ H

H CH₃ CH₃
 45. CH₃ H

H CH₃ CH₃
 46. CH₃ H

H CH₃ CH₃
 47. CH₃ H

H CH₃ CH₃
 48. CH₃ H

H CH₃ CH₃
 49. CH₃ H

H CH₃ CH₃
 50. CH₃ H

H CH₃ CH₃
 51. CH₃ H

H CH₃ CH₃
 52. CH₃ H

H CH₃ CH₃
 53. H H CH₃ H H CH₃
 54. H H CH₂CH₃ H H CH₃
 55. H H CH(CH₃)₂ H H CH₃
 56. H H CH₂CH(CH₃)₂ H H CH₃
 57. H H C(CH₃)₃ H H CH₃
 58. H H CH₂C(CH₃)₃ H H CH₃
 59. H H CH₂CH₂CF₃ H H CH₃
 60. H H CH₂CCF₃(CH₃)₂ H H CH₃
 61. H H

H H CH₃
 62. H H

H H CH₃
 63. H H

H H CH₃
 64. H H

H H CH₃
 65. H H

H H CH₃
 66. H H

H H CH₃
 67. H H

H H CH₃
 68. H H

H H CH₃
 69. H H

H H CH₃
 70. H H

H H CH₃
 71. H H

H H CH₃
 72. H H

H H CH₃
 73. H H

H H CH₃
 74. H H

H H CH₃
 75. H H

H H CH₃
 76. H H

H H CH₃
 77. H H

H H CH₃
 78. H H

H H CH₃
 79. H H CH₃ H CH₃ CH₃
 80. H H CH₂CH₃ H CH₃ CH₃
 81. H H CH(CH₃)₂ H CH₃ CH₃
 82. H H CH₂CH(CH₃)₂ H CH₃ CH₃
 83. H H C(CH₃)₃ H CH₃ CH₃
 84. H H CH₂C(CH₃)₃ H CH₃ CH₃
 85. H H CH₂CH₂CF₃ H CH₃ CH₃
 86. H H CH₂CCF₃(CH₃)₂ H CH₃ CH₃
 87. H H

H CH₃ CH₃
 88. H H

H CH₃ CH₃
 89. H H

H CH₃ CH₃
 90. H H

H CH₃ CH₃
 91. H H

H CH₃ CH₃
 92. H H

H CH₃ CH₃
 93. H H

H CH₃ CH₃
 94. H H

H CH₃ CH₃
 95. H H

H CH₃ CH₃
 96. H H

H CH₃ CH₃
 97. H H

H CH₃ CH₃
 98. H H

H CH₃ CH₃
 99. H H

H CH₃ CH₃
 100. H H

H CH₃ CH₃
 101. H H

H CH₃ CH₃
 102. H H

H CH₃ CH₃
 103. H H

H CH₃ CH₃
 104. H H

H CH₃ CH₃
 105. CH₃ H CH₃ CH₃ H CH₃
 106. CH₃ H CH₂CH₃ CH₃ H CH₃
 107. CH₃ H CH(CH₃)₂ CH₃ H CH₃
 108. CH₃ H CH₂CH(CH₃)₂ CH₃ H CH₃
 109. CH₃ H C(CH₃)₃ CH₃ H CH₃
 110. CH₃ H CH₂C(CH₃)₃ CH₃ H CH₃
 111. CH₃ H CH₂CH₂CF₃ CH₃ H CH₃
 112. CH₃ H CH₂CCF₃(CH₃)₂ CH₃ H CH₃
 113. CH₃ H

CH₃ H CH₃
 114. CH₃ H

CH₃ H CH₃
 115. CH₃ H

CH₃ H CH₃
 116. CH₃ H

CH₃ H CH₃
 117. CH₃ H

CH₃ H CH₃
 118. CH₃ H

CH₃ H CH₃
 119. CH₃ H

CH₃ H CH₃
 120. CH₃ H

CH₃ H CH₃
 121. CH₃ H

CH₃ H CH₃
 122. CH₃ H

CH₃ H CH₃
 123. CH₃ H

CH₃ H CH₃
 124. CH₃ H

CH₃ H CH₃
 125. CH₃ H

CH₃ H CH₃
 126. CH₃ H

CH₃ H CH₃
 127. CH₃ H

CH₃ H CH₃
 128. CH₃ H

CH₃ H CH₃
 129. CH₃ H

CH₃ H CH₃
 130. CH₃ H

CH₃ H CH₃
 131. CH₃ CH₃ CH₃ CH₃ H CH₃
 132. CH₃ CH₃ CH₂CH₃ CH₃ H CH₃
 133. CH₃ CH₃ CH(CH₃)₂ CH₃ H CH₃
 134. CH₃ CH₃ CH₂CH(CH₃)₂ CH₃ H CH₃
 135. CH₃ CH₃ C(CH₃)₃ CH₃ H CH₃
 136. CH₃ CH₃ CH₂C(CH₃)₃ CH₃ H CH₃
 137. CH₃ CH₃ CH₂CH₂CF₃ CH₃ H CH₃
 138. CH₃ CH₃ CH₂CCF₃(CH₃)₂ CH₃ H CH₃
 139. CH₃ CH₃

CH₃ H CH₃
 140. CH₃ CH₃

CH₃ H CH₃
 141. CH₃ CH₃

CH₃ H CH₃
 142. CH₃ CH₃

CH₃ H CH₃
 143. CH₃ CH₃

CH₃ H CH₃
 144. CH₃ CH₃

CH₃ H CH₃
 145. CH₃ CH₃

CH₃ H CH₃
 146. CH₃ CH₃

CH₃ H CH₃
 147. CH₃ CH₃

CH₃ H CH₃
 148. CH₃ CH₃

CH₃ H CH₃
 149. CH₃ CH₃

CH₃ H CH₃
 150. CH₃ CH₃

CH₃ H CH₃
 151. CH₃ CH₃

CH₃ H CH₃
 152. CH₃ CH₃

CH₃ H CH₃
 153. CH₃ CH₃

CH₃ H CH₃
 154. CH₃ CH₃

CH₃ H CH₃
 155. CH₃ CH₃

CH₃ H CH₃
 156. CH₃ CH₃

CH₃ H CH₃
 157. CH₃ CH₃

CH₃ H CH₃
 158. CH₃ CH₃

CH₃ H CH₃
 159. CD₃ H CD₃ H H CD₃
 160. CD₃ H CD₂CD₃ H H CD₃
 161. CD₃ H CD₂CH₃ H H CD₃
 162. CD₃ H CD(CD₃)₂ H H CD₃
 163. CD₃ H CD(CH₃)₂ H H CD₃
 164. CD₃ H CD₂CD(CD₃)₂ H H CD₃
 165. CD₃ H CD₂CH(CH₃)₂ H H CD₃
 166. CD₃ H CD₂C(CD₃)₃ H H CD₃
 167. CD₃ H CD₂C(CH₃)₃ H H CD₃
 168. CD₃ H CD₂CD₂CF₃ H H CD₃
 169. CD₃ H CD₂CH₂CF₃ H H CD₃
 170. CD₃ H CD₂CCF₃(CH₃)₂ H H CD₃
 171. CD₃ H

H H CD₃
 172. CD₃ H

H H CD₃
 173. CD₃ H

H H CD₃
 174. CD₃ H

H H CD₃
 175. CD₃ H

H H CD₃
 176. CD₃ H

H H CD₃
 177. CD₃ H

H H CD₃
 178. CD₃ H

H H CD₃
 179. CD₃ H

H H CD₃
 180. CD₃ H

H H CD₃
 181. CD₃ H

H H CD₃
 182. CD₃ H

H H CD₃
 183. CD₃ H

H H CD₃
 184. CD₃ H

H H CD₃
 185. CD₃ H

H H CD₃
 186. CD₃ H

H H CD₃
 187. CD₃ H

H H CD₃
 188. CD₃ H

H H CD₃
 189. CD₃ H

H H CD₃
 190. CD₃ H

H H CD₃
 191. CD₃ H CD₃ H CD₃ CD₃
 192. CD₃ H CD₂CD₃ H CD₃ CD₃
 193. CD₃ H CD₂CH₃ H CD₃ CD₃
 194. CD₃ H CD(CD₃)₂ H CD₃ CD₃
 195. CD₃ H CD(CH₃)₂ H CD₃ CD₃
 196. CD₃ H CD₂CD(CD₃)₂ H CD₃ CD₃
 197. CD₃ H CD₂CH(CH₃)₂ H CD₃ CD₃
 198. CD₃ H CD₂C(CD₃)₃ H CD₃ CD₃
 199. CD₃ H CD₂C(CH₃)₃ H CD₃ CD₃
 200. CD₃ H CD₂CD₂CF₃ H CD₃ CD₃
 201. CD₃ H CD₂CH₂CF₃ H CD₃ CD₃
 202. CD₃ H CD₂CCF₃(CH₃)₂ H CD₃ CD₃
 203. CD₃ H

H CD₃ CD₃
 204. CD₃ H

H CD₃ CD₃
 205. CD₃ H

H CD₃ CD₃
 206. CD₃ H

H CD₃ CD₃
 207. CD₃ H

H CD₃ CD₃
 208. CD₃ H

H CD₃ CD₃
 209. CD₃ H

H CD₃ CD₃
 210. CD₃ H

H CD₃ CD₃
 211. CD₃ H

H CD₃ CD₃
 212. CD₃ H

H CD₃ CD₃
 213. CD₃ H

H CD₃ CD₃
 214. CD₃ H

H CD₃ CD₃
 215. CD₃ H

H CD₃ CD₃
 216. CD₃ H

H CD₃ CD₃
 217. CD₃ H

H CD₃ CD₃
 218. CD₃ H

H CD₃ CD₃
 219. CD₃ H

H CD₃ CD₃
 220. CD₃ H

H CD₃ CD₃
 221. CD₃ H

H CD₃ CD₃
 222. CD₃ H

H CD₃ CD₃
 223. H H CD₃ H H CD₃
 224. H H CD₂CD₃ H H CD₃
 225. H H CD₂CH₃ H H CD₃
 226. H H CD(CD₃)₂ H H CD₃
 227. H H CD(CH₃)₂ H H CD₃
 228. H H CD₂CD(CD₃)₂ H H CD₃
 229. H H CD₂CH(CH₃)₂ H H CD₃
 230. H H CD₂C(CD₃)₃ H H CD₃
 231. H H CD₂C(CH₃)₃ H H CD₃
 232. H H CD₂CD₂CF₃ H H CD₃
 233. H H CD₂CH₂CF₃ H H CD₃
 234. H H CD₂CCF₃(CH₃)₂ H H CD₃
 235. H H

H H CD₃
 236. H H

H H CD₃
 237. H H

H H CD₃
 238. H H

H H CD₃
 239. H H

H H CD₃
 240. H H

H H CD₃
 241. H H

H H CD₃
 242. H H

H H CD₃
 243. H H

H H CD₃
 244. H H

H H CD₃
 245. H H

H H CD₃
 246. H H

H H CD₃
 247. H H

H H CD₃
 248. H H

H H CD₃
 249. H H

H H CD₃
 250. H H

H H CD₃
 251. H H

H H CD₃
 252. H H

H H CD₃
 253. H H

H H CD₃
 254. H H

H H CD₃
 255. H H CD₃ H CD₃ CD₃
 256. H H CD₂CD₃ H CD₃ CD₃
 257. H H CD₂CH₃ H CD₃ CD₃
 258. H H CD(CD₃)₂ H CD₃ CD₃
 259. H H CD(CH₃)₂ H CD₃ CD₃
 260. H H CD₂CD(CD₃)₂ H CD₃ CD₃
 261. H H CD₂CH(CH₃)₂ H CD₃ CD₃
 262. H H CD₂C(CD₃)₃ H CD₃ CD₃
 263. H H CD₂C(CH₃)₃ H CD₃ CD₃
 264. H H CD₂CD₂CF₃ H CD₃ CD₃
 265. H H CD₂CH₂CF₃ H CD₃ CD₃
 266. H H CD₂CCF₃(CH₃)₂ H CD₃ CD₃
 267. H H

H CD₃ CD₃
 268. H H

H CD₃ CD₃
 269. H H

H CD₃ CD₃
 270. H H

H CD₃ CD₃
 271. H H

H CD₃ CD₃
 272. H H

H CD₃ CD₃
 273. H H

H CD₃ CD₃
 274. H H

H CD₃ CD₃
 275. H H

H CD₃ CD₃
 276. H H

H CD₃ CD₃
 277. H H

H CD₃ CD₃
 278. H H

H CD₃ CD₃
 279. H H

H CD₃ CD₃
 280. H H

H CD₃ CD₃
 281. H H

H CD₃ CD₃
 282. H H

H CD₃ CD₃
 283. H H

H CD₃ CD₃
 284. H H

H CD₃ CD₃
 285. H H

H CD₃ CD₃
 286. H H

H CD₃ CD₃
 287. CD₃ H CD₃ CD₃ CD₃ CD₃
 288. CD₃ H CD₂CD₃ CD₃ CD₃ CD₃
 289. CD₃ H CD₂CH₃ CD₃ CD₃ CD₃
 290. CD₃ H CD(CD₃)₂ CD₃ CD₃ CD₃
 291. CD₃ H CD(CH₃)₂ CD₃ CD₃ CD₃
 292. CD₃ H CD₂CD(CD₃)₂ CD₃ CD₃ CD₃
 293. CD₃ H CD₂CH(CH₃)₂ CD₃ CD₃ CD₃
 294. CD₃ H CD₂C(CD₃)₃ CD₃ CD₃ CD₃
 295. CD₃ H CD₂C(CH₃)₃ CD₃ CD₃ CD₃
 296. CD₃ H CD₂CD₂CF₃ CD₃ CD₃ CD₃
 297. CD₃ H CD₂CH₂CF₃ CD₃ CD₃ CD₃
 298. CD₃ H CD₂CCF₃(CH₃)₂ CD₃ CD₃ CD₃
 299. CD₃ H

CD₃ CD₃ CD₃
 300. CD₃ H

CD₃ CD₃ CD₃
 301. CD₃ H

CD₃ CD₃ CD₃
 302. CD₃ H

CD₃ CD₃ CD₃
 303. CD₃ H

CD₃ CD₃ CD₃
 304. CD₃ H

CD₃ CD₃ CD₃
 305. CD₃ H

CD₃ CD₃ CD₃
 306. CD₃ H

CD₃ CD₃ CD₃
 307. CD₃ H

CD₃ CD₃ CD₃
 308. CD₃ H

CD₃ CD₃ CD₃
 309. CD₃ H

CD₃ CD₃ CD₃
 310. CD₃ H

CD₃ CD₃ CD₃
 311. CD₃ H

CD₃ CD₃ CD₃
 312. CD₃ H

CD₃ CD₃ CD₃
 313. CD₃ H

CD₃ CD₃ CD₃
 314. CD₃ H

CD₃ CD₃ CD₃
 315. CD₃ H

CD₃ CD₃ CD₃
 316. CD₃ H

CD₃ CD₃ CD₃
 317. CD₃ H

CD₃ CD₃ CD₃
 318. CD₃ H

CD₃ CD₃ CD₃
 319. CH₃ CH₂CH₃ CH₃ CH₃ H CH₃
 320. CH₃ CH(CH₃)₂ CH₃ CH₃ CH₃
 321. CH₃ CH₂CH(CH₃)₂ CH₃ CH₃ H CH₃
 322. CH₃ C(CH₃)₃ CH₃ CH₃ CH₃
 323. CH₃ CH₂C(CH₃)₃ CH₃ CH₃ H CH₃
 324. CH₃ CH₂CH₂CF₃ CH₃ CH₃ CH₃
 325. CH₃ CH₂CCF₃(CH₃)₂ CH₃ CH₃ H CH₃
 326. CH₃

CH₃ CH₃ CH₃
 327. CH₃

CH₃ CH₃ H CH₃
 328. CH₃

CH₃ CH₃ CH₃
 329. CH₃

CH₃ CH₃ H CH₃
 330. CH₃

CH₃ CH₃ CH₃
 331. CH₃

CH₃ CH₃ H CH₃
 332. CH₃

CH₃ CH₃ CH₃
 333. CH₃

CH₃ CH₃ H CH₃
 334. CH₃

CH₃ CH₃ CH₃
 335. CH₃

CH₃ CH₃ H CH₃
 336. CH₃

CH₃ CH₃ CH₃
 337. CH₃

CH₃ CH₃ H CH₃
 338. CH₃

CH₃ CH₃ CH₃
 339. CH₃

CH₃ CH₃ H CH₃
 340. CH₃

CH₃ CH₃ CH₃
 341. CH₃

CH₃ CH₃ H CH₃
 342. CH₃

CH₃ CH₃ CH₃
 343. CH₃

CH₃ CH₃ H CH₃
 344. CH₃

CH₃ CH₃ CH₃
 345. CH₃

CH₃ CH₃ H CH₃
 346. CD₃ CD₂CD₃ CD₃ CD₃ H CD₃
 347. CD₃ CD₂CH₃ CD₃ CD₃ CD₃
 348. CD₃ CD(CD₃)₂ CD₃ CD₃ H CD₃
 349. CD₃ CD(CH₃)₂ CD₃ CD₃ CD₃
 350. CD₃ CD₂CD(CD₃)₂ CD₃ CD₃ H CD₃
 351. CD₃ CD₂CH(CH₃)₂ CD₃ CD₃ CD₃
 352. CD₃ CD₂C(CD₃)₃ CD₃ CD₃ H CD₃
 353. CD₃ CD₂C(CH₃)₃ CD₃ CD₃ CD₃
 354. CD₃ CD₂CD₂CF₃ CD₃ CD₃ H CD₃
 355. CD₃ CD₂CH₂CF₃ CD₃ CD₃ CD₃
 356. CD₃ CD₂CCF₃(CH₃)₂ CD₃ CD₃ H CD₃
 357. CD₃

CD₃ CD₃ H CD₃
 358. CD₃

CD₃ CD₃ H CD₃
 359. CD₃

CD₃ CD₃ CD₃
 360. CD₃

CD₃ CD₃ H CD₃
 361. CD₃

CD₃ CD₃ CD₃
 362. CD₃

CD₃ CD₃ H CD₃
 363. CD₃

CD₃ CD₃ CD₃
 364. CD₃

CD₃ CD₃ H CD₃
 365. CD₃

CD₃ CD₃ CD₃
 366. CD₃

CD₃ CD₃ H CD₃
 367. CD₃

CD₃ CD₃ CD₃
 368. CD₃

CD₃ CD₃ H CD₃
 369. CD₃

CD₃ CD₃ CD₃
 370. CD₃

CD₃ CD₃ H CD₃
 371. CD₃

CD₃ CD₃ CD₃
 372. CD₃

CD₃ CD₃ H CD₃
 373. CD₃

CD₃ CD₃ CD₃
 374. CD₃

CD₃ CD₃ H CD₃
 375. CD₃

CD₃ CD₃ CD₃
 376. CD₃

CD₃ CD₃ H CD₃
 377. CD₃ CD₂CD₃ CD₃ CD₃ CD₂CD₃ CD₃
 378. CD₃ CD₂CH₃ CD₃ CD₃ CD₂CD₃ CD₃
 379. CD₃ CD(CD₃)₂ CD₃ CD₃ CD₂CD₃ CD₃
 380. CD₃ CD(CH₃)₃ CD₃ CD₃ CD₂CD₃ CD₃
 381. CD₃ CD₂CD(CD₃)₂ CD₃ CD₃ CD₂CD₃ CD₃
 382. CD₃ CD₂CH(CH₃)₂ CD₃ CD₃ CD₂CD₃ CD₃
 383. CD₃ CD₂C(CD₃)₃ CD₃ CD₃ CD₂CD₃ CD₃
 384. CD₃ CD₂C(CH₃)₃ CD₃ CD₃ CD₂CD₃ CD₃
 385. CD₃ CD₂CD₂CF₃ CD₃ CD₃ CD₂CD₃ CD₃
 386. CD₃ CD₂CH₂CF₃ CD₃ CD₃ CD₂CD₃ CD₃
 387. CD₃ CD₂CCF₃(CH₃)₂ CD₃ CD₃ CD₂CD₃ CD₃
 388. CD₃

CD₃ CD₃ CD₂CD₃ CD₃
 389. CD₃

CD₃ CD₃ CD₂CD₃ CD₃
 390. CD₃

CD₃ CD₃ CD₂CD₃ CD₃
 391. CD₃

CD₃ CD₃ CD₂CD₃ CD₃
 392. CD₃

CD₃ CD₃ CD₂CD₃ CD₃
 393. CD₃

CD₃ CD₃ CD₂CD₃ CD₃
 394. CD₃

CD₃ CD₃ CD₂CD₃ CD₃
 395. CD₃

CD₃ CD₃ CD₂CD₃ CD₃
 396. CD₃

CD₃ CD₃ CD₂CD₃ CD₃
 397. CD₃

CD₃ CD₃ CD₂CD₃ CD₃
 398. CD₃

CD₃ CD₃ CD₂CD₃ CD₃
 399. CD₃

CD₃ CD₃ CD₂CD₃ CD₃
 400. CD₃

CD₃ CD₃ CD₂CD₃ CD₃
 401. CD₃

CD₃ CD₃ CD₂CD₃ CD₃
 402. CD₃

CD₃ CD₃ CD₂CD₃ CD₃
 403. CD₃

CD₃ CD₃ CD₂CD₃ CD₃
 404. CD₃

CD₃ CD₃ CD₂CD₃ CD₃
 405. CD₃

CD₃ CD₃ CD₂CD₃ CD₃
 406. CD₃

CD₃ CD₃ CD₂CD₃ CD₃
 407. CD₃

CD₃ CD₃ CD₂CD₃ CD₃
 408. CH₃ CH₃ H H H CH₃
 409. CH₃ CH₂CH₃ H H H CH₃
 410. CH₃ CH(CH₃)₂ H H H CH₃
 411. CH₃ CH₂CH(CH₃)₂ H H H CH₃
 412. CH₃ C(CH₃)₃ H H H CH₃
 413. CH₃ CH₂C(CH₃)₃ H H H CH₃
 414. CH₃ CH₂CH₂CF₃ H H H CH₃
 415. CH₃ CH₂CCF₃(CH₃)₂ H H H CH₃
 416. CH₃

H H H CH₃
 417. CH₃

H H H CH₃
 418. CH₃

H H H CH₃
 419. CH₃

H H H CH₃
 420. CH₃

H H H CH₃
 421. CH₃

H H H CH₃
 422. CH₃

H H H CH₃
 423. CH₃

H H H CH₃
 424. CH₃

H H H CH₃
 425. CH₃

H H H CH₃
 426. CH₃

H H H CH₃
 427. CH₃

H H H CH₃
 428. CH₃

H H H CH₃
 429. CH₃

H H H CH₃
 430. CH₃

H H H CH₃
 431. CH₃

H H H CH₃
 432. CH₃

H H H CH₃
 433. CH₃

H H H CH₃
 434. CH₃

H H H CH₃
 435. CH₃

H H H CH₃
 436. CD₃ CD₃ H H H CD₂CD₃
 437. CD₃ CD₂CD₃ H H H CD₂CD₃
 438. CD₃ CD₂CH₃ H H H CD₂CD₃
 439. CD₃ CD(CD₃)₂ H H H CD₂CD₃
 440. CD₃ CD(CH₃)₂ H H H CD₂CD₃
 441. CD₃ CD₂CD(CD₃)₂ H H H CD₂CD₃
 442. CD₃ CD₂CH(CH₃)₂ H H H CD₂CD₃
 443. CD₃ CD₂C(CD₃)₃ H H H CD₂CD₃
 444. CD₃ CD₂C(CH₃)₃ H H H CD₂CD₃
 445. CD₃ CD₂CD₂CF₃ H H H CD₂CD₃
 446. CD₃ CD₂CH₂CF₃ H H H CD₂CD₃
 447. CD₃ CD₂CCF₃(CH₃)₂ H H H CD₂CD₃
 448. CD₃

H H H CD₂CD₃
 449. CD₃

H H H CD₂CD₃
 450. CD₃

H H H CD₂CD₃
 451. CD₃

H H H CD₂CD₃
 452. CD₃

H H H CD₂CD₃
 453. CD₃

H H H CD₂CD₃
 454. CD₃

H H H CD₂CD₃
 455. CD₃

H H H CD₂CD₃
 456. CD₃

H H H CD₂CD₃
 457. CD₃

H H H CD₂CD₃
 458. CD₃

H H H CD₂CD₃
 459. CD₃

H H H CD₂CD₃
 460. CD₃

H H H CD₂CD₃
 461. CD₃

H H H CD₂CD₃
 462. CD₃

H H H CD₂CD₃
 463. CD₃

H H H CD₂CD₃
 464. CD₃

H H H CD₂CD₃
 465. CD₃

H H H CD₂CD₃
 466. CD₃

H H H CD₂CD₃
 467. CD₃

H H H CD₂CD₃
 468. CH₃ H CH₃ H H CH₃
 469. CH₃ H CH₂CH₃ H H CH₃
 470. CH₃ H CH(CH₃)₂ H H CH₃
 471. CH₃ H CH₂CH(CH₃)₂ H H CH₃
 472. CH₃ H C(CH₃)₃ H H CH₃
 473. CH₃ H CH₂C(CH₃)₃ H H CH₃
 474. CH₃ H CH₂CH₂CF₃ H H CH₃
 475. CH₃ H CH₂CCF₃(CH₃)₂ H H CH₃
 476. CH₃ H

H H CH₃
 477. CH₃ H

H H CH₃
 478. CH₃ H

H H CH₃
 479. CH₃ H

H H CH₃
 480. CH₃ H

H H CH₃
 481. CH₃ H

H H CH₃
 482. CH₃ H

H H CH₃
 483. CH₃ H

H H CH₃
 484. CH₃ H

H H CH₃
 485. CH₃ H

H H CH₃
 486. CH₃ H

H H CH₃
 487. CH₃ H

H H CH₃
 488. CH₃ H

H H CH₃
 489. CH₃ H

H H CH₃
 490. CH₃ H

H H CH₃
 491. CH₃ H

H H CH₃
 492. CH₃ H

H H CH₃
 493. CH₃ H

H H CH₃
 494. CH₃ H

H H CH₃
 495. CH₃ H

H H CH₃
 496. CD₃ H CD₃ H H CD₂CD₃
 497. CD₃ H CD₂CD₃ H H CD₂CD₃
 498. CD₃ H CD₂CH₃ H H CD₂CD₃
 499. CD₃ H CD(CD₃)₂ H H CD₂CD₃
 500. CD₃ H CD(CH₃)₂ H H CD₂CD₃
 501. CD₃ H CD₂CD(CD₃)₂ H H CD₂CD₃
 502. CD₃ H CD₂CH(CH₃)₂ H H CD₂CD₃
 503. CD₃ H CD₂C(CD₃)₃ H H CD₂CD₃
 504. CD₃ H CD₂C(CH₃)₃ H H CD₂CD₃
 505. CD₃ H CD₂CD₂CF₃ H H CD₂CD₃
 506. CD₃ H CD₂CH₂CF₃ H H CD₂CD₃
 507. CD₃ H CD₂CCF₃(CH₃)₂ H H CD₂CD₃
 508. CD₃ H

H H CD₂CD₃
 509. CD₃ H

H H CD₂CD₃
 510. CD₃ H

H H CD₂CD₃
 511. CD₃ H

H H CD₂CD₃
 512. CD₃ H

H H CD₂CD₃
 513. CD₃ H

H H CD₂CD₃
 514. CD₃ H

H H CD₂CD₃
 515. CD₃ H

H H CD₂CD₃
 516. CD₃ H

H H CD₂CD₃
 517. CD₃ H

H H CD₂CD₃
 518. CD₃ H

H H CD₂CD₃
 519. CD₃ H

H H CD₂CD₃
 520. CD₃ H

H H CD₂CD₃
 521. CD₃ H

H H CD₂CD₃
 522. CD₃ H

H H CD₂CD₃
 523. CD₃ H

H H CD₂CD₃
 524. CD₃ H

H H CD₂CD₃
 525. CD₃ H

H H CD₂CD₃
 526. CD₃ H

H H CD₂CD₃
 527. CD₃ H

H H CD₂CD₃
 528. CH(CH₃)₂ H H CH₃ CH₃ CH₃
 529. CH(CH₃)₂ H H CH₂CH₃ CH₃ CH₃
 530. CH(CH₃)₂ H H CH(CH₃)₂ CH₃ CH₃
 531. CH(CH₃)₂ H H CH₂CH(CH₃)₂ CH₃ CH₃
 532. CH(CH₃)₂ H H C(CH₃)₃ CH₃ CH₃
 533. CH(CH₃)₂ H H CH₂C(CH₃)₃ CH₃ CH₃
 534. CH(CH₃)₂ H H CH₂CH₂CF₃ CH₃ CH₃
 535. CH(CH₃)₂ H H CH₂CCF₃(CH₃)₂ CH₃ CH₃
 536. CH(CH₃)₂ H H

CH₃ CH₃
 537. CH(CH₃)₂ H H

CH₃ CH₃
 538. CH(CH₃)₂ H H

CH₃ CH₃
 539. CH(CH₃)₂ H H

CH₃ CH₃
 540. CH(CH₃)₂ H H

CH₃ CH₃
 541. CH(CH₃)₂ H H

CH₃ CH₃
 542. CH(CH₃)₂ H H

CH₃ CH₃
 543. CH(CH₃)₂ H H

CH₃ CH₃
 544. CH(CH₃)₂ H H

CH₃ CH₃
 545. CH(CH₃)₂ H H

CH₃ CH₃
 546. CH(CH₃)₂ H H

CH₃ CH₃
 547. CH(CH₃)₂ H H

CH₃ CH₃
 548. CH(CH₃)₂ H H

CH₃ CH₃
 549. CH(CH₃)₂ H H

CH₃ CH₃
 550. CH(CH₃)₂ H H

CH₃ CH₃
 551. CH(CH₃)₂ H H

CH₃ CH₃
 552. CH(CH₃)₂ H H

CH₃ CH₃
 553. CH(CH₃)₂ H H

CH₃ CH₃
 554. CH(CH₃)₂ H H

CH₃ CH₃
 555. CH(CH₃)₂ H H

CH₃ CH₃
 556. CD₃ H H CD₃ CD₃ CD₃
 557. CD₃ H H CD₂CD₃ CD₃ CD₃
 558. CD₃ H H CD₂CH₃ CD₃ CD₃
 559. CD₃ H H CD(CD₃)₂ CD₃ CD₃
 560. CD₃ H H CD(CH₃)₂ CD₃ CD₃
 561. CD₃ H H CD₂CD(CD₃)₂ CD₃ CD₃
 562. CD₃ H H CD₂CH(CH₃)₂ CD₃ CD₃
 563. CD₃ H H CD₂C(CD₃)₃ CD₃ CD₃
 564. CD₃ H H CD₂C(CH₃)₃ CD₃ CD₃
 565. CD₃ H H CD₂CD₂CF₃ CD₃ CD₃
 566. CD₃ H H CD₂CH₂CF₃ CD₃ CD₃
 567. CD₃ H H CD₂CCF₃(CH₃)₂ CD₃ CD₃
 568. CD₃ H H

CD₃ CD₃
 569. CD₃ H H

CD₃ CD₃
 570. CD₃ H H

CD₃ CD₃
 571. CD₃ H H

CD₃ CD₃
 572. CD₃ H H

CD₃ CD₃
 573. CD₃ H H

CD₃ CD₃
 574. CD₃ H H

CD₃ CD₃
 575. CD₃ H H

CD₃ CD₃
 576. CD₃ H H

CD₃ CD₃
 577. CD₃ H H

CD₃ CD₃
 578. CD₃ H H

CD₃ CD₃
 579. CD₃ H H

CD₃ CD₃
 580. CD₃ H H

CD₃ CD₃
 581. CD₃ H H

CD₃ CD₃
 582. CD₃ H H

CD₃ CD₃
 583. CD₃ H H

CD₃ CD₃
 584. CD₃ H H

CD₃ CD₃
 585. CD₃ H H

CD₃ CD₃
 586. CD₃ H H

CD₃ CD₃
 587. CD₃ H H

CD₃ CD₃
 588. H CH₃ CH₃ H CH₃ CH₃
 589. H CH₂CH₃ CH₃ H CH₃ CH₃
 590. H CH(CH₃)₂ CH₃ H CH₃ CH₃
 591. H CH₂CH(CH₃)₂ CH₃ H CH₃ CH₃
 592. H C(CH₃)₃ CH₃ H CH₃ CH₃
 593. H CH₂C(CH₃)₃ CH₃ H CH₃ CH₃
 594. H CH₂CH₂CF₃ CH₃ H CH₃ CH₃
 595. H CH₂CCF₃(CH₃)₂ CH₃ H CH₃ CH₃
 596. H

CH₃ H CH₃ CH₃
 597. H

CH₃ H CH₃ CH₃
 598. H

CH₃ H CH₃ CH₃
 599. H

CH₃ H CH₃ CH₃
 600. H

CH₃ H CH₃ CH₃
 601. H

CH₃ H CH₃ CH₃
 602. H

CH₃ H CH₃ CH₃
 603. H

CH₃ H CH₃ CH₃
 604. H

CH₃ H CH₃ CH₃
 605. H

CH₃ H CH₃ CH₃
 606. H

CH₃ H CH₃ CH₃
 607. H

CH₃ H CH₃ CH₃
 608. H

CH₃ H CH₃ CH₃
 609. H

CH₃ H CH₃ CH₃
 610. H

CH₃ H CH₃ CH₃
 611. H

CH₃ H CH₃ CH₃
 612. H

CH₃ H CH₃ CH₃
 613. H

CH₃ H CH₃ CH₃
 614. H

CH₃ H CH₃ CH₃
 615. H

CH₃ H CH₃ CH₃
 616. CD₃ CD₃ CD₃ H CD₃ CD₃
 617. CD₃ CD₂CD₃ CD₃ H CD₃ CD₃
 618. CD₃ CD₂CH₃ CD₃ H CD₃ CD₃
 619. CD₃ CD(CD₃)₂ CD₃ H CD₃ CD₃
 620. CD₃ CD(CH₃)₂ CD₃ H CD₃ CD₃
 621. CD₃ CD₂CD(CD₃)₂ CD₃ H CD₃ CD₃
 622. CD₃ CD₂CH(CH₃)₂ CD₃ H CD₃ CD₃
 623. CD₃ CD₂C(CD₃)₃ CD₃ H CD₃ CD₃
 624. CD₃ CD₂C(CH₃)₃ CD₃ H CD₃ CD₃
 625. CD₃ CD₂CD₂CF₃ CD₃ H CD₃ CD₃
 626. CD₃ CD₂CH₂CF₃ CD₃ H CD₃ CD₃
 627. CD₃ CD₂CCF₃(CH₃)₂ CD₃ H CD₃ CD₃
 628. CD₃

CD₃ H CD₃ CD₃
 629. CD₃

CD₃ H CD₃ CD₃
 630. CD₃

CD₃ H CD₃ CD₃
 631. CD₃

CD₃ H CD₃ CD₃
 632. CD₃

CD₃ H CD₃ CD₃
 633. CD₃

CD₃ H CD₃ CD₃
 634. CD₃

CD₃ H CD₃ CD₃
 635. CD₃

CD₃ H CD₃ CD₃
 636. CD₃

CD₃ H CD₃ CD₃
 637. CD₃

CD₃ H CD₃ CD₃
 638. CD₃

CD₃ H CD₃ CD₃
 639. CD₃

CD₃ H CD₃ CD₃
 640. CD₃

CD₃ H CD₃ CD₃
 641. CD₃

CD₃ H CD₃ CD₃
 642. CD₃

CD₃ H CD₃ CD₃
 643. CD₃

CD₃ H CD₃ CD₃
 644. CD₃

CD₃ H CD₃ CD₃
 645. CD₃

CD₃ H CD₃ CD₃
 646. CD₃

CD₃ H CD₃ CD₃
 647. CD₃

CD₃ H CD₃ CD₃
 648. CH₃ CH₃ CH₂CH₃ H CH₃ CH₂CH₃
 649. CH₃ CH₃ CH(CH₃)₂ H CH₃ CH₂CH₃
 650. CH₃ CH₃ CH₂CH(CH₃)₂ H CH₃ CH₂CH₃
 651. CH₃ CH₃ C(CH₃)₃ H CH₃ CH₂CH₃
 652. CH₃ CH₃ CH₂C(CH₃)₃ H CH₃ CH₂CH₃
 653. CH₃ CH₃ CH₂CH₂CF₃ H CH₃ CH₂CH₃
 654. CH₃ CH₃ CH₂CCF₃(CH₃)₂ H CH₃ CH₂CH₃
 655. CH₃ CH₃

H CH₃ CH₂CH₃
 656. CH₃ CH₃

H CH₃ CH₂CH₃
 657. CH₃ CH₃

H CH₃ CH₂CH₃
 658. CH₃ CH₃

H CH₃ CH₂CH₃
 659. CH₃ CH₃

H CH₃ CH₂CH₃
 660. CH₃ CH₃

H CH₃ CH₂CH₃
 661. CH₃ CH₃

H CH₃ CH₂CH₃
 662. CH₃ CH₃

H CH₃ CH₂CH₃
 663. CH₃ CH₃

H CH₃ CH₂CH₃
 664. CH₃ CH₃

H CH₃ CH₂CH₃
 665. CH₃ CH₃

H CH₃ CH₂CH₃
 666. CH₃ CH₃

H CH₃ CH₂CH₃
 667. CH₃ CH₃

H CH₃ CH₂CH₃
 668. CH₃ CH₃

H CH₃ CH₂CH₃
 669. CH₃ CH₃

H CH₃ CH₂CH₃
 670. CH₃ CH₃

H CH₃ CH₂CH₃
 671. CH₃ CH₃

H CH₃ CH₂CH₃
 672. CH₃ CH₃

H CH₃ CH₂CH₃
 673. CH₃ CH₃

H CH₃ CH₂CH₃
 674. CH₃ CH₃

H CH₃ CH₂CH₃
 675. CD₃ CD₃ CD₂CD₃ H CD₂CH₃ CD₂CH₃
 676. CD₃ CD₃ CD₂CH₃ H CD₂CH₃ CD₂CH₃
 677. CD₃ CD₃ CD(CD₃)₂ H CD₂CH₃ CD₂CH₃
 678. CD₃ CD₃ CD(CH₃)₂ H CD₂CH₃ CD₂CH₃
 679. CD₃ CD₃ CD₂CD(CD₃)₂ H CD₂CH₃ CD₂CH₃
 680. CD₃ CD₃ CD₂CH(CH₃)₂ H CD₂CH₃ CD₂CH₃
 681. CD₃ CD₃ CD₂C(CD₃)₃ H CD₂CH₃ CD₂CH₃
 682. CD₃ CD₃ CD₂C(CH₃)₃ H CD₂CH₃ CD₂CH₃
 683. CD₃ CD₃ CD₂CD₂CF₃ H CD₂CH₃ CD₂CH₃
 684. CD₃ CD₃ CD₂CH₂CF₃ H CD₂CH₃ CD₂CH₃
 685. CD₃ CD₃ CD₂CCF₃(CH₃)₂ H CD₂CH₃ CD₂CH₃
 686. CD₃ CD₃

H CD₂CH₃ CD₂CH₃
 687. CD₃ CD₃

H CD₂CH₃ CD₂CH₃
 688. CD₃ CD₃

H CD₂CH₃ CD₂CH₃
 689. CD₃ CD₃

H CD₂CH₃ CD₂CH₃
 690. CD₃ CD₃

H CD₂CH₃ CD₂CH₃
 691. CD₃ CD₃

H CD₂CH₃ CD₂CH₃
 692. CD₃ CD₃

H CD₂CH₃ CD₂CH₃
 693. CD₃ CD₃

H CD₂CH₃ CD₂CH₃
 694. CD₃ CD₃

H CD₂CH₃ CD₂CH₃
 695. CD₃ CD₃

H CD₂CH₃ CD₂CH₃
 696. CD₃ CD₃

H CD₂CH₃ CD₂CH₃
 697. CD₃ CD₃

H CD₂CH₃ CD₂CH₃
 698. CD₃ CD₃

H CD₂CH₃ CD₂CH₃
 699. CD₃ CD₃

H CD₂CH₃ CD₂CH₃
 700. CD₃ CD₃

H CD₂CH₃ CD₂CH₃
 701. CD₃ CD₃

H CD₂CH₃ CD₂CH₃
 702. CD₃ CD₃

H CD₂CH₃ CD₂CH₃
 703. CD₃ CD₃

H CD₂CH₃ CD₂CH₃
 704. CD₃ CD₃

H CD₂CH₃ CD₂CH₃
 705. CD₃ CD₃

H CD₂CH₃ CD₂CH₃
 706. H CH₃ CH₃ CH₃ CH₂CH₃ CH₂CH₃
 707. H CH₃ CH₂CH₃ CH₃ CH₂CH₃ CH₂CH₃
 708. H CH₃ CH(CH₃)₂ CH₃ CH₂CH₃ CH₂CH₃
 709. H CH₃ CH₂CH(CH₃)₂ CH₃ CH₂CH₃ CH₂CH₃
 710. H CH₃ C(CH₃)₃ CH₃ CH₂CH₃ CH₂CH₃
 711. H CH₃ CH₂C(CH₃)₃ CH₃ CH₂CH₃ CH₂CH₃
 712. H CH₃ CH₂CH₂CF₃ CH₃ CH₂CH₃ CH₂CH₃
 713. H CH₃ CH₂CCF₃(CH₃)₂ CH₃ CH₂CH₃ CH₂CH₃
 714. H CH₃

CH₃ CH₂CH₃ CH₂CH₃
 715. H CH₃

CH₃ CH₂CH₃ CH₂CH₃
 716. H CH₃

CH₃ CH₂CH₃ CH₂CH₃
 717. H CH₃

CH₃ CH₂CH₃ CH₂CH₃
 718. H CH₃

CH₃ CH₂CH₃ CH₂CH₃
 719. H CH₃

CH₃ CH₂CH₃ CH₂CH₃
 720. H CH₃

CH₃ CH₂CH₃ CH₂CH₃
 721. H CH₃

CH₃ CH₂CH₃ CH₂CH₃
 722. H CH₃

CH₃ CH₂CH₃ CH₂CH₃
 723. H CH₃

CH₃ CH₂CH₃ CH₂CH₃
 724. H CH₃

CH₃ CH₂CH₃ CH₂CH₃
 725. H CH₃

CH₃ CH₂CH₃ CH₂CH₃
 726. H CH₃

CH₃ CH₂CH₃ CH₂CH₃
 727. H CH₃

CH₃ CH₂CH₃ CH₂CH₃
 728. H CH₃

CH₃ CH₂CH₃ CH₂CH₃
 729. H CH₃

CH₃ CH₂CH₃ CH₂CH₃
 730. H CH₃

CH₃ CH₂CH₃ CH₂CH₃
 731. H CH₃

CH₃ CH₂CH₃ CH₂CH₃
 732. H CH₃

CH₃ CH₂CH₃ CH₂CH₃
 733. H CH₃

CH₃ CH₂CH₃ CH₂CH₃
 734. CD₃ CD₃ CD₃ CD₃ CD₂CH₃ CD₂CH₃
 735. CD₃ CD₃ CD₂CD₃ CD₃ CD₂CH₃ CD₂CH₃
 736. CD₃ CD₃ CD₂CH₃ CD₃ CD₂CH₃ CD₂CH₃
 737. CD₃ CD₃ CD(CD₃)₂ CD₃ CD₂CH₃ CD₂CH₃
 738. CD₃ CD₃ CD(CH₃)₂ CD₃ CD₂CH₃ CD₂CH₃
 739. CD₃ CD₃ CD₂CD(CD₃)₂ CD₃ CD₂CH₃ CD₂CH₃
 740. CD₃ CD₃ CD₂CH(CH₃)₂ CD₃ CD₂CH₃ CD₂CH₃
 741. CD₃ CD₃ CD₂C(CD₃)₃ CD₃ CD₂CH₃ CD₂CH₃
 742. CD₃ CD₃ CD₂C(CH₃)₃ CD₃ CD₂CH₃ CD₂CH₃
 743. CD₃ CD₃ CD₂CD₂CF₃ CD₃ CD₂CH₃ CD₂CH₃
 744. CD₃ CD₃ CD₂CH₂CF₃ CD₃ CD₂CH₃ CD₂CH₃
 745. CD₃ CD₃ CD₂CCF₃(CH₃)₂ CD₃ CD₂CH₃ CD₂CH₃
 746. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃
 747. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃
 748. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃
 749. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃
 750. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃
 751. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃
 752. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃
 753. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃
 754. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃
 755. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃
 756. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃
 757. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃
 758. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃
 759. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃
 760. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃
 761. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃
 762. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃
 763. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃
 764. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃
 765. CD₃ CD₃

CD₃ CD₂CH₃ CD₂CH₃
 766. CH₃ CH₂CH₃ CH₃ CH₂CH₃ H CH₂CH₃
 767. CH₃ CH(CH₃)₂ CH₃ CH(CH₃)₂ H CH₂CH₃
 768. CH₃ CH₂CH(CH₃)₂ CH₃ CH₂CH(CH₃)₂ H CH₂CH₃
 769. CH₃ C(CH₃)₃ CH₃ C(CH₃)₃ H CH₂CH₃
 770. CH₃ CH₂C(CH₃)₃ CH₃ CH₂C(CH₃)₃ H CH₂CH₃
 771. CH₃ CH₂CH₂CF₃ CH₃ CH₂CH₂CF₃ H CH₂CH₃
 772. CH₃ CH₂CCF₃(CH₃)₂ CH₃ CH₂CCF₃(CH₃)₂ H CH₂CH₃
 773. CH₃

CH₃

H CH₂CH₃
 774. CH₃

CH₃

H CH₂CH₃
 775. CH₃

CH₃

H CH₂CH₃
 776. CH₃

CH₃

H CH₂CH₃
 777. CH₃

CH₃

H CH₂CH₃
 778. CH₃

CH₃

H CH₂CH₃
 779. CH₃

CH₃

H CH₂CH₃
 780. CH₃

CH₃

H CH₂CH₃
 781. CH₃

CH₃

H CH₂CH₃
 782. CH₃

CH₃

H CH₂CH₃
 783. CH₃

CH₃

H CH₂CH₃
 784. CH₃

CH₃

H CH₂CH₃
 785. CH₃

CH₃

H CH₂CH₃
 786. CH₃

CH₃

H CH₂CH₃
 787. CH₃

CH₃

H CH₂CH₃
 788. CH₃

CH₃

H CH₂CH₃
 789. CH₃

CH₃

H CH₂CH₃
 790. CH₃

CH₃

H CH₂CH₃
 791. CH₃

CH₃

H CH₂CH₃
 792. CH₃

CH₃

H CH₂CH₃
 793. CD₃ CD₂CD₃ CD₃ CD₂CD₃ H CD₂CH₃
 794. CD₃ CD₂CH₃ CD₃ CD₂CH₃ H CD₂CH₃
 795. CD₃ CD(CD₃)₂ CD₃ CD(CD₃)₂ H CD₂CH₃
 796. CD₃ CD(CH₃)₂ CD₃ CD(CH₃)₂ H CD₂CH₃
 797. CD₃ CD₂CD(CD₃)₂ CD₃ CD₂CD(CD₃)₂ H CD₂CH₃
 798. CD₃ CD₂CH(CH₃)₂ CD₃ CD₂CH(CH₃)₂ H CD₂CH₃
 799. CD₃ CD₂C(CD₃)₃ CD₃ CD₂C(CD₃)₃ H CD₂CH₃
 800. CD₃ CD₂C(CH₃)₃ CD₃ CD₂C(CH₃)₃ H CD₂CH₃
 801. CD₃ CD₂CD₂CF₃ CD₃ CD₂CD₂CF₃ H CD₂CH₃
 802. CD₃ CD₂CH₂CF₃ CD₃ CD₂CH₂CF₃ H CD₂CH₃
 803. CD₃ CD₂CCF₃(CH₃)₂ CD₃ CD₂CCF₃(CH₃)₂ H CD₂CH₃
 804. CD₃

CD₃

H CD₂CH₃
 805. CD₃

CD₃

H CD₂CH₃
 806. CD₃

CD₃

H CD₂CH₃
 807. CD₃

CD₃

H CD₂CH₃
 808. CD₃

CD₃

H CD₂CH₃
 809. CD₃

CD₃

H CD₂CH₃
 810. CD₃

CD₃

H CD₂CH₃
 811. CD₃

CD₃

H CD₂CH₃
 812. CD₃

CD₃

H CD₂CH₃
 813. CD₃

CD₃

H CD₂CH₃
 814. CD₃

CD₃

H CD₂CH₃
 815. CD₃

CD₃

H CD₂CH₃
 816. CD₃

CD₃

H CD₂CH₃
 817. CD₃

CD₃

H CD₂CH₃
 818. CD₃

CD₃

H CD₂CH₃
 819. CD₃

CD₃

H CD₂CH₃
 820. CD₃

CD₃

H CD₂CH₃
 821. CD₃

CD₃

H CD₂CH₃
 822. CD₃

CD₃

H CD₂CH₃
 823. CD₃

CD₃

H CD₂CH₃
 824. CH₂CH₃ CH₃ H H H CH(CH₃)₂
 825. CH₂CH₃ CH₂CH₃ H H H CH(CH₃)₂
 826. CH₂CH₃ CH(CH₃)₂ H H H CH(CH₃)₂
 827. CH₂CH₃ CH₂CH(CH₃)₂ H H H CH(CH₃)₂
 828. CH₂CH₃ C(CH₃)₃ H H H CH(CH₃)₂
 829. CH₂CH₃ CH₂C(CH₃)₃ H H H CH(CH₃)₂
 830. CH₂CH₃ CH₂CH₂CF₃ H H H CH(CH₃)₂
 831. CH₂CH₃ CH₂CCF₃(CH₃)₂ H H H CH(CH₃)₂
 832. CH₂CH₃

H H H CH(CH₃)₂
 833. CH₂CH₃

H H H CH(CH₃)₂
 834. CH₂CH₃

H H H CH(CH₃)₂
 835. CH₂CH₃

H H H CH(CH₃)₂
 836. CH₂CH₃

H H H CH(CH₃)₂
 837. CH₂CH₃

H H H CH(CH₃)₂
 838. CH₂CH₃

H H H CH(CH₃)₂
 839. CH₂CH₃

H H H CH(CH₃)₂
 840. CH₂CH₃

H H H CH(CH₃)₂
 841. CH₂CH₃

H H H CH(CH₃)₂
 842. CH₂CH₃

H H H CH(CH₃)₂
 843. CH₂CH₃

H H H CH(CH₃)₂
 844. CH₂CH₃

H H H CH(CH₃)₂
 845. CH₂CH₃

H H H CH(CH₃)₂
 846. CH₂CH₃

H H H CH(CH₃)₂
 847. CH₂CH₃

H H H CH(CH₃)₂
 848. CH₂CH₃

H H H CH(CH₃)₂
 849. CH₂CH₃

H H H CH(CH₃)₂
 850. CH₂CH₃

H H H CH(CH₃)₂
 851. CH₂CH₃

H H H CH(CH₃)₂
 852. CD₂CH₃ CD₃ H H CD₂CH₃ CD₂CH₃
 853. CD₂CH₃ CD₂CD₃ H H CD₂CH₃ CD₂CH₃
 854. CD₂CH₃ CD₂CH₃ H H CD₂CH₃ CD₂CH₃
 855. CD₂CH₃ CD(CD₃)₂ H H CD₂CH₃ CD₂CH₃
 856. CD₂CH₃ CD(CH₃)₂ H H CD₂CH₃ CD₂CH₃
 857. CD₂CH₃ CD₂CD(CD₃)₂ H H CD₂CH₃ CD₂CH₃
 858. CD₂CH₃ CD₂CH(CH₃)₂ H H CD₂CH₃ CD₂CH₃
 859. CD₂CH₃ CD₂C(CD₃)₃ H H CD₂CH₃ CD₂CH₃
 860. CD₂CH₃ CD₂C(CH₃)₃ H H CD₂CH₃ CD₂CH₃
 861. CD₂CH₃ CD₂CD₂CF₃ H H CD₂CH₃ CD₂CH₃
 862. CD₂CH₃ CD₂CH₂CF₃ H H CD₂CH₃ CD₂CH₃
 863. CD₂CH₃ CD₂CCF₃(CH₃)₂ H H CD₂CH₃ CD₂CH₃
 864. CD₂CH₃

H H CD₂CH₃ CD₂CH₃
 865. CD₂CH₃

H H CD₂CH₃ CD₂CH₃
 866. CD₂CH₃

H H CD₂CH₃ CD₂CH₃
 867. CD₂CH₃

H H CD₂CH₃ CD₂CH₃
 868. CD₂CH₃

H H CD₂CH₃ CD₂CH₃
 869. CD₂CH₃

H H CD₂CH₃ CD₂CH₃
 870. CD₂CH₃

H H CD₂CH₃ CD₂CH₃
 871. CD₂CH₃

H H CD₂CH₃ CD₂CH₃
 872. CD₂CH₃

H H CD₂CH₃ CD₂CH₃
 873. CD₂CH₃

H H CD₂CH₃ CD₂CH₃
 874. CD₂CH₃

H H CD₂CH₃ CD₂CH₃
 875. CD₂CH₃

H H CD₂CH₃ CD₂CH₃
 876. CD₂CH₃

H H CD₂CH₃ CD₂CH₃
 877. CD₂CH₃

H H CD₂CH₃ CD₂CH₃
 878. CD₂CH₃

H H CD₂CH₃ CD₂CH₃
 879. CD₂CH₃

H H CD₂CH₃ CD₂CH₃
 880. CD₂CH₃

H H CD₂CH₃ CD₂CH₃
 881. CD₂CH₃

H H CD₂CH₃ CD₂CH₃
 882. CD₂CH₃

H H CD₂CH₃ CD₂CH₃
 883. CD₂CH₃

H H CD₂CH₃ CD₂CH₃
 884. CD₂CD₃ CD₃ H H H CD(CH₃)₂
 885. CD₂CD₃ CD₂CD₃ H H H CD(CH₃)₂
 886. CD₂CD₃ CD₂CH₃ H H H CD(CH₃)₂
 887. CD₂CD₃ CD(CD₃)₂ H H H CD(CH₃)₂
 888. CD₂CD₃ CD(CH₃)₂ H H H CD(CH₃)₂
 889. CD₂CD₃ CD₂CD(CD₃)₂ H H H CD(CH₃)₂
 890. CD₂CD₃ CD₂CH(CH₃)₂ H H H CD(CH₃)₂
 891. CD₂CD₃ CD₂C(CD₃)₃ H H H CD(CH₃)₂
 892. CD₂CD₃ CD₂C(CH₃)₃ H H H CD(CH₃)₂
 893. CD₂CD₃ CD₂CD₂CF₃ H H H CD(CH₃)₂
 894. CD₂CD₃ CD₂CH₂CF₃ H H H CD(CH₃)₂
 895. CD₂CD₃ CD₂CCF₃(CH₃)₂ H H H CD(CH₃)₂
 896. CD₂CD₃

H H H CD(CH₃)₂
 897. CD₂CD₃

H H H CD(CH₃)₂
 898. CD₂CD₃

H H H CD(CH₃)₂
 899. CD₂CD₃

H H H CD(CH₃)₂
 900. CD₂CD₃

H H H CD(CH₃)₂
 901. CD₂CD₃

H H H CD(CH₃)₂
 902. CD₂CD₃

H H H CD(CH₃)₂
 903. CD₂CD₃

H H H CD(CH₃)₂
 904. CD₂CD₃

H H H CD(CH₃)₂
 905. CD₂CD₃

H H H CD(CH₃)₂
 906. CD₂CD₃

H H H CD(CH₃)₂
 907. CD₂CD₃

H H H CD(CH₃)₂
 908. CD₂CD₃

H H H CD(CH₃)₂
 909. CD₂CD₃

H H H CD(CH₃)₂
 910. CD₂CD₃

H H H CD(CH₃)₂
 911. CD₂CD₃

H H H CD(CH₃)₂
 912. CD₂CD₃

H H H CD(CH₃)₂
 913. CD₂CD₃

H H H CD(CH₃)₂
 914. CD₂CD₃

H H H CD(CH₃)₂
 915. CD₂CD₃

H H H CD(CH₃)₂
 916. CH₂CH₃ H CH₂CH₃ H CH₂CH₃ CH₂CH₃
 917. CH₂CH₃ H CH(CH₃)₂ H CH₂CH₃ CH₂CH₃
 918. CH₂CH₃ H CH₂CH(CH₃)₂ H CH₂CH₃ CH₂CH₃
 919. CH₂CH₃ H C(CH₃)₃ H CH₂CH₃ CH₂CH₃
 920. CH₂CH₃ H CH₂C(CH₃)₃ H CH₂CH₃ CH₂CH₃
 921. CH₂CH₃ H CH₂CH₂CF₃ H CH₂CH₃ CH₂CH₃
 922. CH₂CH₃ H CH₂CCF₃(CH₃)₂ H CH₂CH₃ CH₂CH₃
 923. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃
 924. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃
 925. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃
 926. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃
 927. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃
 928. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃
 929. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃
 930. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃
 931. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃
 932. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃
 933. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃
 934. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃
 935. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃
 936. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃
 937. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃
 938. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃
 939. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃
 940. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃
 941. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃
 942. CH₂CH₃ H

H CH₂CH₃ CH₂CH₃
 943. CD₂CH₃ H CD₃ H CD(CH₃)₂ CD(CH₃)₂
 944. CD₂CH₃ H CD₂CD₃ H CD(CH₃)₂ CD(CH₃)₂
 945. CD₂CH₃ H CD₂CH₃ H CD(CH₃)₂ CD(CH₃)₂
 946. CD₂CH₃ H CD(CD₃)₂ H CD(CH₃)₂ CD(CH₃)₂
 947. CD₂CH₃ H CD(CH₃)₂ H CD(CH₃)₂ CD(CH₃)₂
 948. CD₂CH₃ H CD₂CD(CD₃)₂ H CD(CH₃)₂ CD(CH₃)₂
 949. CD₂CH₃ H CD₂CH(CH₃)₂ H CD(CH₃)₂ CD(CH₃)₂
 950. CD₂CH₃ H CD₂C(CD₃)₃ H CD(CH₃)₂ CD(CH₃)₂
 951. CD₂CH₃ H CD₂C(CH₃)₃ H CD(CH₃)₂ CD(CH₃)₂
 952. CD₂CH₃ H CD₂CD₂CF₃ H CD(CH₃)₂ CD(CH₃)₂
 953. CD₂CH₃ H CD₂CH₂CF₃ H CD(CH₃)₂ CD(CH₃)₂
 954. CD₂CH₃ H CD₂CCF₃(CH₃)₂ H CD(CH₃)₂ CD(CH₃)₂
 955. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂
 956. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂
 957. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂
 958. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂
 959. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂
 960. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂
 961. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂
 962. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂
 963. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂
 964. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂
 965. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂
 966. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂
 967. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂
 968. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂
 969. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂
 970. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂
 971. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂
 972. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂
 973. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂
 974. CD₂CH₃ H

H CD(CH₃)₂ CD(CH₃)₂
 975. CD₂CD₃ CD₃ CD₃ H H CD₂CD(CD₃)₂
 976. CD₂CD₃ CD₃ CD₂CD₃ H H CD₂CD(CD₃)₂
 977. CD₂CD₃ CD₃ CD₂CH₃ H H CD₂CD(CD₃)₂
 978. CD₂CD₃ CD₃ CD(CD₃)₂ H H CD₂CD(CD₃)₂
 979. CD₂CD₃ CD₃ CD(CH₃)₂ H H CD₂CD(CD₃)₂
 980. CD₂CD₃ CD₃ CD₂CD(CD₃)₂ H H CD₂CD(CD₃)₂
 981. CD₂CD₃ CD₃ CD₂CH(CH₃)₂ H H CD₂CD(CD₃)₂
 982. CD₂CD₃ CD₃ CD₂C(CD₃)₃ H H CD₂CD(CD₃)₂
 983. CD₂CD₃ CD₃ CD₂C(CH₃)₃ H H CD₂CD(CD₃)₂
 984. CD₂CD₃ CD₃ CD₂CD₂CF₃ H H CD₂CD(CD₃)₂
 985. CD₂CD₃ CD₃ CD₂CH₂CF₃ H H CD₂CD(CD₃)₂
 986. CD₂CD₃ CD₃ CD₂CCF₃(CH₃)₂ H H CD₂CD(CD₃)₂
 987. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂
 988. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂
 989. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂
 990. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂
 991. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂
 992. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂
 993. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂
 994. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂
 995. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂
 996. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂
 997. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂
 998. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂
 999. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂
 1000. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂
 1001. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂
 1002. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂
 1003. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂
 1004. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂
 1005. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂
 1006. CD₂CD₃ CD₃

H H CD₂CD(CD₃)₂
 1007. CD₂CH₃ H H CD₃ CD₂CH₃ CD₂CH₃
 1008. CD₂CH₃ H H CD₂CD₃ CD₂CH₃ CD₂CH₃
 1009. CD₂CH₃ H H CD₂CH₃ CD₂CH₃ CD₂CH₃
 1010. CD₂CH₃ H H CD(CD₃)₂ CD₂CH₃ CD₂CH₃
 1011. CD₂CH₃ H H CD(CH₃)₂ CD₂CH₃ CD₂CH₃
 1012. CD₂CH₃ H H CD₂CD(CD₃)₂ CD₂CH₃ CD₂CH₃
 1013. CD₂CH₃ H H CD₂CH(CH₃)₂ CD₂CH₃ CD₂CH₃
 1014. CD₂CH₃ H H CD₂C(CD₃)₃ CD₂CH₃ CD₂CH₃
 1015. CD₂CH₃ H H CD₂C(CH₃)₃ CD₂CH₃ CD₂CH₃
 1016. CD₂CH₃ H H CD₂CD₂CF₃ CD₂CH₃ CD₂CH₃
 1017. CD₂CH₃ H H CD₂CH₂CF₃ CD₂CH₃ CD₂CH₃
 1018. CD₂CH₃ H H CD₂CCF₃(CH₃)₂ CD₂CH₃ CD₂CH₃
 1019. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃
 1020. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃
 1021. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃
 1022. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃
 1023. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃
 1024. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃
 1025. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃
 1026. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃
 1027. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃
 1028. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃
 1029. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃
 1030. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃
 1031. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃
 1032. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃
 1033. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃
 1034. CD₂CH₃ H H

CD₂CH₃ CD₂CH₃
 1035. CD₂CH₃ CD₃ H CD₃ CD(CH₃)₂ CD(CH₃)₂
 1036. CD₂CH₃ CD₃ H CD₂CD₃ CD(CH₃)₂ CD(CH₃)₂
 1037. CD₂CH₃ CD₃ H CD₂CH₃ CD(CH₃)₂ CD(CH₃)₂
 1038. CD₂CH₃ CD₃ H CD₂(CD₃) CD(CH₃)₂ CD(CH₃)₂
 1039. CD₂CH₃ CD₃ H CD(CH₃)₂ CD(CH₃)₂ CD(CH₃)₂
 1040. CD₂CH₃ CD₃ H CD₂CD(CD₃)₂ CD(CH₃)₂ CD(CH₃)₂
 1041. CD₂CH₃ CD₃ H CD₂CH(CH₃)₂ CD(CH₃)₂ CD(CH₃)₂
 1042. CD₂CH₃ CD₃ H CD₂C(CD₃)₃ CD(CH₃)₂ CD(CH₃)₂
 1043. CD₂CH₃ CD₃ H CD₂C(CH₃)₃ CD(CH₃)₂ CD(CH₃)₂
 1044. CD₂CH₃ CD₃ H CD₂CD₂CF₃ CD(CH₃)₂ CD(CH₃)₂
 1045. CD₂CH₃ CD₃ H CD₂CH₂CF₃ CD(CH₃)₂ CD(CH₃)₂
 1046. CD₂CH₃ CD₃ H CD₂CCF₃(CH₃)₂ CD(CH₃)₂ CD(CH₃)₂
 1047. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂
 1048. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂
 1049. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂
 1050. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂
 1051. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂
 1052. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂
 1053. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂
 1054. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂
 1055. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂
 1056. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂
 1057. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂
 1058. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂
 1059. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂
 1060. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂
 1061. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂
 1062. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂
 1063. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂
 1064. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂
 1065. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂
 1066. CD₂CH₃ CD₃ H

CD(CH₃)₂ CD(CH₃)₂
 1067. CD(CH₃)₂ CD₃ H H H


1068. CD(CH₃)₂ CD₂CD₃ H H H


1069. CD(CH₃)₂ CD₂CH₃ H H H


1070. CD(CH₃)₂ CD(CD₃)₂ H H H


1071. CD(CH₃)₂ CD(CH₃)₂ H H H


1072. CD(CH₃)₂ CD₂CD(CD₃)₂ H H H


1073. CD(CH₃)₂ CD₂CH(CH₃)₂ H H H


1074. CD(CH₃)₂ CD₂C(CD₃)₃ H H H


1075. CD(CH₃)₂ CD₂C(CH₃)₃ H H H


1076. CD(CH₃)₂ CD₂CD₂CF₃ H H H


1077. CD(CH₃)₂ CD₂CH₂CF₃ H H H


1078. CD(CH₃)₂ CD₂CCF₃(CH₃)₂ H H H


1079. CD(CH₃)₂

H H H


1080. CD(CH₃)₂

H H H


1081. CD(CH₃)₂

H H H


1082. CD(CH₃)₂

H H H


1083. CD(CH₃)₂

H H H


1084. CD(CH₃)₂

H H H


1085. CD(CH₃)₂

H H H


1086. CD(CH₃)₂

H H H


1087. CD(CH₃)₂

H H H


1088. CD(CH₃)₂

H H H


1089. CD(CH₃)₂

H H H


1090. CD(CH₃)₂

H H H


1091. CD(CH₃)₂

H H H


1092. CD(CH₃)₂

H H H


1093. CD(CH₃)₂

H H H


1094. CD(CH₃)₂

H H H


1095. CD(CH₃)₂

H H H


1096. CD(CH₃)₂

H H H


1097. CD(CH₃)₂

H H H


1098. CD(CH₃)₂

H H H


1099. CD(CD₃)₂ CD₃ H H H


1100. CD(CD₃)₂ CD₂CD₃ H H H


1101. CD(CD₃)₂ CD₂CH₃ H H H


1102. CD(CD₃)₂ CD(CD₃)₂ H H H


1103. CD(CD₃)₂ CD(CH₃)₂ H H H


1104. CD(CD₃)₂ CD₂CD(CD₃)₂ H H H


1105. CD(CD₃)₂ CD₂CH(CH₃)₂ H H H


1106. CD(CD₃)₂ CD₂C(CD₃)₃ H H H


1107. CD(CD₃)₂ CD₂C(CH₃)₃ H H H


1108. CD(CD₃)₂ CD₂CD₂CF₃ H H H


1109. CD(CD₃)₂ CD₂CH₂CF₃ H H H


1110. CD(CD₃)₂ CD₂CCF₃(CH₃)₂ H H H


1111. CD(CD₃)₂

H H H


1112. CD(CD₃)₂

H H H


1113. CD(CD₃)₂

H H H


1114. CD(CD₃)₂

H H H


1115. CD(CD₃)₂

H H H


1116. CD(CD₃)₂

H H H


1117. CD(CD₃)₂

H H H


1118. CD(CD₃)₂

H H H


1119. CD(CD₃)₂

H H H


1120. CD(CD₃)₂

H H H


1121. CD(CD₃)₂

H H H


1122. CD(CD₃)₂

H H H


1123. CD(CD₃)₂

H H H


1124. CD(CD₃)₂

H H H


1125. CD(CD₃)₂

H H H


1126. CD(CD₃)₂

H H H


1127. CD(CD₃)₂

H H H


1128. CD(CD₃)₂

H H H


1129. CD(CD₃)₂

H H H


1130. CD(CD₃)₂

H H H


1131. CH(CH₃)₂ H CH₂CH₃ H H


1132. CH(CH₃)₂ H CH(CH₃)₂ H H


1133. CH(CH₃)₂ H CH₂CH(CH₃)₂ H H


1134. CH(CH₃)₂ H C(CH₃)₃ H H


1135. CH(CH₃)₂ H CH₂C(CH₃)₃ H H


1136. CH(CH₃)₂ H CH₂CH₂CF₃ H H


1137. CH(CH₃)₂ H CH₂CCF₃(CH₃)₂ H H


1138. CH(CH₃)₂ H

H H


1139. CH(CH₃)₂ H

H H


1140. CH(CH₃)₂ H

H H


1141. CH(CH₃)₂ H

H H


1142. CH(CH₃)₂ H

H H


1143. CH(CH₃)₂ H

H H


1144. CH(CH₃)₂ H

H H


1145. CH(CH₃)₂ H

H H


1146. CH(CH₃)₂ H

H H


1147. CH(CH₃)₂ H

H H


1148. CH(CH₃)₂ H

H H


1149. CH(CH₃)₂ H

H H


1150. CH(CH₃)₂ H

H H


1151. CH(CH₃)₂ H

H H


1152. CH(CH₃)₂ H

H H


1153. CH(CH₃)₂ H

H H


1154. CH(CH₃)₂ H

H H


1155. CH(CH₃)₂ H

H H


1156. CH(CH₃)₂ H

H H


1157. CH(CH₃)₂ H

H H


1158. CD(CH₃)₂ H CD₃ H

CD₃
 1159. CD(CH₃)₂ H CD₂CD₃ H

CD₃
 1160. CD(CH₃)₂ H CD₂CH₃ H

CD₃
 1161. CD(CH₃)₂ H CD(CD₃)₂ H

CD₃
 1162. CD(CH₃)₂ H CD(CH₃)₂ H

CD₃
 1163. CD(CH₃)₂ H CD₂CD(CD₃)₂ H

CD₃
 1164. CD(CH₃)₂ H CD₂CH(CH₃)₂ H

CD₃
 1165. CD(CH₃)₂ H CD₂C(CD₃)₃ H

CD₃
 1166. CD(CH₃)₂ H CD₂C(CH₃)₃ H

CD₃
 1167. CD(CH₃)₂ H CD₂CD₂CF₃ H

CD₃
 1168. CD(CH₃)₂ H CD₂CH₂CF₃ H

CD₃
 1169. CD(CH₃)₂ H CD₂CCF₃(CH₃)₂ H

CD₃
 1170. CD(CH₃)₂ H

H

CD₃
 1171. CD(CH₃)₂ H

H

CD₃
 1172. CD(CH₃)₂ H

H

CD₃
 1173. CD(CH₃)₂ H

H

CD₃
 1174. CD(CH₃)₂ H

H

CD₃
 1175. CD(CH₃)₂ H

H

CD₃
 1176. CD(CH₃)₂ H

H

CD₃
 1177. CD(CH₃)₂ H

H

CD₃
 1178. CD(CH₃)₂ H

H

CD₃
 1179. CD(CH₃)₂ H

H

CD₃
 1180. CD(CH₃)₂ H

H

CD₃
 1181. CD(CH₃)₂ H

H

CD₃
 1182. CD(CH₃)₂ H

H

CD₃
 1183. CD(CH₃)₂ H

H

CD₃
 1184. CD(CH₃)₂ H

H

CD₃
 1185. CD(CH₃)₂ H

H

CD₃
 1186. CD(CH₃)₂ H

H

CD₃
 1187. CD(CH₃)₂ H

H

CD₃
 1188. CD(CH₃)₂ H

H

CD₃
 1189. CD(CH₃)₂ H

H

CD₃
 1190. CD(CD₃)₂ H CD₃ H CD(CD₃)₂ CD(CD₃)₂
 1191. CD(CD₃)₂ H CD₂CD₃ H CD(CD₃)₂ CD(CD₃)₂
 1192. CD(CD₃)₂ H CD₂CH₃ H CD(CD₃)₂ CD(CD₃)₂
 1193. CD(CD₃)₂ H CD(CD₃)₂ H CD(CD₃)₂ CD(CD₃)₂
 1194. CD(CD₃)₂ H CD(CH₃)₂ H CD(CD₃)₂ CD(CD₃)₂
 1195. CD(CD₃)₂ H CD₂CD(CD₃)₂ H CD(CD₃)₂ CD(CD₃)₂
 1196. CD(CD₃)₂ H CD₂CH(CH₃)₂ H CD(CD₃)₂ CD(CD₃)₂
 1197. CD(CD₃)₂ H CD₂C(CD₃)₃ H CD(CD₃)₂ CD(CD₃)₂
 1198. CD(CD₃)₂ H CD₂C(CH₃)₃ H CD(CD₃)₂ CD(CD₃)₂
 1199. CD(CD₃)₂ H CD₂CD₂CF₃ H CD(CD₃)₂ CD(CD₃)₂
 1200. CD(CD₃)₂ H CD₂CH₂CF₃ H CD(CD₃)₂ CD(CD₃)₂
 1201. CD(CD₃)₂ H CD₂CCF₃(CH₃)₂ H CD(CD₃)₂ CD(CD₃)₂
 1202. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂
 1203. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂
 1204. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂
 1205. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂
 1206. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂
 1207. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂
 1208. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂
 1209. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂
 1210. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂
 1211. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂
 1212. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂
 1213. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂
 1214. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂
 1215. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂
 1216. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂
 1217. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂
 1218. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂
 1219. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂
 1220. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂
 1221. CD(CD₃)₂ H

H CD(CD₃)₂ CD(CD₃)₂
 1222. CH(CH₃)₂ H H CH₃ H CH₃
 1223. CH(CH₃)₂ H H CH₂CH₃ H CH₃
 1224. CH(CH₃)₂ H H CH(CH₃)₂ H CH₃
 1225. CH(CH₃)₂ H H CH₂CH(CH₃)₂ H CH₃
 1226. CH(CH₃)₂ H H C(CH₃)₃ H CH₃
 1227. CH(CH₃)₂ H H CH₂C(CH₃)₃ H CH₃
 1228. CH(CH₃)₂ H H CH₂CH₂CF₃ H CH₃
 1229. CH(CH₃)₂ H H CH₂CCF₃(CH₃)₂ H CH₃
 1230. CH(CH₃)₂ H H

H CH₃
 1231. CH(CH₃)₂ H H

H CH₃
 1232. CH(CH₃)₂ H H

H CH₃
 1233. CH(CH₃)₂ H H

H CH₃
 1234. CH(CH₃)₂ H H

H CH₃
 1235. CH(CH₃)₂ H H

H CH₃
 1236. CH(CH₃)₂ H H

H CH₃
 1237. CH(CH₃)₂ H H

H CH₃
 1238. CH(CH₃)₂ H H

H CH₃
 1239. CH(CH₃)₂ H H

H CH₃
 1240. CH(CH₃)₂ H H

H CH₃
 1241. CH(CH₃)₂ H H

H CH₃
 1242. CH(CH₃)₂ H H

H CH₃
 1243. CH(CH₃)₂ H H

H CH₃
 1244. CH(CH₃)₂ H H

H CH₃
 1245. CH(CH₃)₂ H H

H CH₃
 1246. CH(CH₃)₂ H H

H CH₃
 1247. CH(CH₃)₂ H H

H CH₃
 1248. CH(CH₃)₂ H H

H CH₃
 1249. CH(CH₃)₂ H H

H CH₃
 1250. CH(CH₃)₂ CH₃ CH₃ H CH₃ CH₃
 1251. CH(CH₃)₂ CH₂CH₃ CH₃ H CH₃ CH₃
 1252. CH(CH₃)₂ CH(CH₃)₂ CH₃ H CH₃ CH₃
 1253. CH(CH₃)₂ CH₂CH(CH₃)₂ CH₃ H CH₃ CH₃
 1254. CH(CH₃)₂ C(CH₃)₃ CH₃ H CH₃ CH₃
 1255. CH(CH₃)₂ CH₂C(CH₃)₃ CH₃ H CH₃ CH₃
 1256. CH(CH₃)₂ CH₂CH₂CF₃ CH₃ H CH₃ CH₃
 1257. CH(CH₃)₂ CH₂CCF₃(CH₃)₂ CH₃ H CH₃ CH₃
 1258. CH(CH₃)₂

CH₃ H CH₃ CH₃
 1259. CH(CH₃)₂

CH₃ H CH₃ CH₃
 1260. CH(CH₃)₂

CH₃ H CH₃ CH₃
 1261. CH(CH₃)₂

CH₃ H CH₃ CH₃
 1262. CH(CH₃)₂

CH₃ H CH₃ CH₃
 1263. CH(CH₃)₂

CH₃ H CH₃ CH₃
 1264. CH(CH₃)₂

CH₃ H CH₃ CH₃
 1265. CH(CH₃)₂

CH₃ H CH₃ CH₃
 1266. CH(CH₃)₂

CH₃ H CH₃ CH₃
 1267. CH(CH₃)₂

CH₃ H CH₃ CH₃
 1268. CH(CH₃)₂

CH₃ H CH₃ CH₃
 1269. CH(CH₃)₂

CH₃ H CH₃ CH₃
 1270. CH(CH₃)₂

CH₃ H CH₃ CH₃
 1271. CH(CH₃)₂

CH₃ H CH₃ CH₃
 1272. CH(CH₃)₂

CH₃ H CH₃ CH₃
 1273. CH(CH₃)₂

CH₃ H CH₃ CH₃
 1274. CH(CH₃)₂

CH₃ H CH₃ CH₃
 1275. CH(CH₃)₂

CH₃ H CH₃ CH₃
 1276. CH(CH₃)₂

CH₃ H CH₃ CH₃
 1277. CH(CH₃)₂

CH₃ H CH₃ CH₃
 1278. CD(CH₃)₂ CD₃ CD₃ H CH₃ CH₃
 1279. CD(CH₃)₂ CD₂CD₃ CD₃ H CH₃ CH₃
 1280. CD(CH₃)₂ CD₂CH₃ CD₃ H CH₃ CH₃
 1281. CD(CH₃)₂ CD(CD₃)₂ CD₃ H CH₃ CH₃
 1282. CD(CH₃)₂ CD(CH₃)₂ CD₃ H CH₃ CH₃
 1283. CD(CH₃)₂ CD₂CD(CD₃)₂ CD₃ H CH₃ CH₃
 1284. CD(CH₃)₂ CD₂CH(CH₃)₂ CD₃ H CH₃ CH₃
 1285. CD(CH₃)₂ CD₂C(CD₃)₃ CD₃ H CH₃ CH₃
 1286. CD(CH₃)₂ CD₂C(CH₃)₃ CD₃ H CH₃ CH₃
 1287. CD(CH₃)₂ CD₂CD₂CF₃ CD₃ H CH₃ CH₃
 1288. CD(CH₃)₂ CD₂CH₂CF₃ CD₃ H CH₃ CH₃
 1289. CD(CH₃)₂ CD₂CCF₃(CH₃)₂ CD₃ H CH₃ CH₃
 1290. CD(CH₃)₂

CD₃ H CH₃ CH₃
 1291. CD(CH₃)₂

CD₃ H CH₃ CH₃
 1292. CD(CH₃)₂

CD₃ H CH₃ CH₃
 1293. CD(CH₃)₂

CD₃ H CH₃ CH₃
 1294. CD(CH₃)₂

CD₃ H CH₃ CH₃
 1295. CD(CH₃)₂

CD₃ H CH₃ CH₃
 1296. CD(CH₃)₂

CD₃ H CH₃ CH₃
 1297. CD(CH₃)₂

CD₃ H CH₃ CH₃
 1298. CD(CH₃)₂

CD₃ H CH₃ CH₃
 1299. CD(CH₃)₂

CD₃ H CH₃ CH₃
 1300. CD(CH₃)₂

CD₃ H CH₃ CH₃
 1301. CD(CH₃)₂

CD₃ H CH₃ CH₃
 1302. CD(CH₃)₂

CD₃ H CH₃ CH₃
 1303. CD(CH₃)₂

CD₃ H CH₃ CH₃
 1304. CD(CH₃)₂

CD₃ H CH₃ CH₃
 1305. CD(CH₃)₂

CD₃ H CH₃ CH₃
 1306. CD(CH₃)₂

CD₃ H CH₃ CH₃
 1307. CD(CH₃)₂

CD₃ H CH₃ CH₃
 1308. CD(CH₃)₂

CD₃ H CH₃ CH₃
 1309. CD(CH₃)₂

CD₃ H CH₃ CH₃
 1310. CD(CD₃)₂ CD₂CD₃ CD₃ H CD₂CD₃ CD₂CD₃
 1311. CD(CD₃)₂ CD₂CH₃ CD₃ H CD₂CD₃ CD₂CD₃
 1312. CD(CD₃)₂ CD(CD₃)₂ CD₃ H CD₂CD₃ CD₂CD₃
 1313. CD(CD₃)₂ CD(CH₃)₂ CD₃ H CD₂CD₃ CD₂CD₃
 1314. CD(CD₃)₂ CD₂CD(CD₃)₂ CD₃ H CD₂CD₃ CD₂CD₃
 1315. CD(CD₃)₂ CD₂CH(CH₃)₂ CD₃ H CD₂CD₃ CD₂CD₃
 1316. CD(CD₃)₂ CD₂C(CD₃)₃ CD₃ H CD₂CD₃ CD₂CD₃
 1317. CD(CD₃)₂ CD₂C(CH₃)₃ CD₃ H CD₂CD₃ CD₂CD₃
 1318. CD(CD₃)₂ CD₂CD₂CF₃ CD₃ H CD₂CD₃ CD₂CD₃
 1319. CD(CD₃)₂ CD₂CH₂CF₃ CD₃ H CD₂CD₃ CD₂CD₃
 1320. CD(CD₃)₂ CD₂CCF₃(CH₃)₂ CD₃ H CD₂CD₃ CD₂CD₃
 1321. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃
 1322. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃
 1323. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃
 1324. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃
 1325. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃
 1326. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃
 1327. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃
 1328. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃
 1329. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃
 1330. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃
 1331. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃
 1332. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃
 1333. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃
 1334. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃
 1335. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃
 1336. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃
 1337. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃
 1338. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃
 1339. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃
 1340. CD(CD₃)₂

CD₃ H CD₂CD₃ CD₂CD₃
 1341. CH(CH₃)₂ CH₃ CH₂CH₃ H CD₂CD₃ CD₂CD₃
 1342. CH(CH₃)₂ CH₃ CH(CH₃)₂ H CD₂CD₃ CD₂CD₃
 1343. CH(CH₃)₂ CH₃ CH₂CH(CH₃)₂ H CD₂CD₃ CD₂CD₃
 1344. CH(CH₃)₂ CH₃ C(CH₃)₃ H CD₂CD₃ CD₂CD₃
 1345. CH(CH₃)₂ CH₃ CH₂C(CH₃)₃ H CD₂CD₃ CD₂CD₃
 1346. CH(CH₃)₂ CH₃ CH₂CH₂CF₃ H CD₂CD₃ CD₂CD₃
 1347. CH(CH₃)₂ CH₃ CH₂CCF₃(CH₃)₂ H CD₂CD₃ CD₂CD₃
 1348. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃
 1349. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃
 1350. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃
 1351. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃
 1352. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃
 1353. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃
 1354. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃
 1355. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃
 1356. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃
 1357. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃
 1358. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃
 1359. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃
 1360. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃
 1361. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃
 1362. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃
 1363. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃
 1364. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃
 1365. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃
 1366. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃
 1367. CH(CH₃)₂ CH₃

H CD₂CD₃ CD₂CD₃
 1368. CD(CH₃)₂ CD₃ CD₂CD₃ H CD₂CD₃ CD₂CD₃
 1369. CD(CH₃)₂ CD₃ CD₂CH₃ H CD₂CD₃ CD₂CD₃
 1370. CD(CH₃)₂ CD₃ CD(CD₃)₂ H CD₂CD₃ CD₂CD₃
 1371. CD(CH₃)₂ CD₃ CD(CH₃)₂ H CD₂CD₃ CD₂CD₃
 1372. CD(CH₃)₂ CD₃ CD₂CD(CD₃)₂ H CD₂CD₃ CD₂CD₃
 1373. CD(CH₃)₂ CD₃ CD₂CH(CH₃)₂ H CD₂CD₃ CD₂CD₃
 1374. CD(CH₃)₂ CD₃ CD₂C(CD₃)₃ H CD₂CD₃ CD₂CD₃
 1375. CD(CH₃)₂ CD₃ CD₂C(CH₃)₃ H CD₂CD₃ CD₂CD₃
 1376. CD(CH₃)₂ CD₃ CD₂CD₂CF₃ H CD₂CD₃ CD₂CD₃
 1377. CD(CH₃)₂ CD₃ CD₂CH₂CF₃ H CD₂CD₃ CD₂CD₃
 1378. CD(CH₃)₂ CD₃ CD₂CCF₃(CH₃)₂ H CD₂CD₃ CD₂CD₃
 1379. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃
 1380. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃
 1381. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃
 1382. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃
 1383. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃
 1384. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃
 1385. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃
 1386. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃
 1387. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃
 1388. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃
 1389. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃
 1390. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃
 1391. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃
 1392. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃
 1393. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃
 1394. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃
 1395. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃
 1396. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃
 1397. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃
 1398. CD(CH₃)₂ CD₃

H CD₂CD₃ CD₂CD₃
 1399.

CD₃ H H H CD₃
 1400.

CD₃ CD₃ H H CD₃
 1401.

CD₃ H CD₃ H CD₃
 1402.

CD₃ CD₃ CD₃ H CD₃
 1403.

CD₃ H H H CD₃
 1404.

CD₃ CD₃ H H CD₃
 1405.

CD₃ H CD₃ H CD₃
 1406.

CD₃ CD₃ CD₃ H CD₃
 1407.

CD₃ H H H CD₃
 1408.

CD₃ CD₃ H H CD₃
 1409.

CD₃ H CD₃ H CD₃
 1410.

CD₃ CD₃ CD₃ H CD₃
 1411.

CD₃ H H H CD₃
 1412.

CD₃ CD₃ H H CD₃
 1413.

CD₃ H CD₃ H CD₃
 1414.

CD₃ CD₃ CD₃ H CD₃
 1415.

CD₃ H H H CD₃
 1416.

CD₃ CD₃ H H CD₃
 1417.

CD₃ H CD₃ H CD₃
 1418.

CD₃ CD₃ CD₃ H CD₃
 1419.

CD₃ H H H CD₃
 1420.

CD₃ CD₃ H H CD₃
 1421.

CD₃ H CD₃ H CD₃
 1422.

CD₃ CD₃ CD₃ H CD₃
 1423.

CD₃ H H H CD₃
 1424.

CD₃ CD₃ H H CD₃
 1425.

CD₃ H CD₃ H CD₃
 1426.

CD₃ CD₃ CD₃ H CD₃
 1427.

CD₃ H H H CD₃
 1428.

CD₃ CD₃ H H CD₃
 1429.

CD₃ H CD₃ H H
 1430.

CD₃ CD₃ CD₃ H H
 1431. CD₃ H H

H H
 1432. CD₃ CD₃ CD₃ H H H.


9. The compound of claim 8, wherein the compound is selected from the group consisting of compound A-1 to compound A-429,600, compound B-1 to compound B-429,600, compound C-1 to compound C-429,600, and compound D-1 to compound D-429,600; wherein Compound k-x has the formula Ir(L_(ki))(L_(Bj))₂; wherein x =300i+j-300; k is A, B, C, or D; i is an integer from 1 to 1432, and j is an integer from 1 to 300; wherein L_(B1) to L_(B300) have the following structure:


10. The compound of claim 1, wherein the compound has a formula of ML_(n)(L_(B))_(m-n); wherein M is Ir or Pt; wherein L_(B) is a bidentate ligand; wherein L and L_(B) are different; wherein, when M is Ir, m is 3, and n is 1 or 2; and wherein, when M is Pt, m is 2, and n is
 1. 11. The compound of claim 10, wherein, wherein L_(B) is selected from the group consisting of:

wherein each X¹ to X¹³ are independently selected from the group consisting of carbon and nitrogen; wherein X is selected from the group consisting of BR′, NR′, PR′, O, S, Se, C═O, S═O, SO₂, CR′R″, SiR′R″, and GeR′R″; wherein R′ and R″ are optionally fused or joined to form a ring; wherein each R_(a), R_(b), R_(c), and R_(d) may represent from mono substitution to the possible maximum number of substitution, or no substitution; wherein R′, R″, R_(a), R_(b), R_(c), and R_(d) are each independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein any two adjacent substituents of R_(a), R_(b), R_(c), and R_(d) are optionally fused or joined to form a ring or form a multidentate ligand.
 12. The compound of claim 10, wherein, wherein L_(B) is selected from the group consisting of L_(B1) to L_(B300) as shown below:


13. The compound of claim 1, wherein the compound is incorporated into a chemical formula.
 14. An organic light emitting device (OLED) comprising: an anode; a cathode; and an organic layer, disposed between the anode and the cathode, comprising a compound comprising a ligand L having the formula:

wherein R¹ and R⁶ represents mono, di, tri, or tetra substitution, or no substitution; wherein R² represents mono, di, or tri substitution, or no substitution; wherein each R¹, R⁶, R⁷, and R⁸ is independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein R³, R⁴, and R⁵ are independently selected from the group consisting of hydrogen, deuterium, alkyl, partially or fully fluorinated alkyl, cycloalkyl, partially or fully fluorinated cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein each R² is independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein any adjacent substituents of R¹, R³, R⁴, R⁵, R⁶, R⁷, and R⁸ are optionally joined or fused into a ring; wherein at least one of R³, R⁴, and R⁵ is not hydrogen or deuterium; wherein a is an integer from 0 to 10; wherein the compound is heteroleptic; wherein (i) when a is 0, at least one of R⁷, R⁸, and an R² adjacent to ring B, is not hydrogen or deuterium, and (ii) when a is 1 to 10, at least one of an R² adjacent to ring A and an R⁶ adjacent to ring C is not hydrogen; wherein the ligand L is coordinated to a metal M having an atomic weight greater than 40; and wherein the ligand L is optionally linked with other ligands to comprise a tridentate, tetradentate, pentadentate or hexadentate ligand.
 15. The OLED of claim 14, wherein the organic layer is an emissive layer and the compound is an emissive dopant or a non-emissive dopant.
 16. The OLED of claim 14, wherein the organic layer further comprises a host, wherein host comprises at least one chemical group selected from the group consisting of triphenylene, carbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, azatriphenylene, azacarbazole, aza-dibenzothiophene, aza-dibenzofuran, and aza-dibenzoselenophene.
 17. The OLED of claim 14, wherein the organic layer further comprises a host, wherein the host is selected from the group consisting of:

and combinations thereof.
 18. A consumer product comprising an organic light-emitting device comprising: an anode; a cathode; and an organic layer, disposed between the anode and the cathode, comprising a compound comprising a ligand L having the formula:

wherein R¹ and R⁶ represents mono, di, tri, or tetra substitution, or no substitution; wherein R² represents mono, di, or tri substitution, or no substitution; wherein each R¹, R⁶, R²⁷, and R⁸ is independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein R³, R⁴, and R⁵ are independently selected from the group consisting of hydrogen, deuterium, alkyl, partially or fully fluorinated alkyl, cycloalkyl, partially or fully fluorinated cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein each R² is independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein any adjacent substituents of R¹, R³, R⁴, R⁵, R⁶, R⁷, and R⁸ are optionally joined or fused into a ring; wherein at least one of R³, R⁴, and R⁵ is not hydrogen or deuterium; wherein a is an integer from 0 to 10; wherein the compound is heteroleptic; wherein (i) when a is 0, at least one of R⁷, R⁸, and an R² adjacent to ring B, is not hydrogen or deuterium, and (ii) when a is 1 to 10, at least one of an R² adjacent to ring A and an R⁶ adjacent to ring C is not hydrogen; wherein the ligand L is coordinated to a metal M having an atomic weight greater than 40; and wherein the ligand L is optionally linked with other ligands to comprise a tridentate, tetradentate, pentadentate or hexadentate ligand.
 19. The consumer product in claim 18, wherein the consumer product is selected from the group consisting of flat panel displays, computer monitors, medical monitors, televisions, billboards, lights for interior or exterior illumination and/or signaling, heads-up displays, fully or partially transparent displays, flexible displays, laser printers, telephones, cell phones, tablets, phablets, personal digital assistants (PDAs), wearable device, laptop computers, digital cameras, camcorders, viewfinders, micro-displays, 3-D displays, virtual reality or augmented reality displays, vehicles, a large area wall, theater or stadium screen, and a sign. 